Post on 07-May-2015
description
transcript
By
Subin. V.R.
Dissertation Submitted to the Rajiv Gandhi University Of Health Sciences,Karnataka, Bangalore.
In partial fulfillment of the requirements for the degree of
AYURVEDA VACHASPATHI M.D. (PANCHAKARMA)
In
PANCHAKARMA
Under the guidance of
Dr. G. Purushothamacharyulu,M.D. (Ayu)
And co-guidance of
Dr. Shashidhar.H. Doddamani,M.D. (Ayu)
Post graduate department of Panchakarma, Shri D. G. Melmalagi Ayurvedic Medical College,
Gadag – 582103.
2005.
Evaluation of Efficacy of Shashtikashalipinda
swedakarma in the managament of
Sandhigatavata (Osteoarthritis)
Rajiv Gandhi University Of Health Sciences, Karnataka, Bangalore.
DECLARATION BY THE CANDIDATE
hereby declare that this dissertation / thesis entitled “Evaluation
of the Efficacy of Shashtikashalipindaswedakarma in the management
of Sandhigatavata (Osteoarthritis)” is a bonafide and genuine research work
carried out by me under the guidance of Dr. G. Purushothamacharyulu, M.D.
(Ayu), Professor and H.O.D, Post-graduate department of Panchakarma and co-
guidance of Dr. Shashidhar. H. Doddamani, M.D.(Ayu), Assistant Professor,
Post graduate department of Panchakarma.
Date:Place: Subin. V.R.
I
CERTIFICATE BY THE GUIDE
This is to certify that the dissertation entitled “Evaluation of
the Efficacy of Shashtikashalipindaswedakarma in the management of
Sandhigatavata (Osteoarthritis)” is a bonafide research work done by Subin.
V.R. in partial fulfillment of the requirement for the degree of Ayurveda
Vachaspathi. M.D. (Panchakarma).
Date:
Place: Dr. G. Purushothamacharyulu, M.D. (Ayu).
Professor & H.O.D
Post graduate department of Panchakarma.
ENDORSEMENT BY THE H.O.D AND PRINCIPAL OF
THE INSTITUTION
This is to certify that the dissertation entitled “Evaluation of
the Efficacy of Shashtikashalipindaswedakarma in the management of
Sandhigatavata (Osteoarthritis)” is a bonafide research work done by Subin.
V.R. under the guidance of Dr.G. Purushothamacharyulu, M.D. (Ayu), Profes-
sor and H.O.D, Postgraduate department of Panchakarma and co-guidance of
Dr. Shashidhar.H. Doddamani, M.D. (Ayu), Assistant Professor, Post graduate
department of Panchakarma.
Dr. G. Purushothamacharyulu, M.D. (Ayu) Dr. G. B. Patil.
Professor & H.O.D, Principal.
Post graduate department of Panchakarma.
CERTIFICATE BY THE CO- GUIDE
This is to certify that the dissertation entitled “Evaluation of
the Efficacy of Shashtikashalipindaswedakarma in the management of
Sandhigatavata (Osteoarthritis)” is a bonafide research work done by Subin.
V.R. in partial fulfillment of the requirement for the degree of Ayurveda
Vachaspathi. M.D. (Panchakarma).
Date: Dr. Shashidhar.H. Doddamani, M.D. (Ayu).
Place: Assistant Professor,
Post graduate Department of Panchakarma.
COPYRIGHT
Declaration by the candidate
I hereby declare that the Rajiv Gandhi University of Health
Sciences, Karnataka shall have the rights to preserve, use and dissemi-
nate this dissertation / thesis in print or electronic format for academic /
research purpose.
Date: Subin V.R.
Place:
© Rajiv Gandhi University of Health Sciences, Karnataka.
I
Acknowledgement “Many hands make light work”. I take this opportunity to mention my deep gratitude to several personalities who have helped me in the successful completion of this work.
I express my obligation to my honorable Guide Dr. G. Purushothamacharyulu M.D. (Ayu), H.O.D., P.G. Department of Panchakarma, P.G.S&R, D.G.M.A.M.C, Gadag for his critical suggestions and expert guidance for the completion of this work.
I am extremely grateful and obliged to my co-guide Dr. Shashidhar.H. Doddamani, Asst. Professor, P.G.S.&R, D.G.M.A.M.C, Gadag for his guidance and encouragement at every step of this work.
I express my deep gratitude to Dr .G.B Patil, Principal, D.G.M.A.M.C, Gadag, for his encouragement as well as providing all necessary facilities for this research work.
I express my sincere gratitude to Dr. P. Shivaramudu M.D (Ayu), Assistant Professor and Dr. Santhosh. N.Belavadi MD (Ayu), Lecturer for their sincere advices and assistance.
I express my sincere gratitude to Dr. V. Varadacharyulu M.D (Ayu), Dr.M.C.Patil M.D (Ayu), Dr. Mulgund M.D (Ayu), Dr. K. S. R. Prasad M.D (Ayu), Dr. Dilip Kumar M.D (Ayu), Dr. R.V. Shetter M.D (Ayu), Dr. Kuber Sankh M.D (Ayu), Dr.G.Danappa Gowda M.D (Ayu) and other PG staff for their constant encouragement.
I also express my sincere gratitude to Dr.B.G.Swamy, Dr.V.M.Sajjan, Dr.U.V.Purad, Dr.Mallagowder, Dr.K.S.Paraddi, Dr.G.Yargeri, Dr.S.H.Radder and other undergraduate teachers for their support in the clinical work. I thank to Shri. Nandakumar (Statistician), Dr. Arun Baburao Biradar, Shri. V.M. Mundinamani (Librarian), Shri. B.S. Tippanagoudar (lab technician), Shri. Basavaraj (X-Ray technician) and other hospital and office staff for their kind support in my study.
I express my sincere thanks to my colleagues and friends Dr. Satheesh.R.Warrier, Dr. Febin .K. Anto, Dr.Renjith.P.Gopinath, Dr.Shajil.N, Dr.Shyju Ollakode, Dr. Sreenivasa Reddy, Dr. Hadimani, Dr. C. S. Hanumanta Gouda, Dr. Sankadal, Dr. Vanitha, Dr.Naveen, Dr.Santhosh.L.Y, Dr.Varsha.S.Kulkarni, Dr.P.Chandramouleeswaran, Dr.Uday Kumar, Dr. K. Krishnakumar, Dr.Ashwini Dev, Dr.Ratna Kumar, Dr.Jayaraj Basarigidad, Dr.Kendadamath, Dr.V.M.Hugar, Dr.Shyla.B, Dr. Suresh Hakkandi, Dr.Manjunath Akki, Dr. L. R.Biradar, Dr.Vijay Hiremath, and other post graduate scholars for their support.
II
I pay homage to my late ancestors whose lives and achievements in Ayurveda have inspired me to take up Ayurveda as my profession. I pay my respect to my elder uncle Brahmasree Ashtavaidyan Vaidyamadham Cheriya Narayanan Nambudiri who has been a source of inspiration for many.
I also express my obligations to my elders Sreemati Umadevi Antarjanam,
Ashtavaidyan Dr. V.M. Brahmadathan Nambudiri, Ashtavaidyan Dr. V.M. Rishikumaran Nambudiri, Prof. V.M. Narayanan, Shri. V.M. Narayanan, Ashtavaidyan V.N. Neelakandhan Nambudiri, Ashtavaidyan V.S. Krishnan Nambudiri, Shri. V.S. Dileepan, Shri. C.R. Dinesh, Dr.V.N.Prasanna, Dr. K. N. Subrahmanian, Shri. K.P. Damodaranunni, Shri. Dipu Karuthedam, Dr. V.N. Vasudevan and Dr. V.B. Rajeev for their constant encouragements. I am also thankful to my maternal grand father and grandmother and several other relatives for their moral support.
I would like to mention the support and inspiration provided by Dr.
R.Ramabhadran, Director (ISM, Kerala), Dr. P. S. Gopi, Retd. DMO (ISM, Kerala), Dr. D. Ramanathan, CCIM Member, Shri. M.P.R. Bhattathirippad (G.M., Vaidyamadham Vaidyasala) and Dr. Saidas, Retd. Joint Director (ISM, Kerala). I also acknowledge the support and inspiration provided by my teachers Dr. K.P. Muralidharan, Principal, S.J.S. Ayurveda College, Chennai, Dr. S. Swaminathan, H.O.D., Samhita & Siddhanta, S.J.S. College, Dr. S. Venugopal, Reader in Sanskrit, Dr. Vasudevareddy, H.O.D. Shalya dept. and Dr. Ramdas Maganti, H.O.D., Kaya chikitsa, S.J.S. College. I also thank Shri. C. S. Bhatt and family and Shri. Prasad and family for the support and encouragement provided during my stay at Gadag.
I acknowledge my patients for their wholehearted consent to participate in
this clinical trial. I express my thanks to all the persons who have helped me directly and indirectly with apologies for my inability to identify them individually.
Finally I dedicate this work to my respected parents Shri. V. S. Raman and Sreemati C. M. Leela who are the prime reasons for all my success. Date : Signature of the scholar Place : (Dr. Subin V.R.)
III
ABSTRACT
The study “Evaluation of the efficacy of Shashtikashalipindaswedakarma
in the management of Sandhigatavata (Osteoarthritis)” is focused on an important
technique of pinda sweda and a common disorder Sandhigatavata.
Shashtikashalipindasweda is believed to have a note worthy role in the management of
such degenerative conditions by imparting strength to the body musculature and nervous
system. Sandhigatavata is the most common joint disorder worldwide.
The objectives of this study are 1) to evaluate the efficacy of
Shashtikashalipindaswedakarma in Sandhigatavata (Osteoarthritis), 2) to evaluate the
efficacy of Bashpaswedakarma in Sandhigatavata (Osteoarthritis) and 3) to evaluate the
comparative efficacy of Shashtikashalipindaswedakarma and Bashpaswedakarma in
Sandhigatavata (Osteoarthritis).
The aim of this study was to find out the effect of
Shashtikashalipindaswedakarma in the management of Sandhigathavata and to check its
advantage over Bashpaswedakarma in managing the same disease. Therefore, two groups
were made and the results obtained in both the individual groups were compared. The
study design selected for the present study was prospective comparative clinical trial.
In group A (Shashtikashalipindaswedakarma), 7 patients (46.66%) had
good response to the treatment (> 60% improvement in all the parameters) and 8 patients
(53.33%) had moderate Response to the treatment (31-60% improvement in all the
parameters). In group B (Abhyanga & Bashpasweda), 14 patients (93.33%) had
moderate response to the treatment and one patient (6.66%) had poor response to the
treatment (1-30% in all the parameters). Among the groups A and B the parameters ‘Ruk’
and ‘AIMS score’ showed high significance and other parameters were not significant in
the comparative study (as by using unpaired t-test, p-value is <0.05).
IV
Observance of Shamana sweda gunas were performed in both the
treatment groups and all the benefits were found highly significant in both the groups. At
the same time overall treatment response was better in the Shashtikashalipindasweda
group, as no patient in the Bashpa sweda group got good response. This suggests that
there was considerable improvement in both the groups but Shashtikashalipindasweda
group got more beneficial effects.
Sandhigatavata is a Vatavyadhi affecting people in the vardhakya avastha.
The disease is characterized by dhatu kshaya and lakshanas reflective of vitiated Vata.
Therefore, the agents/therapies of brimhana-shoolahara-stambhahara-balya properties
should be used in this disease. Shashtikashalipindaswedakarma imparts Swedana and
opens up the srotas in the shareera facilitating more nourishment and free movement of
Vata dosha. This results in the relief of stambha and facilitates free movement of the
sandhis. All the drugs are having shoolahara properties and the Swedana by itself is
shoolahara due to the pacification of Vata. Thereby, it is an ideal treatment of choice in
Sandhigatavata.
Key words: - Shashtikashalipindaswedakarma; Sandhigatavata; Osteoarthritis;
Bashpaswedakarma; Shamana sweda gunas; Dhatu kshaya; Degeneration.
V
LIST OF ABBREVIATIONS
⇒ A. H. – Ashtanga Hridaya.
⇒ B. P. – Bhavaprakasha
⇒ C. S. – Charaka Samhita.
⇒ G. R. – Good response.
⇒ M. R. – Moderate response.
⇒ N. R. – No response.
⇒ P. R. – Poor response.
⇒ S. S. – Sushruta Samhita.
VI
TABLE OF CONTENTS Chapters Page No.
1. Introduction 1-4
2. Objectives 5-7
3. Review of literature 8-70
4. Methodology 71-97
5. Results 98-145
6. Discussion 146-160
7. Conclusion 161-162
8. Summary 163
9. Bibliography
10. Annexure
VII
LIST OF TABLES Page No. 1. Table showing different layers of Twak and diseases originating from each layer 13 2. Table showing the composition of sweat 19 3. Table showing the sites of different types of sandhis 21 4. Table showing properties of Swedana dravyas 26 5. Table showing Sweda yogyas 27 6. Table showing Sweda ayogyas 28 7. Table showing Samyak swinna lakshanas 30 8. Table showing Ati swinna lakshanas 31 9. Table showing Aaharaja nidana of Sandhigatavata 47 10. Table showing Viharaja nidanas of Sandhigatavata 47 11. Table showing lakshanas of Sandhigatavata 58 12. Table showing vyavachedaka nidana between Sandhigatavata and Vataraktha 62 13. Table showing vyavachedaka nidana between Sandhigatavata and Amavata 62 14. Table showing vyavachedaka nidana between Sandhigatavata and Kroshtrukasheersha63 15. Table showing differential diagnosis between OA, RA, Gout and Rheumatic fever 63 16. Table showing gunas of Shashtikashali 71 17. Table showing chemical composition of rice 73 18. Table showing gunas of Bala 74 19. Table showing gunas of Go-ksheera 75 20. Table showing gunas of Nirgundi 76 21. Table showing gunas of Chincha 77 22. Table showing gunas of the ingredients of Gandharvahastadi Kwatha 78 23. Table showing gunas of the ingredients of Sahacharadi taila 80 24. Table showing the variables in AIMS 95 25. Table showing the distribution of patients by age 99 26. Table showing the response of patients in age groups 100 27. Table showing the distribution of patients by sex 101 28. Table showing the response of patients in sex groups 102 29. Table showing the distribution of patients by occupation 103 30. Table showing the response of patients in occupation groups 104 31. Table showing the distribution of patients by economical status 105 32. Table showing the distribution of patients by religion 106 33. Table showing the distribution of patients by dietary habits 107 34. Table showing the distribution of patients by agni 108 35. Table showing the response of patients in agni types 109 36. Table showing the distribution of patients by koshta 110 37. Table showing the response of patients in koshta types 111 38. Table showing the distribution of patients by Nidra 112
VIII
39. Table showing the distribution of patients by vyasana 113 40. Table showing the distribution of patients by prakriti 114 41. Table showing the response of patients in prakriti types 115 42. Table showing the distribution of patients by satmya 116 43. Table showing the distribution of patients by various grades of ruk 117 44. Table showing the response of patients in ruk grades 118 45. Table showing the distribution of patients by various grades of graha 119 46. Table showing the response of patients in graha grades 120 47. Table showing the distribution of patients by various grades of Sparsha akshamatva 121 48. Table showing the response of patients in Sparsha akshamatva grades 122 49. Table showing the distribution of patients by various grades of Sandhigati asaamarthya123 50. Table showing the response of patients in Sandhigati asaamarthya grades 124 51. Table showing the distribution of patients by various grades of atopa 125 52. Table showing the response of patients in atopa grades 126 53. Table showing the distribution of patients by various grades of shopha 127 54. Table showing the response of patients in shopha grades 128 55. Table showing the percentage of presenting complaints 129 56. Table showing the distribution of patients by various grades of duration 130 57. Table showing the response of patients in duration grades 131 58. Table showing the distribution of patients by various grades of onset 132 59. Table showing the response of patients in onset grades 133 60. Table showing the distribution of patients by various joints affected 134 61. Table showing the response of patients of various joints affected 135 62. Table showing the distribution of patients by the type of joint involvement 135 63. Table showing the distribution of patients by various Aharaja nidanas 137 64. Table showing the response of patients of various Aharaja nidanas 139 65. Table showing the distribution of patients by various viharaja nidanas 140 66. Table showing the response of patients of various viharaja nidanas 141 67. Table showing the distribution of patients by various manasika nidanas 142 68. Table showing the distribution of patients by radiological interpretations 143 69. Table showing the distribution of patients by overall treatment response 143 70. Chart showing the before and after treatment values of clinical & functional parameters in group A 143 71. Chart showing the before and after treatment values of clinical & functional parameters in group B 143 72. Chart showing the before and after values of Sweda kaarmukata parameters 73. Table showing the individual study of group-A 143 74. Table showing the individual study of group-B 143 75. Chart showing inter group comparison 143 76. Table showing the study of Sweda kaarmukata parameters 143
IX
LIST OF FIGURES, PHOTOGRAPHS AND GRAPHS Title Page No.
1. Figure showing section of skin 15 2. Figure anatomy of knee joint and lumbar spine 22 3. Flow chart on types of Sweda 33 4. Flow chart on Samprapti 55 5. Photo of drugs used in Shashtikashalipindasweda 74 6. Photo of procedure of Shashtikashalipindasweda and bashpa Sweda 89 7. Graph showing distribution of age 99 8. Graph showing distribution of sex 101 9. Graph showing distribution of occupation 103 10. Graph showing distribution of economical status 105 11. Graph showing distribution of religion 106 12. Graph showing distribution of diet 107 13. Graph showing distribution of agni 108 14. Graph showing distribution of koshta 110 15. Graph showing distribution of nidra 112 16. Graph showing distribution of vyasana 113 17. Graph showing distribution of deha prakriti 114 18. Graph showing distribution of satmya 116 19. Graph showing distribution of ruk 117 20. Graph showing distribution of graha 119 21. Graph showing distribution of sparsha akshamatva 121 22. Graph showing distribution of sandhigati asamarthya 123 23. Graph showing distribution of atopa 125 24. Graph showing distribution of shopha 127 25. Graph showing distribution of chief complaints 129 26. Graph showing distribution of joints affected 133 27. Graph showing distribution of aharaja nidana 136 28. Graph showing distribution of viharaja nidana 139 29. Graph showing distribution of overall assessment 143
INTRODUCTION
Ayurveda is termed as the science of life wherein are laid down the good
and bad of life, the happy and unhappy life, and what is wholesome and what is
unwholesome in relation to life. It is important to realize that Ayurveda is not confined to
life only; it takes the whole subject of life in its various ramifications. The purpose of life
is four-fold, to achieve dharma (virtue), artha (wealth), kama (enjoyment) and moksha
(salvation). In order to attain success in this four-fold purpose of life, it is essential to
maintain life not only in a disease-free state but also in a positive healthy state of body,
mind and spirit. Equal importance is given to mental health; hence, strict mental
discipline and strict adherence to moral values is considered a pre-requisite for mental
health, which influences the physical state of the body.
Ayurveda is the rich storehouse of time-tested and effective recipes for the
treatment of several obstinate and otherwise incurable diseases. More important than
these recipes are the specialized therapies, which while curing such diseases strengthen
the immune system in the body and help in the preservation of positive health. These
specialized therapies in Ayurveda are called as Panchakarmas. It is no wonder that the
scientists and physicians in India and abroad are evincing deep interest in the classical
form of Ayurvedic treatment. Panchakarma therapy primarily aims at cleansing the body
of its accumulated impurities and nourishing the tissues. Once this is achieved, it
becomes very easy to rejuvenate the tissues and prevent the process of ageing. This helps
the individual to lead a disease free old age and he/she becomes capable of serving the
society with his/her accumulated experience without any mental disability and physical
decay.
Introduction 1
The term ‘Panchakarma’ literally means five-fold therapy. The word
‘Pancha’ has a meaning ‘Vistara’ (elaborate) also. Thus, it implies the meaning elaborate
procedures. Both the meanings are really true in their sense. The therapies that are
included under this collective term are Vamana karma, Virechana karma, Nirooha basti,
Anuvasana basti and Nasya karma. Sushruta’s school, which deals with surgery
primarily, includes Rakthamokshana in the place of Nasya karma.
Panchakarmas play a vital role in Ayurvedic therapeutics and as such they
occupy an important place in Ayurveda. It is not known why the number was restricted to
five, but it is definite that these measures were in vogue in the times of Charaka samhita.
Charaka samhita begins with the bheshaja chatushka in sutra sthana, which is primarily
devoted to the drugs used in Panchakarma. Chakrapanidatta extensively discussed the
restriction of the number of Panchakarmas to five. He noted that, here the word karma
denotes the extensive management and pronounced potency for elimination of impurities.
Snehana, Swedana etc. are not covered by this definition and as such are not included in
it.
It is necessary at this state to make it clear that these Panchakarmas do not
imply simple administration of emesis, purgation, enema or nasal drops as is
conventionally understood. Elaborate methods are described for the preparation of these
therapies, their administration, preparation of the individual prior to the administration of
these and the management of the patient after the therapy is administered.
Prior to the administration of these therapies, the body of the patient is to
be suitably prepared and the therapeutic measures used for this purpose are called Poorva
karmas or preparatory therapies. According to Dalhana, Pachana, Snehana and Swedana
Introduction 2
are the Poorva karmas. Pachana involves the internal administration of medicines having
teekshna-rooksha-ushna properties and those that are capable of eradicating the ama
dosha and strengthening the agni. Snehana is administered in two different ways, viz.,
bahya (external) and abhyantara (internal). The external form of Snehana is done through
different types of massages, matra basti, anuvasana basti, karna poorana, anjana etc. with
the help of unctuous preparations (ghrita, taila, vasa and majja). Swedana involves the
application of heat (from various medicinal and non-medicinal sources) to the whole
body or the affected part alone.
During the course of time, some special massage therapies have been
developed in Ayurveda. These special massage therapies cause both oelation and
fomentation of the body. Apart from curing some of the obstinate and otherwise incurable
diseases, these special massage therapies help in rejuvenating the body. If used
periodically, they prevent the ageing process while simultaneously preventing the
manifestation of diseases. Thus these therapies, apart from their utility as preparatory
measures for the Panchakarmas are specialized therapies in their own merit.
Among these modified therapies, Pinda sweda is the most important. In
Shashtikashalipindasweda, a bolus of payasam made up of new coarse rice cooked in
cows milk and bala kwatha is used for fomentation/massage on the body. A successfully
employed Shashtikashalipindasweda is believed to help to a great extent, the patients
suffering from different neuro-muscular disorders and also several systemic diseases.
Vata, the most important among the doshas when excited by its
aggravating factors, produces a variety of diseases. These diseases are collectively termed
as Vatavyadhis. In this group, there are sub-classes according to the nature of
Introduction 3
manifestation and specificity of the affected body part. When the vitiated Vata gets seated
in the ashayas, dhathus, sandhis etc., the conditions are termed as Gatavatas. In this
group, the most important disease condition is Sandhigatavata, which is also the most
common joint disorder in the humans. This disease is characterized by pain in the joints,
joint stiffness, joint swelling, difficulty in joint movements and crepitations.
Sandhigatavata is considered as Osteoarthritis in modern parlance due to the resemblance
in the aetio-pathological factors and clinical features.
Vatavyadhi, in general, and Sandhigatavata in particular is treated with
Snehana and Swedana therapies. The chapter on the treatment of Vatavyadhi, as per
Charaka samhita, emphasizes the adoption of both these therapies in curing these
diseases. Also, Sandhigatavata is characterized by its association with dhatu kshaya as it
commonly occurs in the old age. This is representative of the degenerative state of the
body. Shashtikashalipindasweda is believed to have a note worthy role in the
management of such degenerative conditions by imparting strength to the body
musculature and nervous system. Therefore, this study had been undertaken as an attempt
to help the patients suffering from Sandhigatavata in our society and also to evaluate the
efficacy of this treatment modality over another treatment modality of the same group
(Bashpa sweda) in managing this disease.
Introduction 4
Need for the study : Swedakarma or sudation or fomentation therapy is one among the
Poorvakarmas (Panchakarma sub-procedures). Swedakarma itself is said to be the best
treatment for Vata and Kapha disorders. Sankara sweda is one among the thirteen Sweda
karmas described by Charaka. Shashtikashali can be made use for this purpose, which
relieves the pain and nourishes the body.
Sandhigatavata is the most common joint disorder worldwide. The overall
prevalence of the disease in the population above 40 years of age is about 49% with a
female to male ratio of 1:1. In the contemporary system of medicine, NSAIDs and
surgery are practiced in the management of this disease, but have their own limitations.
This disease restricts the normal movements of the affected joint, thereby rendering the
patient incapable of performing his/her normal activities.
Contemporary medical science is able to pacify the painful condition
through analgesics and surgery mainly. But, this provides only temporary relief, as the
underlying pathology is not managed. So, in search of an effective therapeutic measure to
counter the degenerative process and also provide cure to the disease,
Shashtikashalipindasweda was considered as the therapy in this study. It has been
considered to provide all the benefits of Swedakarma and have a rejuvenating effect over
the patient’s body. This study, along with focusing the efficacy of
Shashtikashalipindasweda in Sandhigatavata, also compared its efficacy with the efficacy
of another Swedana technique (Bashpasweda) in Sandhigatavata.
Objectives 5
It will be relevant to mention some of the research works conducted earlier
on Shashtikashalipindasweda, Bashpasweda and on the management of Sandhigatavata
with Panchakarma therapies.
• Rangachari V G (IPGTRA, Jamnagar) studied on the comparative efficacies of
Navarakkizhi and Pizhichil in 1963.
• Chaturvedi, G N and Singh, R H published their work “Studies on Panchakarma
therapy-III - A clinical study on the treatment of certain neuromuscular and
articular disorders with Pindasweda” in 1964.
• Shinde, S K (IPGTRA, Jamnagar) worked on Bashpaswed ka vaigyanika evam
prayogik adhyayan.
• Reddy, S A (Govt. Ayurveda College, Trivandrum) studied Pindasweda with
special reference to Shashtikashalipindasweda in 1984.
• Sinha, A K (Puri University) studied the clinical effect of
Shashtikashalipindasweda in Sandhigatavata (Osteoarthritis) in 1993.
Shashtikashalipindasweda and Bashpasweda are simple techniques;
ingredients are easily available and economical. Also, these are indicated in the
management of Sandhigatavata and have no proven adverse effects. This study was
intended to assess the efficacy of these Sweda techniques in the management of this
disease and to compare the efficacy of Shashtikashalipindaswedakarma with that of
Bashpaswedakarma. So the present study “Evaluation Of The Efficacy Of
Shashtikashalipindaswedakarma In The Management Of Sandhigatavata
(Osteoarthritis)” was undertaken.
Objectives 6
Objectives Of The Study :
To evaluate the efficacy of Shashtikashalipindaswedakarma in Sandhigatavata
(Osteoarthritis).
To evaluate the efficacy of Bashpaswedakarma in Sandhigatavata
(Osteoarthritis).
To evaluate the comparative efficacy of Shashtikashalipindaswedakarma and
Bashpaswedakarma in Sandhigatavata (Osteoarthritis).
Objectives 7
Historical view
Karma
It is customary, on the part of researchers belonging to various fields of
knowledge, to search the Vedas, as they are the prime sources of ancient wisdom. Such a
search of Vedas for references regarding Panchakarmas, Swedana in particular was not
fruitful.
The works during and after the samhitakala provide ample description on
Panchakarmas and their Poorvakarmas i.e. Snehana and Swedana. Among the
samhitagranthas, Charaka samhita (1000B.C.)1 was the first to describe Swedakarma
under the Shadupakramas. In this text, one can find definition, classification, indications,
contra-indications and benefits of Swedana. Bhela2, considered contemporary to Charaka,
had also described Swedana in detail in the Sweda adhyaya of sutrasthana. Kashyapa
samhita3, written by Vriddha Jeevaka (600B.C.) did mention Swedakarma and
descriptions are found with minor differences from Charaka samhita. The next book that
provides equal details is Sushruta samhita4 written in 2nd century A.D. Ashtanga
samgraha5 and Ashtanga hridaya6 had also allotted separate chapters for Sweda karma.
All these texts have recorded the technique of pindasweda too7a,b,c,d,e,f.
Various literary works belonging to the Classical Age of Indian Literature
(320 AD – 740 AD) 8 had also mentioned the usefulness of Swedakarma. Later textbooks
on Ayurveda such as Sharangadhara samhita9 and Chakradatta10 had described Swedana
karma under a separate chapter, while texts such as Bhavaprakasha11,
Bhaishajyaratnavali12 and Yogaratnakara13 had mentioned the utility of Swedakarma in
various diseases.
Historical Review 8
Even though all major textbooks on Ayurveda had mentioned the
medicinal use of Shashtikashali14a,b,c. and its importance among shalees, nowhere it’s
utility as pindasweda was described. References for Shashtikashali are available in the
works of Krishna atreya, Kharanada and Parashara as quoted by Arunadatta in his
Sarvangasundari commentary on Ashtanga hridaya15. Textbooks on Ayurveda originating
from Kerala such as Chikitsamanjari16, Arogyakalpadruma17, Ayurvedic Treatments of
Kerala18 etc. had described Shashtikashalipindasweda as an effective Swedana technique
in various diseases. Encyclopedia Britannica19 states that the cultivation of rice for food
and medicinal purposes started in India 4000 years ago and gradually spread to other
parts of the world. Buchanan (1807) has recorded that Navara (Malayalam name of
Shashtikashali) was grown in Kerala in the early 19th century20.
Vyadhi
Sandhis and the diseases affecting them were well known in the Vedic
period. One can observe description of body parts in Atharvanaveda where in the words
“Januni and Ashtivantau” were used to denote knee joints21. The disease Sandhigatavata
had not been mentioned as such in Vedic literature. But, Rigveda while describing
various skills of Ashwinikumaras had recorded their skill in treating joint diseases too22.
One of the mantras of Rigveda states that, “I am removing your diseases from each
organ, hair and joint”23. Atharvanaveda had mentioned Parvashoola and Vateekrita24,
two diseases similar to Sandhigatavata. In Atharvanaveda, records about Vatavikaras are
mentioned25. A mantra says, “destroy the balasa seated in the organs and joints which is
responsible for loosing bones and joints”26.
Historical Review 9
Samhitagranthas. and Samgrahagranthas except Sharangadhara samhita
had described the disease Sandhigatavata with lakshana-chikitsa under the
Vatavyadhees27a,-h. Even though the description of Sandhigatavata is unavailable in
Bhela samhita28, it is assumed that the verses are missing, as the description of Gatavatas
such as amashayagatavata, pakwashayagatavata and raktagatavata etc. is available.
Osteoarthritis (OA) is the most common joint disorder in human beings
and other vertebrates. Even in giant dinosaurs, osteophytes leading to ankylosis were
detected. In all mammalian species like whales and dolphins and in fish birds and some
amphibians, Osteoarthritis is observed29.
In the early ages, Hippocrates observed the prevalence of OA in aged
individuals (Benard, 1944)30. Heberden (1803) studied this disease in detail and the nodes
on the fingers in OA disease were named after him31. Osteoarthritis was differentiated
from Rheumatoid Arthritis and named as degenerative arthritis by Nichols and
Richardson (1909) on morbid anatomical grounds32. Although the most ancient of the
diseases, OA was first identified as a distinct entity in the 20th century33. Gold th ait in
1904 made a distinction between hypertrophic and atrophic arthritis and A.E Garrod
recognized OA as a clinical entity in 190734.
Historical Review 10
Vyutpatti & Paribhasha
The word Shashtikashalipindaswedakarma is comprised of five words viz.,
shashtika, shali, pinda, sweda and karma.
Shashtika35 : - Shashtika is a word of masculine gender. When ‘Kan’ pratyaya is added
to the word ‘Shashti’, the word shashtika is derived. “Shastikaaha shashtiratrena
pachyante” - Shashtika are those particular types of grains, which get matured in sixty
nights.
Shali36 : - Shali is a word of masculine gender. Shali word is coined by the
combination of ‘Shru’ dhathu and ‘Inj’ pratyaya. “Kantakena vina shuklaaha
haimantaaha shaalayaha smritaaha” - White coloured grains from which chaff has been
separated and are grown in hemanta ritu are called shali.
Pinda37 : - Pinda is a word of masculine gender. When ‘Ach’ pratyaya is added to
‘Pindi’, the word pinda is derived. “Pindi samhatau, bolaha” - Pinda means bolus (a
rounded mass) or lump.
Sweda38 : - Sweda is a word of masculine gender. Sweda word is coined by the
combination of “Swit” dhathu and “Dhanj” pratyaya. Sweda is a shareeramala, which is
associated with body heat mechanism.
Karma39 : - Karma word is derived from the dhathu ‘Kru’. Performance of an act
is called karma. Here, swedakarma means the act of producing sweda and it is one
among the Shadupakramas and poorvakarmas. Thus, collectively, the word
Shashtikashalipindasweda means the act of producing sweat by the application of
shashtikashali boluses.
The word “Sandhigatavata” is comprised of three words, Viz., sandhi, gata
and vata.
Vyutpatti 11
Sandhi40 : - Sandhi is a word of masculine gender. Sandhi is coined from three
parts ‘Sam’, ‘Dha’ and ‘Kihi’. “Sandhaanamiti, asthidvayasamyogasthanam”- The place
of union of something together is called sandhi. Here, it means the union of bones.
Gata41 : - Gata word exists in all the three genders and it is derived from ‘Gama’
dhathu and ‘Ktin’ pratyaya. “Gachati, janaati, yaateeti va” - That which has went or
reached. Hence, gata word may be used to denote an initiation of movement, carrying
something along with, to reach a particular site, through any particular pathway or
leading to occupancy at a particular site. Here, in the context of Sandhigatavata, the
occupancy is at asthi-sandhis in the body.
Vata42 : - Vata is a word of masculine gender. The word is coined from ‘Vaa’
dhathu and ‘Ktin’ pratyaya. It is one among the tridoshas. Thus, collectively, the word
Sandhigatavata means the disease resulting from the settling of vitiated Vata dosha in the
bony joints of the body.
The word ‘Osteoarthritis’ is a combination of three words. ‘Osteon’,
‘arthron’ and ‘itis’ respectively means bone, joint and inflammation43. The meaning of
this word is ‘inflammation to the bony joint’. In fact, there is no inflammation in this
disease; hence, the disease is also known as Osteoarthrosis and Degenerative joint
disease.
Vyutpatti 12
Shareera
Focus of this study is on Shashtikashalipindaswedakarma. Therefore, a
discussion on the anatomy and physiology of skin, where the Shashtikashalipinda is
applied, is necessary prior to the discussion on the anatomy and physiology of joints that
are the sites of this disease.
Twak shareera
Ayurveda has recognized twak as an upadhatu of mamsa44. The twak is a
modification of mamsadhatu in its developmental state i.e. during intrauterine life45.
Sushruta described the seven layers of twak and the diseases arising from the twak46. The
following table shows the thickness of the seven layers of twak and the diseases arising
from them.
Table No. 1. Showing the different layers of twak
Sl. Layer of twak Size Diseases arising from each layer
1 Avabhasini 1/18 Vrihi Sidhma, Padma, Kantaka
2 Lohitha 1/16 Vrihi Tilakalaka, Nyaccha, Vyanga
3 Swetha 1/12 Vrihi Charmadala, Ajagalli, Mashaka
4 Tamra 1/8 Vrihi Kilasa, Kushta
5 Vedinee 1/5 Vrihi Kushta, Visarpa
6 Rohinee 1 Vrihi Granthi, Apachi,
Arbuda, Shlipada, Galaganda
7 Mamsadhara 2 Vrihi Bhagandara, Vidradhi, Arshas
According to Sushruta, these seven layers of twak are formed, as the
cream is formed layer after layer in the boiling milk.
Shareera 13
Charaka slightly differs from Sushruta and had described only six layers
of twak without naming them47. Order of these six layers is 1) udakadhara, 2) asrigdhara,
3) sidhma-kilasa sambhavadhishthana, 4) dadrukushta sambhavadhishthana, 5) alaji-
vidradhi sambhavadhishthana and 6) arumshika adhishthana. Among these if, the
innermost layer i.e. arumshika adhishthana is injured the patient goes into shock and
develops a very serious skin disease called arumshika, a type of boils on the phalanges
and elbow joint.
Bhrajakapitta, one among the panchavidha Pittas, is located in the twak. It
is this bhrajakapitta that takes up and metabolizes the drugs applied in the form of
abhyanga, parisheka, avagaha, alepa etc48.
Modern View
Most of the modern scientists recognize the possibilities of considering
skin as a Large, Highly Complex Organ and as a Structuraly Integrated Organ System.
The components of the integumentary system are the cutaneous membrane or skin and
the associated hairs, nails and exocrine glands. The system accounts for about 16% of
ones body weight49.
Cutaneous membrane has two components – the superficial epithelium or
epidermis and the underlying connective tissues of the dermis. The associated or
accessory structures are located in the dermis and protrude through the epidermis to the
skin surface. Function of the skin is supported by an extensive network of blood vessel
branches (through the dermis) and sensory receptors that monitor touch, pressure,
temperature and pain. The loose connective tissue of the subcutaneous layer or superficial
fascia or the hypodermis which lies beneath the dermis separates the integument from the
deep fascia around the other organs such is muscles and bones.
Shareera 14
General functions of the skin: -
Protection of underlying tissues and organs.
Excretion of salts, water and organic wastes.
Maintenance of normal body temperature.
Synthesis of a steroid, vitamin D3 that is subsequently converted to the hormone
calcitriol, important to normal calcium metabolism.
Storage of nutrients.
Detection of touch, pressure, pain and temperature stimuli and the relay of that
information to the nervous system.
HISTOLOGY OF SKIN :
Epidermis
It provides mechanical protection and keeps microorganisms outside the
body; this layer consists of a stratified squamous epithelium. The most abundant
epithelial cells, called kertinocytes, form several different layers. In thick skin, found on
the palms of the hands and soles of the feet, five layers can be distinguished. Only four
layers can be distinguished in the thin skin that covers the rest of the body.
Five layers of epidermis, beginning at the basement membrane and
traveling toward the free surface, are stratum germinativum, stratum spinosum, stratum
granulosum, and stratum lucidum and stratum corneum. The innermost epidermal layer is
the stratum germinativum, which is firmly attached to the basement membrane that
separates the epidermis from the loose connective tissue of the adjacent dermis. Stratum
spinosum which is a spiny layer consists of 8 -10 layers of cells. Stratum granulosum or
Shareera 15
grained layer consists of 3-5 layers of kertinocytes displaced from the stratum spinosum.
In the thick skin of the palms and soles, a glassy stratum lucidum covers the stratum
granulosum. Stratum corneum, which is found at the surface of both thick and thin skin,
consist of 15 – 30 layers of keratinized cells.
Keratinization or cornification occurs on all exposed skin surfaces suspect
the anterior surface of the eyes. The dead cells within each layer of the stratum corneum
remain highly interconnected by desmosomes. Those connections are so secure that
cornified cells are generally shed in large groups or sheets rater than individuals. This
arrangement places the deeper portions of the epithelium and underlying tissues beneath a
protective barrier composed of dead, durable and expendable cells.
Epidermal growth factor (EGF) is one of the peptide growth factors
produced by the salivary glands and glands of the duodenum. This has wide spread
effects on epithelia, especially the epidermis. Its effects include –
Promoting the divisions of germinative cells in the stratum germinativum and
stratum spinosum.
Accelerating the production of keratin in differentiating epidermal cells.
Stimulating epidermal development and epidermal repair after injury.
Stimulating synthetic activity and secretion by epithelial cells.
The colour of the skin is due to an interaction between pigment (carotene
and melanin) composition and concentration and the dermal blood supply.
Dermis
The dermis lying beneath the epidermis has two major components – a
superficial papillary layer and a deeper reticular layer. The papillary layer consists of
Shareera 16
loose connective tissue. This region contains the capillaries and the sensory neurons that
supply the surface of the skin. The reticular layer deep to the papillary layer consists of
an interwoven meshwork of dense irregular connective tissue. Bundles of collagen fibers
leave the reticular layer to blend into those of the papillary layer above. Accessory organs
of epidermal origin, such as hair follicles and sweat glands, extend into the dermis. In
addition, the reticular and papillary layers of the dermis contain networks of blood
vessels, lymph vessels and nerve fibers.
Dermal circulation and innervations
Arteries supplying the skin form a network in the subcutaneous layer
along its border with the reticular layer of the dermis. This network is called the
cutaneous plexus. Tributaries of these arteries supply the adipose tissues of the
subcutaneous layer and the tissues of the integument. As small arteries travel toward the
epidermis, branches supply the hair follicles, sweat glands, and other structures in the
dermis. On reaching the papillary layer, these small arteries form another branching
network, the papillary plexus, which provides arterial blood to capillary loops that follow
the contours of the epidermis-dermis bound artery. These capillaries empty into a
network of small veins connected to larger veins in the subcutaneous layer.
Nerve fibers in the skin control blood flow, adjust gland secretion rates
and monitor sensory receptors in the dermis and the deeper layers of the epidermis. The
epidermis also contains the extensions of sensory neurons that provide sensations of pain
and temperature. The dermis contains similar receptors as well as other more specialized
receptors.
Shareera 17
Hypodermis
The connective tissue fibers of the reticular layer are extensively
interwoven with those of the subcutaneous layer. Although the hypodermis is not a part
of the integument, it is important in stabilizing the position of the skin in relation to
underlying tissues, such as skeletal muscles or other organs, while permitting
independent movement50.
Sweat glands51
Among the associated structures of the skin, only sweat glands are
discussed here due to their contextual relevance. The skin contains two different types of
sweat glands or sudoriferous glands – apocrine glands and merocrine sweat glands.
Apocrine sweat glands communicate with hair follicles in the armpits
(axillae), around the nipples and in the groin. These are coiled tubular glands that produce
a sticky, cloudy and potentially odorous secretion. Apocrine sweat glands begin secreting
at puberty. The sweat produced is a nutrient source for bacteria, which intensity its odour.
Myoepithelial cells contract, squeezing the gland and thereby discharging the
accumulated secretion into the hair follicles. The secretary activities of the glands cells
and the contractions of myoepithelial cells are controlled by the nervous system and by
circulating hormones.
Merocrine sweat glands, also known an eccrine sweat glands, are far more
numerous and widely distributed than apocrine glands. They are smaller than apocrine
sweat glands and they do not extend as far into the dermis. Palms and soles have the
highest numbers. These are coiled, tubular glands that discharge their secretions directly
onto the surface of the skin.
Shareera 18
The sweat produced by merocrine sweat glands is called sensible
perspiration. Sweat is 99 percent water, but it also contains some electrolytes (chiefly
sodium chloride), organic nutrients and waste products. It has a pH of 4-6.8 and the
presence of sodium chloride gives sweat a salty taste. The functions of merocrine sweat
gland include: (1) cooling the surface of the skin to reduce body temperature, (2)
excretion of water and electrolytes and (3) protection from environmental hazards55.
Table No. 02. Showing the composition of sweat52
Sl. Test Normal ranges
1 PH 4-6.8
2 Specific gravity 1.001-1.008
Electrolytes (mEq/l)
3 Potassium 4.3-14.2
4 Sodium 0-104
5 Calcium 0.2-6
6 Magnesium 0.03-4
7 Chloride 34.3
8 Proteins (mg/dl) 7.7
Metabolites (mg/dl)
9 Amino acids 47.6
10 Glucose 3.0
11 Urea 26-122
12 Lipids -
Sweda and Swedavahasrotas
Sweda is produced from medodhathu as a mala during dhathuparinama53.
When the body becomes hot, the udaka that comes out from the romakupas is called
sweda54. Sweda is an apyadravya55. Sweda is brought to the surface of the skin through
Shareera 19
the swedavaha srotases by the action of vyanavata56. The excretion of the sweda bestows
moisture and delicate nature to the skin57. According to Hemadri, the hair on the skin is
supported by the sweda58.
Medas and romakupa are the moolas of swedavaha srotas59. They get
vitiated due to ativyayama, atisantapa, indiscriminate indulgence in cold & heat, krodha,
shoka and bhaya60. Their vitiation produces the following lakshanas- aswedana
(anhydrosis), atiswedana (hyperhydrosis), parushya (roughness of the body),
atislakshnata (excessive smoothness of the body), paridaha (general burning sensation)
and lomaharsha (horripulations)61.
Sandhishareera
The word sandhi indicates ‘sandhana’ i.e. the union of two or more
structures together. Here, it means the union of two or more asthis including taruna asthis
and dantas.
Shleshaka kapha62 :- This division of kapha is situated to all the sandhis and does the
function of sandhisamshleshana.
Vyanavata63 :- Vyanavata is located in hridaya but at the same time functions throughout
the body and giving all the movements of the body such as prasarana, akunchana,
vinamana, unnamana and tiryak gamana. It is responsible for rasa samvahana, sweda and
raktha sraava.
Shleshmadharakala64 :- Located in the sandhi, it is responsible for proper alignment of all
joints. As the lubrication of the aksha (axis) results in proper movements of the wheel,
the shleshmadharakala in the body is responsible for the proper joint movements.
Shareera 20
Functionally, Sushruta had classified sandhis into two varieties65- (1)
chestavanta sandhi (movable) and (2) sthira sandhi (immovable). Cheshtavanta sandhis
are present in sakhas (upper and lower limbs), hanu (temporomandibular joint) and kati
(hip). All the remaining i.e. cranial sutures, intervertebral, costovertebral,
sternoclavicular, sternocostal and dental are sthira sandhis (immovable or slightly
movable joints).
Structurally, joints are of eight types66, viz., kora (resembling a budding
flower), ulookhala (resembling a mortar), saamudga (as if fitted into one another), pratara
(floating, i.e. supported by a cushion like intervertebral discs), tunnasevani (sutural, i.e.
both the articular ends are supported and jammed and one another), vaayasatunda (a
cow’s beak like portion of a bone enters into a similarly shaped hole), mandala (rounded)
and sankhaavarta (looks like the circles of a snail or sankha).
Table No. 03. Showing the sites of different sandhis.
Sl. Name of Sandhis Sites 1 Kora In anguli (interphalangeal joints),
manibandha (wrist), gulpha (ankle), janu (knee) & kurpara (elbow)
2 Ulookhala Kaksha (shoulder), vankshana (hip),& danta (alveolar sockets & teeth)
3 Saamudga Amsapeetha (sternoclavicular), guda (sacrococcygeal), bhaga (symphysis pubis), & nitamba (lumbosacral)
4 Pratara Greevaprishta (intervertebral) 5 Tunnasevani Shira, kati & kapala (sutural joints) 6 Vaayasatunda Hanusandhi (temporomandibular) 7 Mandala Kantha (tracheal rings) 8 Sankhaavarta Shrothra (cochlea)
In total, there are 210 sandhis in the body according to Ayurveda67.
Shareera 21
Modern View
The human skeleton is designed with a number of individual bones that
are articulated at joints to allow the movements in different directions, angles and
positions68. In this particular study, only cases with Osteoarthritis of knee and lumbar
spine have been considered. So, the descriptions of these are being dealt with in detail
here.
Knee Joint69
The knee is structurally complex and subjected to severe stresses in the
course of normal activities. Although the knee functions as a hinge joint, the articulation
is far more complex than that of the elbow or even the ankle. The rounded femoral
condyles roll across the top of the tibia, so the points of contact are constantly changing.
The joint permits flexion and extension and very limited rotation. There is no single,
unified capsule at the knee joint, nor is there a common synovial cavity. A pair of fibro
cartilage pads, the medial and lateral menisci, lies between the femoral and tibial
surfaces. The menisci – (1) act as cushions, (2) conform to the shape of the articulating
surface as the femur changes position and (3) provide lateral stability to the joint.
Prominent fat pads cushions the margin of the joint and assist the many bursae in
reducing the friction between the patella and other tissues.
Ligaments
Seven major ligaments stabilize the knee joint. They are the patellar
ligament, two popliteal ligaments, the anterior cruciate and posterior cruciate ligaments,
the tibial collateral ligament and the fibular collateral ligament.
Shareera 22
Muscles associated
Flexors of the knee - biceps femoris, semimembranosus, semitendinosus
and the sartorius.
The flexion of knee and rotation (lateral) of the thigh is done by sartorius
muscle. The first three flexors are collectively known as hamstring muscles. Collectively,
the knee extensors are known as the quadriceps femoris (Vastus muscles).
Blood supply
The external iliac artery crosses the surface of the iliopsoas muscle and
penetrates the abdominal wall to emerge on the anteromedial surface of the thigh as
femoral artery. The deep femoral artery, which gives rise to the medial and lateral
circumflex arteries, supplies blood to the ventral and lateral regions of the skin and deep
muscles of the thigh. The femoral artery at the popliteal fossa becomes the popliteal
artery. This artery crosses the popliteal fossa and branches to form the posterior and
anterior tibial arteries. The venous drainage of the knee and associated structures is
through the great saphenous and small saphenous veins which inturn drains to femoral
vein.
Innervations
1. Femoral nerve, through its branches to the vasti, especially the vastus medialis.
2. Sciatic nerve, through the genicular branches of the tibial and common peroneal
nerves.
3. Obturator nerve, through its posterior division.
Shareera 23
Lumbar spine70
The five lumbar vertebrae are the largest of the vertebrae. The body of a
typical lumbar vertebra is thicker than that of a thoracic vertebra and the superior and
inferior surfaces are oval rather than heart-shaped. Other noteworthy features include the
following :
(1) Lumbar vertebrae neither have whole facets nor demifacets on their body,
(2) The slender transverse processes, which lack costal facets, projects dorsolaterally,
(3) The vertebral foramen is triangular,
(4) The stumpy spinous processes projects dorsally,
(5) The superior articular process face medially and
(6) The inferior articular process face laterally.
The lumbar vertebrae bear the most weight. Their massive spinous
processes provide surface area for the attachment of lower back muscle that reinforce or
adjust the lumbar curvature.
Muscles associated
Spinal extensors or erector spinae (spinalis, longissimus and iliocostalis),
sacrospinal muscles, semispinalis, multifudus, interspinalis, intertransversarii and
rotators, quadratus lumborum.
Blood supply
Lumbar arteries and lumbar veins [connected to the azygos vein (right
side) and hemizygos vein (left side)].
Innervations
Lumbar plexus and its branches.
Shareera 24
Snayus71 :- Totally there are 900 snayus in the body; among them 600 are in the
extremities, 10 in the janu, 60 in the kati and 80 in the prishta. The pratanavati type of
snayus is located in the sandhis of the body. All the joints are attached with snayus that
are responsible for their compactness.
Peshishareera72 :- There are 500 peshis in body; among them, 400 are in the extremities
(upper and lower), 5 in the janu and 10 in the prishta. All the siras, snayus, asthis, parvas
and sandhis are covered by peshis that protects them.
Marmas73 :- Marmas are the vital anatomical points in the human body. The janu marma
is located between jangha and urvi and if injured causes khanjata. It is a sandhi marma of
3 angula measurement and is a vaikalyakaramarma. In the prishta, there are 4 pairs of
important marmas. They are (1) kateekataruna - 2 in number, asthi marmas of ½ angula
and are a kalantarapranahara marmas, (2) kukundara – 2 in number, sandhi marmas of ½
angula and are vaikalyakara marmas, (3) nitamba – 2 in number, asthi marma of ½ angula
and are kalantarapranahara marmas and (4) parshwasandhi – 2 in number, siramarmas of
½ angula and are kalanatarapranahara marmas.
Synovial fluid
Synovial membrane secretes a liquid, the synovial fluid. It has many
functions - serves as a lubricant, a shock absorber and a nutrient carrier. This belongs to a
rather unusual group of liquids known as dilatent liquids. These liquids are characterized
by the rare quality of becoming thicker when shear is applied to them. Thus, the synovial
fluid in our knees and hips assume a very viscous nature at the moment of shear in order
to protect the joints, and then it thins out again to its normal viscosity instantaneously to
resume its lubricating function between shocks. Synovial fluid is the liquid that must
carry the raw materials from the blood to the cartilage.
Shareera 25
Sweda karma
The process which relieves stambha (stiffness), gourava (heaviness),
sheeta (coldness) and which induce sweda (sweating) is known as Sweda karma74. In
general, Sweda karma represents the therapy by which a person is made to sweat.
Swedana will cure Vata, Kapha and Vatakaphaja disorders75. But, it is not recommended
in disorders due to excitement of Pitta.
Even though, swedana is poorva karma, it has its own entity as pradhana
karma in some diseases. Charaka included Sweda karma in Shadupakramas and he has
treated it as main therapy76. For samshodhana purpose, it is considered as poorva karma.
In sweda sadhya diseases it acts as main therapy.
Properties of Swedana drugs77
Generally guru, teekshna and ushna dravyas induce sweating. Drugs with
the sara, snigdha, rooksha, sukshma, drava and sthira gunas are also utilized in Sweda
karma.
Table No. 04. Showing the properties, action and predominance of mahabhootas of
swedana dravyas:
Sl. Properties Main actions Mahabhuta
1 Ushna Anutsaha, moorchakrit, swedakrit and dahakrit Agni
2 Teekshna Daha-pakakara, shodhananga, sraavana Agni
3 Snigdha Snehakrit, mardavakrit, bala-varnakrit Apa and Prithwi
4 Rooksha Opposite to snigdha and stambhakara, khara Vayu and Agni
5 Sara Anulomana, prerakata and pravrittisheela Vayu and Agni
6 Sthira Chirakaritha, sthairyakara and stambhakara Prithwi
7 Sookshma Sookshmachidrapraveshayogyata, vivarana sheelata
Akasha, Vayu and Agni
8 Guru Sada, upalepa, tarpanakrit and brimhanakrit Prithwi and Jala
9 Drava Kledana, alodana, syandanakaraka Jala
Sweda karma 26
Swedayogyas (Swedarhas) 78,79,80
Table No. 05. Showing the persons and diseases that are fit for swedana.
Sl. Vyadhi C.S. S.S. A.H. Sl. Vyadhi C.S. S.S. A.H.1 Pratishyaya + - + 30 Uru ruk / graha + - + 2 Kasa + - + 31 Jangha ruk / graha + - + 3 Hikka + - + 32 Kshavathu + - - 4 Swasa + - + 33 Khalli + - + 5 Alaghava + - - 34 Ayama + - + 6 Karna shoola + - - 35 Sheeta + - - 7 Manya shoola + - - 36 Vepathu + - + 8 Shira shoola + - - 37 Vatakantaka + - + 9 Swara bheda + - + 38 Sankocha + - + 10 Gala graha + - - 39 Ayamashoola + - + 11 Ardita + - + 40 Stambha + - + 12 Ekanga roga + - + 41 Gourava + - + 13 Pakshaghata + - + 42 Supti + - + 14 Ardita + - + 43 Nasyarha + + + 15 Vinamaka + - + 44 Bastyarha + + + 16 Koshtanaha + - + 45 Shodhaneeya + + + 17 Vibandha + - + 46 Aahritashalya - + - 18 Mutraghata + - - 47 Anupadrava
moodhagarbha - + -
19 Vijrimbhaka + - + 48 Samyak prajata - + - 20 Parshwagraha + - + 49 Bhagandara - + - 21 Prishtagraha + - + 50 Arsha - + - 22 Kateegraha + - + 51 Ashmari - + - 23 Kukshigraha + - + 52 Shleshma roga - - + 24 Gridhrasi + - + 53 Amaroga - - + 25 Mutrakrichra + - + 54 Hanugraha - - + 26 Vriddhi + - + 55 Arbuda - - + 27. Angamarda + - + 56 Granthi - - + 28 Pada ruk / graha + - + 57 Shukraghata - - + 29 Janu ruk / graha + - + 58 Adhyamaruta
(Urustambha) - - +
Sushrutha had specified that those who are fit for Nasya, Basthi and
Shodhana are Poorvam Swedyas ; Ahritashalya, Moodhagarbha and Samyak prajata are
Paschat Swedyas ; and Bhangandara & Arsha are Poorvam Cha Paschat cha Swedyas81.
Sweda karma 27
We can conclude that, in general, there are three categories of diseases
wherein swedana is indicated – a) Vatapradhana rogas, b) Kaphapradhana rogas and c)
Shodhaneeya & Shadyakarmayogyas.
Sweda ayogyas (Sweda anarhas) 82,83,84
Table No. 06. Showing the persons and diseases those are unfit for Swedakarma.
Sl. Vyadhi C.S. S.S. A.H. Sl. Vyadhi C.S. S.S. A.H.1 Kashayanitya + - - 24 Adhyaroga
(Vataraktha) + - +
2 Madyanitya + + - 25 Durbala + + + 3 Garbhini + + + 26 Ativisushka + - - 4 Rakthapitha + + - 27 Ksheenaoja + - - 5 Pithakopa + - + 28 Timira + - + 6 Atisara + + - 29 Pandu - + + 7 Rooksha + - - 30 Kshaya - + + 8 Madhumeha + + + 31 Kshama - + + 9 Vidagdhabradhna + - + 32 Ajeerna - + - 10 Bhrashtabhradna + - + 33 Chardi - + - 11 Visha + + - 34 Moorcha - - + 12 Madyavikara + - + 35 Stambhaneeya - - + 13 Shrantha + - - 36 Visarpa - - + 14 Nashtasamjna + - - 37 Kushta - - + 15 Sthoola + - + 38 Peeta dugdha - - + 16 Pithameha + - - 39 Peeta sneha - - + 17 Trishna + + + 40 Peeta dadhi - - + 18 Kshut + - + 41 Peeta madhu - - + 19 Krodha + - + 42 Krita virechana - - + 20 Shoka + - + 43 Glani - - + 21 Kamala + - + 44 Bhaya - - + 22 Udara + + + 45 Pushpitha - - + 23 Kshatha + - + 46 Sootha - - +
Reasons for the exemption of these diseases from swedana have been
explained by various acharyas. Sushrutha stated that in these conditions, which are
contra-indicated for swedana, if swedana is performed either the body gets destroyed, or
the diseases progress to incurable stage. He also permits the performance of swedana in
Sweda karma 28
durbala and ajeernabhaktha, if their vikaras are curable only by swedana85. Chakrapani,
commenting on the verses of Charaka, says that kashayanityas become rookshas and
atistabdha gatras; hence, the swedana if performed causes parvabheda. Also persons
suffering from rakthapitha, pithameha, kamala etc. and pittaprakriti persons are
exempted from swedana even prior to shodhana as it may cause further pittakopa.
Madhumeha persons develop shareera shaithilya and in such a condition, swedana is
contra indicated. He also adds that if the condition of the patient is Sweda eka sadhya,
then the sweda be permitted. 86
Arunadatha, commenting on the verses in Ashtangahridaya, states that
swedana if done to an atisthoola person causes medovilayana resulting in shareera
kshobha. For rooksha, durbala, kshataksheena, kshama etc. The swedana may cause
extreme emaciation. A person having good appetite if undergoes swedana suffers from
dehaglani. In kamala and pandu rogas, the Swedakarma causes pitta vidradhi resulting in
roga vridhi. In garbhini, the swedana induces gabrha vyapat. For pushpitha ladies, it
causes excessive bleeding. For sootha, it causes emaciation. 87
As Vagbhata88 had stated if these conditions are atyayika, then mridu
sweda can be stated, Arunadatha89 too supports this view. Hemadri90 further states that
even if a condition/disease is aswedya, the stage being atyayika (due to the inevitability
of swedana) mridu sweda can be performed.
In general, we can conclude that Swedakarma is contra-indicated in four
conditions: – (1) pitta, (2) raktha, (3) durbala avastha and (4) sweda asaha. Also it is to
be noted that swedana can be performed in mridu mode if these conditions are sweda eka
sadhya.
Sweda karma 29
Samyak swinnalakshanas91
Table No. 07. Showing the lakshanas to be observed on the patient.
Sl. Lakshana C.S. S.S. A.H. 1 Seetha vyuparama + - + 2 Shoola vyuparama + - + 3 Sthambhanigraha + - - 4 Gouravanigraha + - - 5 Sanjathamardava + + + 6 Swedasrava - + - 7 Vyadhihani - + - 8 Laghutva - + - 9 Seetharthiva - + -
Among these shoola vyuparama, sthambhanigraha, gourvanigraha,
laghutva, mardava and vyadhihani are not evident immediately after swedakarma every
day, but manifest after the total course of proper swedana. Sheeta vyuparama, swedasrava
and seetharthitva are to be observed daily at the end of swedakarma daily.
Aswinnalakshanas
If the swedana performed is not sufficient or proper, then the lakshanas
opposite to the samyak swinnalakshanas occur. Dalhana adds that heaviness of the body,
ushnabhilasha and hardness of the body also occur. He has stated that mithya swinna
means both alpa swinna and mithya swinna (improper sudation) and that vyadhi vridhi
also occurs. 92
Atiswinnalakshanas 93,94,95
If the swedana performed is in excess, it leads to many complications.
Sweda karma 30
Table No. 08. Showing the Atiswinna lakshanas on the patient.
Sl. Lakshana C.S S.S. A.H.1 Pitta prakopa + + + 2 Murcha + + + 3 Shareerasadana + - - 4 Trishna + + + 5 Daha + + - 6 Swaradourbalya + - + 7 Angadourbalya + - + 8 Sandhipeeda - + + 9 Sphototpathi - + - 10 Rakthaprakopa - + - 11 Bhranthi - + - 12 Vidaha - + - 13 Klama - + - 14 Bhrama - - + 15 Jwara - - + 16 Syava-raktha mandaladarshana - - + 17 Chardi - - +
Management of Atiswinna: -
Charaka96 advises the adoption of greeshma ritu charya along with
consumption of madhura-snigdha-seetha aharas and to follow snigdha-seetha upacharas.
This includes consumption of sasharkara mantha, jangala mriga-pakshimamsa, ghee, milk
and shashtikashali. Madya should be avoided. Ahara dravyas with lavana, amla, katu and
ushna properties and viharas such as vyayama should be avoided. Patient should live in
seethagriha during the day and in the room cooled by moon rays in the night.
Seethadravyas like chandana can be applied over the body. Mukthamani dharana also
can be done. Patient can also be taken to cool forests and ponds. He/She should not
indulge in intercourse. 97 Sushruta says that all kinds of seetha upachara should be
performed immediately98.
Sweda karma 31
Vagbhata had advised the adoption of stambhana chikitsa in case of
atiswinna. 99 Drugs, which are having the properties of laghu, manda, seetha, slakshna,
rooksha, sookshma, sura & drava and having tiktha-kashaya-madhura rasas, are
stambhana oushadhas. These are to be administered internally and externally to prevent
further complications of the patients.
Classification of Sweda
Several types of classification of Sweda are made with different points of
view.
A. According to agni bheda. 100
1. Sagni (Thermal) & 2. Niragni (Non-thermal).
B. According to guna bheda. 101
1. Rooksha (Dry) & 2. Snigdha (Unctuous).
C. According to sthana bheda. 102
1. Ekanga (Local) & 2. Sarvanga (Total).
D. According to rogi bala and roga bala. 103 Mrudu (Gentle), Madhyama (Medium) &
Mahan (Maximum).
E. According to the source of heat. 104,105 Tapa (Direct heat), Ushma (Steam),
Upanaha (Poultice) & Drava (Warm liquid).
F. According to the method of sudation. 1061. Sankara (Mixed), 2. Prastara (hot bed),
3.Nadi (Steam kettle), 4. Parisheka (Affusion), 5. Avagaha (Bath), 6. Jentaka
(Sudatorium), 7. Asmaghna (Stone bed), 8. Karshu (Trench), 9. Kuti (Cabin), 10.
Bhu (Ground bed), 11. Kumbhi (Pitcher bed), 12. Kupa (Pit sudation) and 13.
Holaka (Under bed).
G. According to the usefulness in the Chikitsa, Samshamaneeya &
Samshodhanangabhoota. 107
Sweda karma 32
H. According to the route of application. Bahya & Abhyantara108.
I. On the basis of applicability in children. Hasta, Pradeha, Nadi, Prastara, Sankara,
Upanaha, Avagaha and Parisheka. 109
Niragni Sweda is further classified into ten types, viz., vyayama
(exercise), ushna sadana (warm rooms), guru pravarana (heavy blankets), kshudha
(hunger), bahupana (excessive drinking), bhaya (fear), krodha (anger), upanaha (plasters),
ahava (war) and atapa (sun bath). 110
Dalhana had said that jentaka, karshu, kuti, kupa and holaka are tapa
swedas ; sankara, prastara, ashmaghna, nadi, kumbhi and bhu are ushma swedas. 111
Bashpasweda and Shahtikashalipindasweda belong to the Ushma type of
Swedana. Dalhana has defined Ushma sweda as “Ushma bashpaha”. He has opined that
all the techniques of ushma sweda can be collectively called as bashpa sweda. 112
Nadi sweda
This is done with the steam coming from the vessel full of boiled
mamsarasa, milk, curd, dhanyamla or vataharapatrabhanga kwatha. The top of the vessel
is to be covered with kambala etc. for the prevention of excessive heat affecting the
patient. 113 Otherwise, the mouth of another vessel, which has a hole in its side, should
cover the top of this vessel. Sandhibandhana is done on the mukhas of the vessels. To the
hole of the upper vessel, a nadi (tube) resembling hastishunda (trunk of an elephant) of
one or ½ vyama (hand) length, having three folds and made of trina, kasha etc. is
connected. Before performing nadi sweda, the patient should be done abhyanga and
covered with a thick blanket. This is a very good method of swedana where all the angas
are done proper sudation without any difficulty. 114 The Bashpasweda used in this study is
a modification of this classical technique.
Sweda karma 33
Sankara sweda115
The process of thermal sudation by means of a bolus containing tila,
masha etc. with or without wrapping cloth is known as sankara sweda or pinda sweda. It
is of two types viz., Snigdha &Ruksha.
Sudation is done with the boluses of the seeds of tila, masha, kulatha
mixed with amla dravya, ghee, taila, mamsa, odana, payasa and krishara is called as
Snigdha pinda sweda. It is specially indicated in Vata rogas.
Sudation with the excreta of various animals like cow, ass, camel, pig etc.
and other substances such as satushayava, sand, powder, stones, dry cow dung cake, iron
powder etc. is called as ruksha pinda sweda, which is indicated in Kapha rogas.
According to Sushruta and Vagbhata, Upanaha type of sweda is
considered as one among saagni swedas. At the same time, Charaka and Vagbhata have
considered this as a niragni sweda also. Chakrapani, commenting on Charaka samhita,
stated that upanaha is of two types – Sagni & Niragni. 116 The sagni upanaha is nothing
but sankara sweda itself. An example for it is the Kolakulathadi yoga explained in
Charaka samhita Suthrasthana- 3/18.
All the Pindaswedas are based on the principle of Sankarasweda. 117
Pinda swedas
As this study is on a major technique of pinda sweda, it will be relevant to
describe in brief other techniques of pinda sweda too.
Sweda karma 34
Pinda sweda is a process by which the whole body or a specific part of the
body is made to perspire by the application of certain heated medicinal puddings applied
externally in the form of pinda or boluses tied up in square pieces of cloths. The
technique is a combination of snehana (oelation), mardana (massage) and swedana
(fomentation). Pinda Sweda will come under sankara sweda of Charaka and Kashyapa
and ushma sweda of Sushruta and Vagbhata.
The following pinda swedas are being practiced commonly.
1. Shashtikashalipindasweda
2. Patrapotalipindasweda
3. Choornapindasweda
4. Valukasweda
5. Tushapindasweda
6. Jambeerapindasweda
7. Mamsapindasweda
8. Kukkutandapindasweda
9. Mashapindasweda
10. Godhumapindasweda
11. Dhanyapindasweda
12. Haridradi pindasweda
1. Shashtikashalipindasweda 118
Details of this process will be discussed in the methodology chapter as this
study deals specially about Shashtikashalipindasweda.
Sweda karma 35
Effects Of Shashtikashalipindasweda - The effects of this treatment, if
properly done, are many. It cures powerful Vatarogas affecting all parts of the body;
diseases due to Rakthaprakopa; diseases which are very difficult to treat and diseases
which are affecting the strength (or immunity) of the body. In addition to these,
Shashtikashalipindasweda cures all types of diseases of the nervous system, chronic
rheumatism, pain in the joints, emaciation of the limbs and diseases born of vitiated
blood. This karma makes the body strong and sturdy with well-developed musculature. It
maintains the metabolism in a healthy condition from every point of view. This treatment
is found to be efficacious in subjects suffering from blood pressure and in certain kinds of
skin diseases resulting from impurity of the blood. This may also be resorted to once a
year, by healthy persons to keep up perfect health during old age and to prevent
premature aging.
2. Patrapotalipindasweda 119
Also known as “Ila kizhi” or “Pachakkizhi” (common names), this type of
pinda sweda uses cut Vataharapatras in the form of pottali. Patras of arka, eranda, shigru,
nirgundi, karanja, chincha etc. are taken in equal quantity and cut into small pieces.
Coconut scrapings and citrus fruit can also be mixed together with the patras. This
mixture should be roasted in suitable taila (e.g. Bala taila, Masha taila, Nimba taila etc.)
fit for disease. After proper frying, the mixture should be tied as two boluses in clean,
square clothes.
Sweda karma 36
These pindas are again heated in suitable taila and applied to the body in
comfortable heat. Out of the two pindas, one pinda should be in the vessel over gentle fire
while the other pinda is used for massage. Bolus should be taken by the right hand and
the intensity of heat is tested by the outer surface of the left hand before starting the
procedure. The patient should be well massaged with vatahara taila or taila suitable to
disease in prior. As soon as the bolus, which is in use losses the heat, it should be
replaced by the bolus, which is kept over the fire. Left hand of the attender should do the
light massage in the direction of the bolus.
The process has to be done without any interruption for a minimum time
of 30 minutes on the first day. Application should be done by asking the patient to
position in all the seven postures. If the physician decides to perform the therapy for 7
days, the duration should be increased by five minutes each day, thus reaching 45
minutes on the fourth day. From there it is reduced by five minutes per day to reach the
original duration (30 minutes) on the seventh day. If the therapy is for 14 days, the
increase in the duration is the same reaching the maximum of one hour on the seventh
day. Sometimes is the duration on eighth day also and from there, the duration is reduced.
These are subject to the individual rationality of the physician.
After the prescribed duration, the oil is wiped off the body with a dry
towel. Patient should be protected from immediate exposure to cold, sun, wind etc. and
allows to take rest for a few minutes. Then he is advised to take bath in water boiled with
vataharapatras.
Sweda karma 37
The drava in which the bolus is heated may be dhanyamla, gomutra,
vataharakashaya etc. The bolus of the contents should be changed daily or at least once in
three days. Two attendants are needed for the karma – one to perform the pinda sweda
and other to heat the bolus. Indications are prasupthi, kampa, angamarda, pakshaghata,
askhepaka, gridhrasi, sandhigatavata, kateeshoola etc.
3. Choornapindasweda120
This is performed with boluses of medicinal powders and is also known as
‘Podikkizhi’ (common name). Powders of rasa, ashwagandha, sarala, shunti, vacha,
shigru, devadaru, sarshapa, kola, kulatha, masha, godhuma, mudga, tila etc has to be
taken and added saindhava lavana. Each has to be taken 10 gms and 30 gms of coconut
scrapings and 2 or 3 pieces of citrus fruits can also be added. These powders and other
items well mixed are to be fried in suitable oils and made into two boluses.
The procedure and duration are same as the patrapottali sweda. This
procedure is the snigdha variety of choorna pinda sweda. The rooksha variety of choorna
pinda sweda is also common. Powders of kulatha, tusha etc are fried in iron pan along
with saindhava lavana without oil and then made into bolus.
Snigdha choornapindasweda is indicated in Vatarogas like apabahuka,
gridhrasi etc. and rooksha choornapindasweda is indicated in saama-kaphanubandha
Vatarogas like amavata.
4.Valuka sweda121
In this the bolus is prepared of sand. This is a typical rooksha sweda
indicated in amavata, vatarakta, urustambha etc. Here, the sand can be fried in dhanyamla
along with saindhava lavana. Much care should be taken in testing the heat of the bolus
and only moderate heat should be applied.
Sweda karma 38
5.Tushapindasweda 122
It is a process by which the bolus is prepared by the husk of the paddy.
Husk of the wheat also can be used. It is a household practice in our country in swasa and
kasa.
6.Jambeerapindasweda 124
Drugs used in this are jambeeraphala, saindhava lavana, and fried powders
of methika, kulatha, haridra and shatapushpi. 10 citrus fruits of big size should be cut into
the small pieces and 30 gms of haridra choorna and 5 gms of saindhava is added and fried
in suitable oil and made into bolus. It is beneficial in pakshaghata, apabahuka, sandhi
gatavata, bhagna etc.
7. Mamsapindasweda 125
It is similar to Shashtikashalipindasweda. If mamsa is alone made into
bolus, the drava dravya for cooking and heating is mamsa rasa. If mamsa is used along
with shashtikashali, balamoola kwatha along with ksheera are the drava dravyas for
cooking the mamsa and shali and also for heating the bolus. Meat of goats, hen, pig,
peacock etc. are generally used.
It is mainly indicated in emaciation (Shosha) prominent conditions such as
atrophy, dystrophy, myopathy, pakshaghata, balavata etc. It arrest the premature aging,
promotes the growth, tonicity and strength of muscles.
Sweda karma 39
8. Kukkutandapindasweda 126
Egg yolk of hen is used for this technique. Two lemon fruits are taken and
cut into pieces. It is mixed with three boiled egg yolks and fried in suitable oils and made
into bolus. It is beneficial in ardita, greevagraha, hanugraha, apabahuka etc.
9. Mashapindasweda 127
Here, instead of Shashtikashali, masha (Phaseolus radiatus) is used and the
procedure, duration and indications are similar to Shashtikashalipindaswedakarma.
10. Godhumapindasweda
Here, instead of Shashtikashali, godhuma (wheat) is used and the
procedure, duration and indications are similar to Shashtikashalipindasweda.
11. Haridradi pindasweda 128
This is specially indicated in Kshata (Trauma). Here, haridra choorna and
laja choorna are taken in more quantity and sarja choorna, jeeraka choorna and manjishta
choorna in less quantity. The white part of two boiled eggs is mixed thoroughly with
these powders and the end product is used as a bolus.
12. Dhanyapindasweda 129
Fried powders of masha, mudga, tila, sarshapa, shashtikashali, kulatha,
methika, shatapushpa and eranda beeja are made into bolus. Also, these can be cooked in
milk squeezed from coconut scrapings and made into bolus and used instead of
shashtikashalipinda.
Sweda karma 40
Swedakarmas & Karmukata
Swedakarma has four major actions over the body - (1) stambhaghnata, (2)
gouravaghnata, (3) seethaghnata and (4) swedakarakata.
1. Stambhaghnata
Stambha means stiffness. This attribute is a resultant of excess seetha guna
and also influence of factors such as samanavata, sleshakakapha, ama, mamsa, vasa &
medas is contributory to the production of stambha. Samanavata is rooksha gunapradhana
and hence if vitiated does excessive shoshana of shareera there by producing contractures
and stiffness. Sleshakakapha is snigdha and pichila and hence if decreased (kshaya)
results in less lubrication of joints causing stiffness.
Swedakarma being snigdha and ushna corrects both these deranged dosha
ghatakas and relieves stiffness. Chakrapani had stated that stambha also means
obstruction or block. Therefore, swedana not only relieves stiffness, but also clears
blocking of passages (srotorodha). Srotas as a structural entity is Kaphapradhana. Ayana
or transport is the most important function of srotas. This is under the control of Vata.
There by it is evident that there is a predominant influence of Vata and Kapha over the
srotas. Vitiation of these two hampers the structural and functional aspects of the srotas.
We know that swedana has the opposite qualities to that of Vata & Kapha, thereby
producing a palliative effect on them and the srotas is becoming normal. It is well known
that unless there is a srotodushti there is no disease. Thus, it is evident that swedana
clears the srotodushti or sanga.
In other words, by contact of bearable warmth, the area in contact gets
more circulation. The lumina of the contracted body architecture get smoother and
wider. This rendering a stiff entity smooth relieves variety of obstructions. Widening of
Sweda karma 41
the core and simultaneous liquefaction of the solid or semi-solid material makes the flow
easier. Widening of the tract and fluid character of the material inside makes the
obstructions released slowly.
2. Gouravaghnata
Heaviness of the body is being relieved by Swedana. By means of
swedana, the fluids in the body are being excreted through the sweda (sweat) and hence
the feeling of lightness in the body. Swedana stimulates the nerve endings and promotes
muscle strength.
3. Seethaghnatha
Seethaghnatha has to be understood as the patient is relieved of the
coldness existing prior (the ushna guna pradhana sweda karma is performed). In fact, by
the excretion of sweat, the heat in the body is being transferred out.
4. Swedakarakata
Swedana produces perspiration. This is a mala (excretory product). In
this, the wastes of all the layers of skin, muscles, nerves, rasa, raktha, meda etc. are
mixed. Therefore, it is a mechanism of excreting the metabolic wastes in the body
tissues.
Apart from these major actions, Swedana also produces the following
effects.
Sweda karma 42
1. Doshadraveekarana
Snehana performed prior to swedana makes the doshas mridu and
eradicates the mala sanga. The swedana penetrates to each and every channel in the body
and liquefies the doshas. These liquefied doshas has to be eliminated from the body
means of shodhana karma.
2. Vata shamana
Snehapoorvayukthasweda pacifies the Vata dosha, thereby curing the
pureesha-mutra-shukra sanga. By its properties opposite to that of Vata, it pacifies the
Vata. Sweda is also one of the upakramas of Vata.
3. Gatra vinamana
Charaka says that by application of oil and heat, even dry wood can be
bent then what is the wonder about shareera. It cures harsha, ruk, ayama, shopha,
stambha and graha and produces mardava, thereby permitting normal flexible body
movements.
4. Agnideepana
As swedana is ushna guna pradhana, it does the ama pachana there by
promoting the agni in the body.
5. Twak mardava & Prasadana
Perspiration is dependent on skin, where in the hair follicles which are the
moolas of swedavaha srotas are situated. Due to sweating and excretion of wastes, the
skin becomes soft and pleasant.
Sweda karma 43
6. Bhakthasradha
As the swedana promotes agni, more interest on food consumption is
resulting.
7. Srotosuddhi
The mechanism of making srotosuddhi has been explained under the
action stambhaghnata.
8. Nidra-Tandra nasha
Swedana pacifies Vata. Vata is responsible for the functions of indriyas
wherein nidra and tandra are affecting. Sweda also pacifies Kapha thereby making the
body light, and providing relaxation. Thus it prevents excessive sleep & drowsiness.
9. Sandhicheshtakara
Swedana relieves stambha and graha thereby promoting the sandhicheshta.
10. Dosha shodhana
The doshas situated in the dhathus, koshta and sakha-asthi and those leena
in the srotas gets kledana by snehana and gets liquefied by the swedana and comes to the
koshta and get ready for elimination by means of shodhanakarma.
Sweda karma 44
Modern View On Mechanism Of Action
Rapid diffusion of lipid soluble substances through cell membranes and
the dependency of the rate of diffusion on solubility in lipids have been proved.
Application of heat on an unctuous area causes the generation of a temperature gradient
across the cell membrane. Besides facilitating the diffusion of liquid substances through
the cell membrane, this plays key role in the formation of lipoid vesicles from the
dropouts in the membrane in areas of flow temperature. This causes an expansion in the
cell volume as well as surface area. But it cannot expand freely especially in the
peripheral direction as it is bound by other cells around. This makes the blebbing of cell
membrane inside.
The temperature gradient and pressure gradient caused by the heat further
helps in blebbing in this particular direction. These lipoid vesicles or blebs detached
from the cell organelle or other side of membrane and remain there till a critical surface is
reached. This membrane then blebs out and spread further. The whole phenomenon of
dropping of cell membrane vesicles and their incorporation into other membranous
structure was described as “Membrane flow hypothesis” by Palade in 1959.
Sweda karma 45
TYPES OF SWEDA
01. Snigdha 02. Rooksha
01. Ekanga 02.Sarvanga
01. Samshamaneeya 02. Samshodhaneeya
01. Mridu 02. Madhyama 03. Mahan
01. Sagni 02. Niragni
Tapa Upanaha Ushma Drava
Pani Pradeha Pinda Parisheka
Kamsya Bandhana Samstara Avagaha
Phala Sankara Nadi
Valuka Ghanashma
Vastra Kumbhi
Ghatika Kupa
Kuti
Jentaka
01. Vyayama 02.Ushnasadana 03. Gurupravarana 04. Kshudha
05. Bahupana 06. Krodha 07. Bhaya 08. Upanaha
09. Aahava 10. Aatapa
Sandhigatavata
Sandhigatavata is a disorder caused by the localization of vitiated doshas
in the asthi sandhis of the body. It is one among the many Vatavyadhees described by all
acharyas.130 It comes under the various Gatavatas explained in Vatavyadhiprakarana. 131
Terminology of Osteoarthritis132 :-
Four names, none of which are adequate are used interchangeably to
describe the disease. They are Osteoarthritis, Osteoarthrosis, Degenerative joint disease
and Hypertrophic arthritis. Osteoarthritis is less than ideal since the primary event is not
inflammatory, although secondary synovitis is usually present. Osteoarthrosis is perhaps
the best because the inflammation is secondary and the suffix denotes an increase and an
invasion, physiologic or pathologic, or a general over production. This early on, is a
relatively clear description of what the disorder is. Degenerative joint disease is
unsuitable, since degenerative implies aging, a running down, a deterioration, a catabolic
process; in fact for long periods, often years, the disease may not be clinically
progressive. Hypertrophic arthritis now completely out of style, describes one phase the
osteophytosis or overgrowth of bone.
Nidana
Specific nidana for Sandhigatavata is not mentioned in any Ayurvedic
texts. The nidanas for the Vatavyadhees in general itself is the nidana of Sandhigatavata.
The nidanas for Vatavyadhi and Vataprakopa are listed under the following headings:-
1.Aharaja, 2.Viharaja, 3.Manasika, 4.Abhighataja and 5.Anyat.
Sandhigatavata 46
Table No. 09. Showing the aharaja nidana133,134,135,136
Sl. Nidana C.S. S.S. A.H. B.P.1 Rooksha bhojana + + + + 2 Laghu bhojana + + - + 3 Seethanna + + - + 4 Alpa bhojana + + + - 5 Ama + - - + 6 Abhojana + + - + 7 Pramita bhojana - - + - 8 Vishama bhojana - + - - 9 Tikta-katu-kashaya rasa - + + + 10 Adhyashana - + - - 11 Sushkasaka - + - - 12 Vallura-varaka-uddalaka-koradusha-syamaka-adhakee-
harenu-kalaya-nishpava - + - -
In short, the excessive consumption of tikta-katu-kashaya rasas, laghu-
rooksha-sheeta gunapradhana aharas and dravyas such as shushkasaka etc and food habits
such as alpa bhojana, abhojana, pramita bhojana, vishama ashana and adhyashana causes
the vitiation of Vatadosha in the body.
Table No. 10. Showing the viharaja nidana
Sl. Nidana C.S. S.S. A.H. B.P. 1 Ativyavaya + + + + 2 Atiprajagara + + + + 3 Vishama upachara + - + - 4 Plavana + + - - 5 Atyadhva + + - - 6 Ativyayama + + + + 7 Dukshashayya + - - - 8 Dukhaasana + - - - 9 Divaswapna + - - - 10 Vegadharana + + + + 11 Gaja-ashwa-ushtra-sheeghrayana + + - - 12 Vega udeerana - - + - 13 Atyuchhabhashana - - + - 14 Prapatana + + - - 15 Pradhavana - + - - 16 Prapeedana - + - - 17 Bharaharana - � - -
Sandhigatavata 47
Manasika Nidanas
Mental factors like chinta, shoka, krodha, bhaya etc are the aggravating
factors of Vata. Vata is the controller of manas. Hence, any affliction to manas vitiates
the Vatadosha.
Abhighataja Nidanas :-
Abhighata to shareera especially to the marmas vitiates the Vatadosha. In
case of Sandhigatavata, the abhighata to the sandhis, janu marma, and other marmas like
kateekataruna, kukundara, nitamba, parshwasandhi etc are important causative factors.
Anyat (other nidanas): -
Panchakarma apacharas like atidoshasravana, atirakthasravana, atiyoga of
langhana, apatamsana etc and dhatukshayakarabhavas like rogakarshana, gadakrita
atimamsakshaya, etc vitiate Vata. Dhatukshaya is an important vitiating factor of Vata.
Sthoulya is another causative factor for Vata prakopa. The meda-avarana
of Vata is the mechanism causing inter-relationship between sthoulya and
Vatavyadhis137. All types of avaranas are also important vitiating factors of Vata. Vata
dominates vardhakya avastha138. During this period, dhatukshaya occurs causing Vata
prakopa.
Living in jangaladesha is another causative of Vata prakopa139. Vata gets
vitiated in the end of day and night140. Vata also get vitiated during the end of greeshma
ritu, varsha ritu and shishira kala141. Vata prakriti persons are more susceptible to Vata
vikaras. Persons who are rooksha-kashaya-katu-tikta satmya are also more susceptible to
Vata vikaras.
Sandhigatavata 48
Among all the types of nidanas mentioned some need special attention.
Adhyashana leads to excessive body weight and this results in more pressure over weight
bearing joints. This gradually weakens the sandhis and produces Sandhigatavata. Excess
exercise may not only vitiate Vata but further leads to shleshaka kapha kshaya
contributing to Sandhigatavata. Excess walking and excessive weight bearing also are
important in the context of Sandhigatavata. Abhighata to marmas or sandhis is another
important risk factor for Sandhigatavata. Vardhakya avastha characterized by
dhatukshaya leading to peshi-snayu-marma shosha, thereby resulting in looseness of
joints is also a major risk factor for Sandhigatavata. The factors like that vitiate
asthivahasrotas (ativyayama, atisamkshobhana, asthivighattana and vatalasevana) 142 also
need to be mentioned in the nidana of Sandhigatavata.
Risk factors for Osteoarthritis (OA) 143
• Age factor –
Age is the most powerful risk factor for OA. The association between OA
and aging is non-linear. It usually begins after a person is 40 or more years old. By the
age of 60 years, almost everyone has OA. More than 80% of people over 60 years old
have radiological evidence of OA in one or both knees and 30% in one or both hips.
• Sex factor –
It is told that women are at high risk than men in developing OA. Over
30% of women (elderly) have OA in the interphalangeal joints of the hands. Except in the
hands, men and women are affected equally, though the lesions often appear at a young
age in men. Only 3% of elderly men have primary OA in the hands.
Sandhigatavata 49
• Hereditary factor –
The relation of heredity is less ambiguous. Thus, the mother and sister of a
woman with distal interphalangeal joint OA are respectively twice and thrice as likely to
exhibit OA as the mother and sister of an unaffected woman.
• Race factor –
Racial difference exists in both the prevalence of OA and the pattern of
joint involvement. OA is more frequent in Native Americans than in whites. The Chinese
in Hong Kong have a lower incidence of hip OA than in whites. Interphalangeal joint OA
and especially hip OA are much less common in South African blacks than in whites in
the same population. Whether these differences are genetic or are due to differences in
joint usage related to life style or occupation is unknown.
• Obesity factor –
Obese persons have a high risk of OA. For those in the highest quintile for
body mass index at base line examination, the relative risk for developing knee OA in the
ensuing 36 years was 1.5 for men and 2.1 for women. For severe knee OA, the relative
risk rose to 1.9 for men and 3.9 for women, suggesting that obesity plays an even larger
role in the etiology of the most serious cases of knee OA.
• Occupational factor –
Repetitive movements may leads to excessive strain leading to erosion and
joint damage. Men whose jobs require knee bending and at least medium physical
demand had a higher rate of radiographic evidence of knee OA and more severe
radiographic changes.
Sandhigatavata 50
• Traumatic factors –
Trauma to the joint seems to enhance the occurrence of arthritis. It
disturbs the alignment of the joints and over a period of time, this malalignment may lead
to excessive wear and tear leading to OA.
According to the cause of OA, it is classified as primary and secondary.
Primary OA is the term used when the disorder arises form unknown or hereditary
causes. Secondary OA describes cases in which direct causes for the disorder are known.
Classification based on causes144
I. Primary
A. Idiopathic, B. Primary generalized osteoarthritis and C. Erosive osteoarthritis.
II. Secondary
A. Congenital or developmental defects (Hip dysplasias, shallow acetabulum,
Morquio’s syndrome, etc.),
B. Traumatic
a. Acute, b. Chronic and c. Charcot’s arthropathy,
C. Inflammatory (RA, psoriatic arthritis, septic arthritis, pseudogout),
D. Endocrinal influence (Acromegaly, diabetes mellitus, sex hormone
abnormalities, hypothyroidism with myxedema) and
E. Metabolic (Gout, itemochromatosis, ochronosis, chondrocalcinosis, paget’s
disease).
Sandhigatavata 51
Poorva roopa
Poorva roopa is the prodromal symptoms of a forth-coming disease, which
do not clarify the peculiarity of the dosha taking part in the samprapthi of the disease.
These symptoms will be few and not clear. 145 These are produced at the stage of
sthanasamshraya, when the disease has not completely evolved. 146
Specific poorvaroopa have not been mentioned for Sandhigatavata in
Ayurveda. Hence, the poorvaroopa of Vatavyadhi can be considered. Thus the
unmanifested symptoms of the particular Vatavyadhi should be considered as
poorvaroopa.
Observations based on the present clinical trail reveals that sandhi-gurutva
(heaviness of joints) and occasional pain in the joints, which were ignored by the patients,
were the poorvaroopas.
Samanya samprapti
Samprapti of Sandhigatavata has not been separately discussed in any of
the textbooks of Ayurveda. Hence, the common samprapti of Vatavyadhees are to be
considered here.
Charaka and Vagbhata had stated that the kupitavata circulate through the
empty channels in the body (riktasrotas) and fills them. This settling in the channels
produces Vata specific symptoms in the avayavas related to those channels. 147 Another
possibility is that the kupitavata entering the srotas can get avarana by other doshas etc
and manifest the symptoms. 148,149 Both these mechanisms are possible in case of
Sandhigatavata. The general pattern of samprapti is as follows: –
Sandhigatavata 52
Intake of rooksha-sheeta ahara & vihara like ativyayama, abhighata etc Reduction
of sneha bhava in the body Dhatukshaya where by sushirata in the channels
results Vata purana of these channels Manifestation of symptoms.
That is, the above said ahara vihara induces reduction of sneha bhava and
simultaneously produces vata kopa due to the dhatu kshaya. Reduction of shleshaka
kapha occurs and this allows the settling of vitiated vata (vyana vata) in the joints thereby
gradually resulting in the manifestation of Sandhigatavata.
Concept of Gatavata
As the disease belongs to Gatavata group of Vatavyadhees, it will be
relevant to discuss the concept of Gatavata here. While mentioning Gatavata, acharyas
have mentioned the gatatva of dhatu, upadhatu, ashaya, avayava etc. The various
terminologies used to denote this Gatavata are gate, sthithe, avasthite, ashrite, prapte, etc.
150 These all terminologies can imply two important factors – A) related to the gati of the
vitiated Vata and B) related to the occupation of a particular site.
When these two factors combine then such a condition is termed by
adding objective of that site, for e.g. Sandhigatavata. Though Vata is present all over the
body, its gata condition specially indicates its abnormal localization at the particular
dhatu or ashaya. In this condition, the etiological factors are only of Vata and not of dual,
i.e., not of both dosha and dooshya. For example, in Vataraktha, the atisevana of ahara
vihara vitiating Vata and Rakta at a time leads to the prakopa of both simultaneously,
resulting in Vataraktha. While in Sandhigatavata, the kopa of Vata alone occurs and this
vitiated Vata by involving the sandhis produces Sandhigatavata.
Sandhigatavata 53
Particularities of these Gatavatas are that here the Vata vitiation is active,
Vata dosha is more important, vitiation of Vata is due to it’s own nidanas and there is a
state of dhatu kshaya and rikta srotas. 151
Also the samprapti of Sandhigatavata can be discussed under two headings
for better understanding – 1. Dhatukshayajanya and 2. Margavaranajanya.
Dhatukshayajanya
Here-in, the initiation of the process of samprapti is due to the strong
involvement of nidana factors such as vardhakya avastha, abhighata, ativyayama,
marmaghata etc. These factors lead to the Vata vridhi followed by Kapha kshaya. This
results in agni mandya. Then the state of dhatukshaya is the resultant and hence there is
kshaya of asthi dhatu too. Kapha kshaya reflects in the decrease of shleshaka kapha also.
This permits the settling of vitiated Vata in the sandhis and then the manifestation of the
symptoms.
Margavaranajanya
Here, the samprapti process is initiated by the nidana ghataka, sthoulya.
Sthoulya results in increase of medas only and mal-nourishment of subsequent dhatus
including asthi. This results in Vata prakopa. But, its gati is obstructed by vridha medas.
This leads to gradual avarana of Vata and there by lodging of it in the sandhis due to
nidana specificity and hence, the manifestation of symptoms.
Sandhigatavata 54
Sushruta has indicated manifestation of Vata vikaras as a complication of
sthoulya. 152 That is the intake of sleshmala ahara etc results in the formation of ama and
production of medas due to atisneha. This causes sthoulya. Along with many other
complications, the sthoola’s body movements are reduced. Due to avrita marga by Kapha
and medas, nourishment of subsequent dhatus does not occur leading to their kshaya.
Vata vikaras manifests as the resultant of medahkritha margavarana. 153
Three main factors involving in the production of Sandhigatavata, in any
form of samprapti are –
Kopa of vyana vata, which normally controls all the movements of the body
Kshaya of shleshaka kapha, which normally aligns the joints and maintains its
compactness and
Deterioration of sleshmadhara kala, which lubricates the joints.
Samprapti ghatakas
• Dosha – Vata –Vyana vata vridhi
Kapha – Shleshaka kapha
• Dushya – Asthi, Majja, Peshi, Snayu, Sleshmadhara kala
• Srotas – Asthivaha, Medovaha, Majjavaha, Mamsavaha
• Agni – Jatharagni, Asthidhatwagni, Medodhatwagni
• Ama – Jatharagni mandyajanya, Asthidhatwagni mandyajanya,
Medodhatwagni mandyajanya
• Udbhava – Pakwashaya
• Rogamarga – Madhyama
• Adhisthana – Sandhi
Sandhigatavata 55
Pathogenesis of Osteoarthritis 154
The association between OA and aging is non-linear; the prevalence
increases exponentially beyond the age of fifty. About 80% to 90 % of the individuals, of
both sexes, have evidence of OA by the time they reach the age of 65. The age related
changes in cartilage include alteration in proteoglycans and shorten fatigue life. Despite
this relationship, it is an over simplification to consider OA as merely a disease cartilage
wear and tear.
Chondrocytes play a primary role in the process and constitute the cellular
basis of the disease. For example, the chondrocytes in the osteoarthritic cartilage produce
IL-1 and TNE-alpha, which are known to stimulate the production of catabolic
metalloproteinases and inhibit the synthesis of both type 2 collagen and proteoglycans.
The effects of these cytokines are potentiated because their receptors show an increased
sensitivity. Other mediators, such as prostaglandin derivatives and IL-6, also have a role
in this cascade of matrix degradation. Most of these cytokines also have pro-
inflammatory properties, and inflammatory cells are present in many osteoarthritic joints.
The precise events that lead to the secretion of cytokines however are not clear.
Degeneration & OA
OA is caused by the degeneration of the articular cartilage in the joints
involved. In the regions involved, the cartilaginous matrix and the chondrocytes swell.
The proteoglycans in these regions are smaller then the normal. The proportion of
chondrotin sulfate falls and the proportion of keratin sulfate rises. The change in the
character of the proteoglycans exposes the collagen fibers in the cartilage. Poorly formed
Sandhigatavata 56
type I collagen tends to replace the type II collagen normal in the cartilage. In the
degenerating regions, small fissures develop in the cartilage. The fissures separate
irregular brands of cartilage that project perpendicular to the articular surface, a change
called fibrillation. Clumps of chondrocytes are often present near the clefts. As years
pass, much or all of the articular cartilage is slowly worn away. Eventually, only irregular
patches of articular cartilage remain on the articular surfaces of the bones1.
Degeneration of the synchondral joints of the spine causes loss of water
from the nucleus pulposus. It becomes smaller and less resilient and often is fissured or
calcified. Chondrotin sulfate is lost from the nucleus. Keratin sulfate and collagen
accumulate in it. The thin cartilaginous plates that separate the intervertebral disc from
the vertebrae degenerate, becoming fissured or fibrillated like the articular cartilages in
the osteoarthritic diarthrodial joints. Often the nucleus pulposus herniate through the
cartilaginous plate into one or both of the adjacent vertebrae. The herniated part of the
nucleus pulposus is usually 1-2cm across and is called a Schmorl’s node. The annulus
fibrosis of the disc is weakened, allowing the disc to bulge anteriorly and laterally2.
Weightman has shown that the ability of the articular cartilage to
withstand fatigue testing diminishes progressively with age3. Because OA is most
common in aging patients, it is often proposed that the disease is an intrinsic part of the
aging process. The wear and tear theory assumes a decreasing capacity with the age of
articular cartilage to resist mechanical stress4.
Sandhigatavata 57
Roopa
Sandhigatavata manifests in the body with the following lakshanas.
1. Vatapoornadrithisparshaha shothaha: - Swelling over the joint resembling an air–
filled bag on touch. Arunadatta says that the shopha is similar to an air –filled
bag. 155
2. Prasarana akunchanayoho savedana pravritti: - Painful flexion and extension is
another feature of Sandhigatavata. 156
3. Hanti sandheen: - This, according to Dalhana, is the absence of joint movements
(flexion & extension) implying the joint damage. According to Gayadasa, it is the
difficulty in joint movements. According to the Madhukosha commentary on
Madhava nidana, it means that the Vata vitiated in the joints either hampers the
functioning of joints or produce stiffness etc. 157
4. Shoola: - Pain in the joints. 158
5. Atopa: - Crepitus (Characteristic sound produced from the joints). 159
Table No. 11. Showing the lakshanas of Sandhigatavata.
Sl Lakshana C.S. S.S. A.H. Others 1 Shoola - + - Madhavanidana
Bhavaprakasha Gadanigraha
2 Shotha + + + Bhavaprakasha Gadanigraha
3 Vatapoornadrithi sparshaha sothaha
+ - + -
4 Prasarana akunchanayoho savedana pravritti
+ - + -
5 Hanti sandheen - + - Madhavanidana Bhavaprakasha Gadanigraha
6 Atopa - - - Madhavanidana 7 Sandivishlesha - - - Madhukosha 8 Sandhi stambha - - - Madhukosha 9 Prasarana akunchanayoho
abhava - - - Dalhana
10 Prasarana akunchanayoho asamarthya
- - - Gayadasa
Sandhigatavata 58
Acharyas of Ayurveda have not mentioned that Sandhigatavata affects
only any particular sandhi of the body. Modern medicine also supports this view.
Clinical features of Osteoarthritis 160
Symptoms
No systemic manifestations
Pain on use; pain at rest in severe and advanced diseases
Localized stiffness 15-30 minutes in morning and after immobilization in daytime
Muscle spasm
Limitation of motion in advancing disease
Symptoms uncommon before age 40, except in secondary OA
Pain related to specific joints
Joints most commonly involved –
Distal interphalangeal joints
Proximal interphalangeal joints
First carpometatarsal joint
Scaphotrapezoid joints
Knees
Hips, often unilateral
Spine, cervical and lumbar
First metatarsophalangeal joint
Signs
• Joints, enlarged, synovium and capsule synovial fluid, and bony and cartilage
Proliferation
• Tenderness, local at joints
• Crepitus, creaking, grating, cracking
• Warmth without redness of joints
• Palpable osteophytes
• Joint effusion of normal or high viscosity fluid
Sandhigatavata 59
• Deformity of joint with preservation of function with exception of hip joint and
First carpometacarpal joint
• Sometimes episodic course, e.g. primary generalized OA
• Soft synovial proliferation without bony proliferation, rare
• Genu varus and valgus
• Hallux valgus
• Heberdens and Bouchar’s nodes and first carpometacarpal enlargement
• Rare involvement: elbows, shoulder, metacarpophalangeal, lateral
metatarsophalangeal, proximal interphalangeal and joints of feet, ankle, subtalar
and midtarsal, thoracic spine.
Diagnosis of OA is made accurately by clinical history, physical examination
radiological study, and when etiology and pathogenesis are not clear, by certain
laboratory examinations. The symptoms and signs are usually confined to one or only a
few joints. If many joints are involved, the diagnosis is more likely a systemic form of
rheumatic disease. 161
Radiologic and laboratory characteristics of Osteoarthritis162
Normal radiographic findings occur in early OA. Joint space narrowing
follows degeneration and disappearance of hyaline cartilage. Early in the disease with
effusion and swelling of cartilage, there may be joint space widening. Subchondral bony
sclerosis or eburnation is very characteristic and represents deposition of excessive new
bone. Marginal osteophytes in a variety of patterns in various joints reflect bone, cartilage
and synovial cell proliferation. Sub location and gross deformities with loose bodies in
the joint appears late. Radiologic criteria for diagnosis of osteoarthritis as defined in the
Atlas on standard radiographs is given below:
Sandhigatavata 60
1. Formation of osteophytes in the joints margins or at ligamentous attachments, e.g.
tibial spine
2. Periarticular ossicles, mainly distal and proximal interphalangeal joints
3. Narrowing of the joints space associated with sclerosis of subchondral bone and
4. Altered shape of bone end e.g. head of the femur.
The following five step grading system is used according to the number of
criteria present: 0 = No OA, 1 = Doubtful OA, 2 = Minimal OA, 3 = Moderate OA
and 4 = Severe OA.
There are no specific laboratory abnormalities in primary OA. The
synovial fluid is essentially normal, a few cells above normal counts, a slightly reduced
viscosity or string test, a normal mucin clot and total protein concentration. An increased
concentration of inorganic pyrophosphate (PPi) is found in OA and is positively
correlated with the severity of radiologic OA. The application of thermography and
scintillation scans of joints has little or no clinical usefulness but has shown negligible
evidence of inflammation in OA compared to the inflammatory arthropathies.
Association of OA has also been noted with elevated Westergren
sedimentation rate, elevated C-reactive protein, serum uric acid and ASO titers. In
primary generalized OA, elevated serum cholesterol and transient rises in other acute
phase reactants occur, Specific laboratory studies may be needed for diagnosis of
secondary OA associated with specific primary disease. Arthroscopy thus far has little
practical use in OA.
Sandhigatavata 61
Vyavachedakanidana
Sandhigatavata is a disease affecting the bony joints. So virtually every
disease that affects the joints has to be differentiated with Sandhigatavata. The most
common differentiation is to be made with Vatarakta, Amavata and Kroshtrukasheersha.
Table No. 12. Showing Vyavachedakanidana between Sandhigatavata and Vataraktha
Sl. Criteria SGV Vatarakta 1 Nidana Vatavridhikara
ahara-vihara Vidahi, viruddha, rakthaprakopakara ahara
2 Poorva roopa Avyaktharoga lakshana
Kushtasama
3 Roopa Sandhishoola, Prasarana akunchanayohovedana, Sandhi shopha, Vatapoornadrithi sparsha
Teevra ruk, Grathita-paki shvayathu
4 Adhisthana Sandhi Padamoola, Hastamoola
5 Doshas Vata Vata, Rakta 6 Upashaya Ushna - snigdha Sheeta
Table No. 13. Showing Vyavachedakanidana of Sandhigatavata and Amavata
Sl. Criteria SGV Amavata 1 Nidana Vatavridhikara
ahara-vihara Viruddha ahara-cheshta
2 Poorva roopa Avyaktharoga lakshana
Hridaya dourbalya, gourava
3 Roopa Sandhishoola, Prasarana akunchanayohovedana, Sandhi shopha, Vatapoornadrithi sparsha
Vrischika damshavat peeda, Pidakayukta shopha
4 Adhisthana Sandhi Hasta, Pada, Gulpha, Trika, Janu etc.
5 Dosha Vata Vata, Kapha 6 Upashaya Ushna, snigdha Ushna-rooksha
Sandhigatavata 62
Table No. 14. Showing Vyavachedakanidana of Sandhigatavata & Kroshtrukasheersha
Sl. Criteria Sandhigatavata Kroshtrukasheersha 1 Nidana Vatavridhikara
ahara-vihara Vatavridhikara ahara-vihara
2 Poorva roopa Avyaktharoga lakshana Avyaktharoga lakshana 3 Roopa Sandhishoola,
Prasarana akunchanayohovedana, Sandhi shopha, Vatapoornadrithi sparsha
Maharuja, Janushopha
4 Adhisthana Sandhi Jan Madhya 5 Dosha Vata Vata, rakta 6 Upashaya Ushna, snigdha Snigdha, seetha
Table No. 15. Showing Differential diagnosis between OA, RA, Gout and Rheumatic
fever.
Sl. Criteria OA RA Gout Rheumatic Fever
1 Symptoms Pain & swelling on major weight bearing joints, stiffness, crepitations, tenderness, enlargement of joint space
Inflammation in multiple joints, morning stiffness >30ms
Polyarticular pain, swelling & inflammation, exquisite tenderness
Painful and tender joints
2 Mode of On set
Gradual Abrupt Acute Acute
3 Joints Involved
Weight bearing joints
Polyarticular Metatarso- phalangeal joints
Polyarticular
4 Systemic Features
- Autoimmune disease, rise in temperature, anemia etc.
- Carditis, fever, chorea
5 Investigations RA-ve, ESR normal, X-ray- narrowing of joint space, subchondral bony sclerosis, osteophytes etc.
ESR raised, X-ray-soft tissue swelling.
Serum uric acid raised, punched out lesions in subchondral bone.
ESR increased, CRP high, WBC elevated.
Sandhigatavata 63
Upadravas (Complications) 163 Upadrava is produced after the manifestation of the pradhana vyadhi and it
is dependent on it. Osteoarthritis if long standing will be having complications like
muscle wasting, various deformity, intra articular loose bodies etc. This state is very
complicated one where the patient feds much difficulty in managing the daily routines.
Upashaya-anupashaya164
Upashaya & anupashaya are very much important; especially during the
treatment usually drugs having snigdha & ushna gunas are prescribed as these pacify the
Vata kopa. This should be adopted in the nirama avastha of vatavyadhi only. This is the
upashaya method. When the same drugs are prescribed in the saama avastha of
vatavyadhi the disease aggravates. This is the anupashaya.
Sadhyaasadhyata
Vatavyadhis are considered as one among the mahagadas by acharyas. 165
Generally, Vata rogas are very difficult to cure due to the deep–seated nature of them.
Sandhigatavata usually occurs in the vardhakya kala, the kala, which is predominant of
Vata. Charaka had mentioned some Vatavyadhees, which are either not curable due to
sthana gambheerata or curable with effort in case they are of recent origin, in strong
patients and if without any complications. Khudavatata is one among them, which
according to Chakrapani is Sandhigatavata. 166
Sandhigatavata 64
Chikitsa
Treatment of a disease in Ayurveda starts with nidana parivarjana. This
has to initiated first before administering any medicine or adopting any line of treatment.
Line of treatment of Sandhigatavata
(1) Snehana167
All types of bahya & abhyantara snehana are to be adopted in treatment in
order to pacify the Vridhavata and to provide enough sneha amsha to the body that has
underwent kshaya. Various modalities of abhyantara snehana are bhojana, pana, nasya
and snehabasti. Various modalities of bahya snehana are abhyanga, lepa, mardana,
udvartana, samvahana, moordha taila, gandusha, karnapoorana, akshitarpana, parisheka
and pichu.
(2) Upanaha168
This is of two types- 1) saagni and 2) niragni. Saagni upanaha is nothing
but Sankara sweda. Niragni upanaha is the tying of Vatahara dravyas over the affected
body part for a time period of 12 hours.
(3) Agnikarma169
This procedure is a Shastra karma explained by Ayurveda. This karma
utilizes various heated materials to cauterize the particular body part affected. Sushruta
states that in the vitiation of Vata in twak, mamsa, sira, snayu and sandhi Agnikarma
provides good relief. Dahana karma is a synonym of Agnikarma.
(4) Bandhana170
This has been explained under Upanaha.
Sandhigatavata 65
(5) Unmardana171
This is a massage technique utilized in case of bahya snehana procedures.
The massage is performed by applying gentle pressure.
Apart from these, the Basti karma should also be adopted, as it is the
parama oushadha for Vata. 172
Shamana oushadhees
1) Kwatha : - Maharasnadi, Rasnadi, Dhanvantaram, Sahacharadi.
2) Choorna : - Alambushadi choorna, Abhadi choorna.
3) Vati : - Ajamodadi vati, Tab. Sallaki, Tab. Sallaki plus.
4) Guggulu : - Kaishoraguggulu, Yogarajaguggulu, Brihat yogaraja,
Adityapakaguggulu, Simhanadaguggulu.
5) Rasaoushadhi : - Panchanana rasa, Vatarakshasa, Brihat vatachintamani.
6) Sneha : - Dhanvantaram taila, Kottam chukkadi taila, Sahacharadi taila,
Vatashani taila.
Pathya173
Ahara
1. Rasas : - Madhura-amla-lavana
2. Shukadhanya : - Nava godhuma, Nava shali, Rakta shali, Shashtika shali.
3. Shimbi varga : - Nava tila, Masha, Kulatha.
4. Shaka varga : - Patola, shigru, vartaka, lashuna.
5. Mamsa varga : - Ushtra, Go, Varaha, Mahisha, Magura, Bheka, Nakula, Chataka,
Kukkuta, Tittira, Kurma.
Sandhigatavata 66
6. Jala varga: - Ushnajala, Shrithasheetajala, Narikelajala.
7. Dugdhavarga: - Go, Aja, Dadhi, Ghritha, Kilata, Kurchika.
8. Mutravaga: - Gomutra.
9. Madyavarga: - Dhanyamla, Sura.
10. Snehavarga: - Tilaja, Ghrita, Vasa, Majja.
Vihara
Veshtana, Trasana, Mardana, Snana, Bhushayya, etc.
Among present day food stuffs & activities-
1. Can be taken: - Orange juice, carrot, all fibrous fruits and certainoids.
2. Should do: - Slight walking, swimming, steam bath etc.
Apathya174
Ahara
1. Rasa: - Katu, Tikta, Kashaya.
2. Shimbivarga: - Rajamasha, Nishpava, Mudga, Kalaya.
3. Shukavarga: - Truna, Kangu, Koradusha, Neevara, Syamaka.
4. Phalavarga: - Jambu, Udumbura, Kramuka, Tinduka.
5. Mamsavarga: - Sushka mamsa, Kapota, Paravata.
6. Jalavarga: - Sheeta jala.
7. Ksheeravarga: - Gardabha.
Sandhigatavata 67
Vihara
1. Manasika: - Chinta, Shoka, Bhaya.
2. Shareerika: - Jagarana, Shrama, Vyayama, Vyavaya, Chankramana, Vegadharana etc.
Among the present day food stuffs and activities-
1. Can be taken: - Fast food, cold beverages, liquor.
2. Should be avoided: - Long standing sitting, driving, staying in AC etc.
Management of Osteoarthritis175
This involves many measures like pharmacological means, non-
pharmacological means and surgery.
Pharmacological means –
1. Simple analgesics
A large number of medicines are prescribed for relief of pain. The
recognition that pain in OA is not necessarily due to inflammation has led to an increased
awareness of the role of simple analgesics in the treatment. The ACR guidelines
emphasize the use of acetaminophen (Tylenol) as the first line treatment for OA.
2. Opioid containing analgesics
Code line and propoxyphene can be used for short periods to treat
exacerbations of pain.
3. NSAIDS
Trials comparing simple analgesics and NSAIDs found that
acetaminophen along can control pain in a substantial number of patients with OA
celecoxib, a cox-2 inhibitor, and rofecoxib are recent advances among NSAIDs.
Sandhigatavata 68
4. Local analgesics
Among the local applications, capsaicin cream is used commonly.
5. Intra articular cortico-steroid injections.
6. Intra articular administration of hyaluronic acid like products.
Agents used to treat Osteoarthritis
Acetaminophen, NSAIDS (Salicylates, Propionic acids, Acetic acid,
Oxicams), Cyclo-oxgenase inhibitors, Irritants/Counter irritants, Hyaluronic acids and
Glucocorticoids.
Non-pharmacologic means
Patient education
Exercise: - To maintain range of motion, muscle strength and general health.
Patients may also be referred to aerobic exercise programs such as fitness walking
or swimming.
Assistive devices: - Many patients with OA of hips and knee are more
comfortable; wearing shoes with good shock-absorbing properties orthoses. The
use of an appropriately selected cane can reduce hip loading by 20-30%. Patients
with specific physical disabilities may benefit from physical and occupational
therapy.
Weight management: - There is a longitudinal association between obesity and
OA of knee in men and women. Therefore, primary preventive strategies may
include measures to avoid weight gain, or to achiever weight loss in over weight
patients.
Supplements: - Glucosamine sulphate and chondrotin sulfate.
Sandhigatavata 69
Surgery176
Surgical procedures are of value in the management of OA. They may be
grouped under 3 major categories. Procedures to correct mal alignment and eliminate
abnormal joint stresses (osteotomies) not only may slow down disease progression but
may-also bring healthier articular cartilages into opposition and provide symptomatic
relief. Debridement with removal of free bits of cartilage or large ecostoses may relieve
pain and locking and help in prevention of rapid and extensive cartilage degeneration. In
advanced disease, arthroplasty or joint replacement may be required to reduce pain and
improve function; at times arthrodesis is required to control pain, even though motion
must be sacrificed.
Sandhigatavata 70
SAMPRAPTI OF SANDHIGATAVATA
Ahara
Vihara
Vardhakya Sthoulya
Abhighata
Ativyayama
Vataprakopa and Kapha kshaya
Agnimandya Margavarana of Vata by vridha medas
Dhatu kshaya
Asthi kshaya
Vatapurana in rikta srotas
Sthanasmashraya in sandhis
Shleshaka kapha kshaya and Vyana vata kopa
SANDHIGATAVATA
Dha
tuks
haya
jany
a sam
prap
ti
Margavaranajanya sam
prapti
DRUG REVIEW
1) Shashtikashali
All the textbooks of Ayurveda claim that this rice variety is the most beneficial in the Vreehivarga.
Table No. 16. Showing the rasa, guna, veerya, vipaka, guna and doshakarmas of Shashtikashali177.
Botanical Name Family Synonyms Parts used Rasa Veerya Vipaka Guna Dosha karma
Oryza sativa Linn.
Gramineae Vreehi, Tandula, Dhanya
Grain, Spirit, Vinegar
Madhura; Kashaya anurasa
Sheetha Madhura Mrudu, Snigdha, Grahi, Laghu, Sthira, Balavardhana, Tarunyasthapaka, Dehadardhyakrit
Tridoshaghna
Pittanilahara,
Kaphashukrala
Charaka had stated that there are two varieties of Shashtikashali, viz., goura and krishnagoura and that goura is the best
among them. Vagbhata and Arunadatha178 have accepted this view. But, Sushrutha179 had given a list of Shashtikashalees among
which Shashtika (goura) is the best one. Dalhana180, commenting on the same verse, had said that among these varieties Shashtika is
the gourashashtika and rest all are either krishnashashtikas or gourakrishnas. Dalhana also says that even though Shashtika is a
Vreehibheda and the best one among them, there is a difference between other Vreehis and Shashtika. That is, Shashtika gets matured
fast (sheeghrapaki) and Vreehes mature late (chirapaki).
71
In this study, the white (goura) variety of Shashtika was used.
Incidentally, the year of conduction of this study (2004) was observed as the International Year Of Rice. The
compendium of papers published on the seminar “Science-Society Interface on Medicinal and Aromatic Rices”, organized by
M.S.Swaminathan Research Foundation, Chennai and Kerala Agricultural University, Thrissur in partnership with National Medicinal
Plants Board, Govt. Of India and International Fund for Agricultural Development, Rome at the Paddy Research Institute, Pattambi,
Kerala provides some valuable information on Shashtikashali.
Morphology & Duration of growth181
Navara (Shashtikashali’s Malayalam name) is in the group of very early maturing type of rice (Some farmers claim that
they have harvested it within 57days). If it is grown in proper field (commonly rain fed upper and low land) and there is no fault in
cultural practices, it matures in the sixtieth day. However, in no case its duration will exceed 90 days.
There are two clearly distinguished ecotypes existing in this cultivar - one with golden-yellow glumes and the other
with black glumes. Within each ecotype, there are two different forms - one with awn and another without awn. Thus, in this variety
there exists four morphologically distinguishable strains, but adapted to same kind of agro-ecological conditions. Plant generally
grows up to 1metre tall. Grains are narrowly ellipsoid, small, slender and light in weight with red kernel.
72
Chemical constitution182
There are few reports to show that this variety of rice possesses some characteristic amino acids (Menon & Potty,
1995,1997,1998). These authors have attempted to understand the amino acid composition in the two known strains. It shows that total
free amino acid composition in them is more when compared to other high yielding varieties. They reported that the amino acid
content varies under different agro-ecological conditions. According to them, the methionine might be the responsible active
compound for the medicinal quality. Methionine is the only common amino acid with either linkage and is an important donor of
active methyl groups.
Although variety like Navara is being used in the traditional medicine for a very long time, the bio-chemical or physico-
chemical components governing its unique medicinal property is neither established nor scientifically validated.
Table No. 17. Showing chemical composition of rice183
Moisture 12.4% Ash 0.4% Crude fiber 0.2% Carbohydrate 79.2% Protein 7.4% Fat 0.4%
Processing of Shashtikashali in Goksheera and Balamula Kashaya will be explained in the treatment schedule.
73
2) BALA
The rasa-guna-veerya-vipaka-guna-doshakarmas of Bala184 is summarized in the table given below.
Botanical
Name
Family Synonyms Parts
used
Rasa Veerya Vipaka Guna Doshakarmas
Sida
cordifolia
Linn.
Malvaceae Vatyalika
Kharayashika
Odanika
Samanga
Mula
Beeja
Madhura Sheetha Madhura Laghu
Snigdha
Pichila
Vatapitha-
shamaka
Major components of seeds are alkaloids. Alkaloids contain mainly ephedrine. It also contains fatty acid, mucin,
potassium nitrate and resin. It is the agrya oushadha in Vatarogas. Locally, it is applied over inflammation and eye disorders. It is a
nervine tonic and cardiac tonic.
74
3) GOKSHEERA
The rasa-guna-veerya-vipaka-guna-doshakarmas of Goksheera is summarized in the table given below.
English Name
Varga Synonyms Rasa Veerya Vipaka Guna Doshakarmas
Cow’s
Milk
Dugdha-
Varga
Gavya
Payaha
Madhura
Sheetha
Madhura
Mridu
Snigdha
Bahala
Slakshna
Pichila
Guru
Manda
Prasanna
Rasayana
Jeevaneeya
Rakthapithahara
Vatapithaghna
It is made up of 87.4% water and 12.6% milk solids (3.75 fat, 8.9% milk solids-not-fat). The milk solids-not-fat
contains protein (3.4%), lactose (4.8%) and minerals (0.7%). Cows milk is a heterogeneous mixture of proteins. About 80% of total
proteins in milk are casein and 20% is whey protein. It also contains small amount of various enzymes (lipoprotein lipase, alkaline
phophatase, lactoperoxidase etc.) and traces of non-protein nitrogenous compound (e.g.: ammonia, urea, creatinine, uric acid etc.) 185.
75
4) NIRGUNDI – The rasa-guna-veerya-vipaka-guna-doshakarmas of Nirgundi186 is summarized in the table given below.
Botanical
Name
Family Synonyms Parts
used
Rasa Veerya Vipaka Guna Doshakarma
Vitex
Negundo
Linn.
Verbenaceae Sephalika
Swetasurasa
Vrikshaka
Sinduvara Leaves
Root
Seeds
Katu
Tiktha
Ushna Laghu
Rooksha
Sothahara
Kapha-
vata-
shamana
Leaves contain a colourless essential oil of the drug, and a resin ; fruits contain an acid resin, an astringent organic acid,
malic acid, traces of an alkaloid and a colouring matter. Leaves are useful as anti-inflammatory ; also over sprained limbs, contusions,
leech bites etc. Oil is useful in glandular swelling, sloughing wounds, ulcers etc. Rheumatic patients will be benefited by baths of
Nirgundi leaves boiled in water. Root is used in dyspepsia, colic, rheumatism, worms, boils and leprosy. Various extracts of the leaves
and root of the Vitex negundo possess anti-inflammatory and analgesic activities187.
76
5) CHINCHA – The rasa-guna-veerya-vipaka-guna-doshakarmas of Chincha188 is summarized in the table given below.
Botanical
Name
Family Synonyms Parts
used
Rasa Veerya Vipaka Guna Doshakarma
Tamarindus
indicus
Linn.
Leguminoseae Chukrika
Chukra
Amlika
Fruit-
pulp
Seeds
Leaves
Flowers
Bark
Amla Ushna Amla Guru
Rooksha
Kapha-
pitha-
shamana;
Vata-
shamana
Pulp contains tartaric acid 5%, citric acid 4%, malic and acetic acids, tartaric of Potassium 8%, invert sugar 25-40%, gum and
pectin. Seeds contain a fixed oil and insoluble matter. Seeds contain albuminoids, fat, carbohydrates 63.22%, fibre and ash containing
phosphorus and nitrogen. Fruit contains trace of oxalic acid. Therapeutically useful as laxative, antidote for intoxication from Dathura,
Pachana, in inflammatory swellings etc. Poultice of leaves are recommended as applications to inflammatory swelling to relieve pain.
77
6) Gandharvahastadi Kwatha189 –
It was prepared according to the Kashayakalpana.
No valid information on the chemical composition is available regarding
this yoga. This Kwatha can be administered along with Saindhavalavana or Guda. This
pacifies Vatakopa, increases the strength of Jatharaagni, promotes taste and induces
proper Malashodhana. The chemical compositions and therapeutic actions of the
individual drugs in this Yoga are as follows: -
Eranda190 – It contains stable oil (45%), slimy substance, sugar, white juice and
salt (10%). Seeds contain toxic element called ricin. This dissolves in alcohol.
Ricin contains ricin oil, palmitin and sterine. Oil obtained is clean, light,
yellowish and without much smell, but slightly pungent. Internally used, it is
Vatashamaka, Rasayana, and Medhya and hence indicated in Pakshaghatha,
Arditha, Gridhrasi, Kampa, Shiroruk and Angaruk. Castor oil is best as purgative.
Externally applied, it alleviates Vata, Shopha and Ruk and therefore used in
Kateegraha, Gridhrasi, and Amavata.
Chirubilva191 – Extract of seed gives a yellowish oil (37.4%). Bark is applied
locally as anti-inflammatory. It is indicated in indigestion, tastelessness, Krimi,
Udarashoola, Udara, Arbuda, Arshas etc.
Chithraka192 – It contains a pungent, yellow and irritant principle called
plumbagin (91%). It doesn’t dissolve in cold water; dissolves easily in alcohol or
boiled water. It is a stimulant in low dose, but sedative in higher doses
(internally). It is widely used in Arshas, Grahani, Krimi, Shopha, Pleehavikaras,
Yakritvikaras etc. Also useful externally in Sleepada, Shopha, Swithra, Amavata
etc.
Clinical study 78
Shunti193 – It contains 1-5% yellow volatile oil, gingerol, gingerin, carbohydrates,
oil and resin. It is the best medicine in digestive system diseases. Also, indicated
widely in Vatarogas, Rakthadushya, Swasa, Shopha, Amavata etc.
Hareethaki194 – Fruit contains tannin (24.6-32.5%). Constituents of tannin are
chebulagic acid, chebulinic acid and corilagin. Also, it contains sugar, amino
acids, phosphorus etc. 36.4% oil can be extracted from the fruit pulp. Local
application of Hareethaki is anti-inflammatory. It is useful in Vata disorders,
Amapradoshajavikaras, Vataraktha, Prathishyaya, Kasa, Swarabheda,
Shukrameha, Visarpa etc.
Punarnava195 – It contains punarnavine (0.04%), a bitter alkali, potassium nitrate
(0.52%) etc. It is anti-inflammatory, Rakthashodhaka, Anulomana, Deepana and
Muthrala and indicated in Shopha, Rakthapitha, Pandu, Kasa, Swasa,
Muthrakrichra and Muthraghatha.
Dusparshaka196 – Gum of the stem is called Yasasharkara (Manna). It contains
26.4% ikshusharkara. It is indicated externally in Shopha and Rakthasrava.
Internally, it is useful in Chardi, Trishna, Swasa, Mutrarogas, Arshas, Tvakdosha
etc.
Musali197 – It contains asparagin, albumin matter, slimy substance and celluloid.
It is Shukrala, Muthrala, Balya, Brimhana, and Rasayana. It is useful in
Vatapithapradhanavyadhees. It is an alternate food for diabetes patients, as it
doesn’t contain any starch.
Clinical study 79
7) Sahacharadi Taila198,199 –
It was prepared according to the Snehakalpana. No valid information on
the chemical composition is available regarding this yoga. This Yoga is indicated in
Vatavyadhees, especially, those affecting the lower part of the body. The chemical
compositions and therapeutic actions of the individual drugs in this Yoga are as follows: -
♥ Sahachara200– Externally used in inflammation, ulcers, urticaria, boils, tooth ache
etc. Internally cures Rakthadushya, Vataraktha, Vatavyadhees especially
adharangavyadhis.
♥ Devadaru201 – It contains dark coloured oil and resin. Internally useful in all
rukpradhana vyadhees, in Aruchi & Krimi, in Rakthadushya & Kaphajakasa.
♥ Shunti202 – It contains 1-5% yellow volatile oil, gingerol, gingerin, carbohydrates, oil
and resin. It is the best medicine in digestive system diseases. Also, indicated widely
in Vatarogas, Rakthadushya, Swasa, Shopha, Amavata etc.
Clinical study 80
CLINICAL STUDY
Methodological approach is the backbone of research. Utmost care is
taken in designing a methodology for conducting a research. Clinical research involves
the experimentation of a drug/therapy on a population and recording the feedback based
on which postulations are made regarding the usefulness of the drug/therapy in the
disease. Hence, in this section, the researchers put forward the systemic procedures,
which are followed by the researchers right from the identification of the problem to the
final conclusion.
Research Approach
In the present study, the investigator’s objective was to “evaluate the
efficacy of Shashtikashalipindaswedakarma in the management of Sandhigathavata
(Osteoarthritis)”. The efficacy was determined by finding out the difference between the
baseline data of the parameters to the after treatment data. Also, this was compared with
another technique of Swedakarma, Bashpasweda, to study any advantage of
Shashtikashalipindaswedakarma over Bashpasweda karma in the management of
Sandhigathavata.
Study Design
The study design selected for the present study was prospective
comparative clinical trial. Here, Shashtikashalipindaswedakarma group of patients are
compared with the Bashpaswedakarma group of patients. Demographic data and disease-
specific data are collected according to the case-record form given in the appendix.
Clinical study 81
Reasons For Selection Of The Study Design
The results and conclusions of a clinical trial depends on the study design.
The aim of this study was to find out the effect of Shashtikashalipindaswedakarma in the
management of Sandhigathavata and to check its advantage over Bashpaswedakarma in
managing the same disease. Therefore, two groups were made and the results obtained in
both the individual groups were compared.
Source Of Data
Patients suffering from Sandhigathavata were selected from the P.G.S & R
(Panchakarma) OPD & IPD of Shri D G Melmalgi Ayurvedic College Hospital.
Sample Size & Grouping
The sample size for the present study was thirty patients suffering from
Sandhigathavata as per the selection criteria. Patients were randomly distributed to both
the groups of equal size. In group A, 15 patients received Shashtikashali
pindaswedakarma and in group B, 15 patients received Bashpaswedakarma.
Selection Criteria
The cases were selected strictly as per the pre-set inclusion and exclusion
criteria.
A) Inclusion Criteria
♣ Patients fit for Snehana & Swedana
♣ Patients with the clinical features of Sandhigathavata (Osteoarthritis)
♣ Patients between 30 and 60 years of age
♣ No discrimination of sex & chronicity
♣ Patients with radiological findings of Osteoarthritis along with clinical
features
Clinical study 82
B) Exclusion Criteria
Θ Patients below 30 and above 60 years of age
Θ Patients suffering from Gout, Rheumatoid Arthritis, Septic Arthritis and other
cases of secondary Osteoarthritis.
Θ Patients with marked deformity
Θ Patients with systemic disorders like Hypertension, Diabetes mellitus etc.
Θ Pregnant women and lactating mother
Θ Patients unfit for Snehana & Swedana
Duration Of The Study
The total study duration was 28 days, i.e., 14 days of Swedana and 14 days
as pariharakala for both the groups. Follow-up was done for one month.
Data Collection
Patients were thoroughly examined both subjectively and objectively.
Detailed history pertaining to the mode of onset, previous ailment, previous treatment
history, family history, habits, ashtavidhapareeksha and dashavidhapareeksha and
physical examination findings were noted. Routine investigations were done to exclude
other pathologies. Radiological features also were investigated.
Clinical study 83
Examination Of Knee Joint & Lumbar Spine
KNEE JOINT203
History
The common symptoms with which a patient generally presents are pain,
swelling, stiffness, mechanical disorders (e.g. Locking, giving way, click etc.) and limp.
Inspection
• Both the lower limbs were fully exposed
• Patient was first examined in the standing position, both from front and behind,
secondly in the seated position, thirdly in the supine position and lastly in the
prone position.
• Swelling
A) The limits of the swelling were clearly made out.
B) The gradings were allotted on the basis of criteria explained in the end of
this section.
C) The Varna of the Shopha was examined (Raga, Shyava or Prakrutha).
D) Any deformities like genus valgum, varum etc. were examined.
E) Joint instability or buckling of the joint was examined.
F) Any abnormalities in the gait were examined.
G) Walking time was recorded (the time taken to cover 21 metres).
H) Any presence of muscular spasm was examined.
I) Muscular wasting above and below the joint was examined.
Palpation
• Local temperature was examined with the back of the hand and compared to that
of the other side.
• Local tenderness was also examined.
Clinical study 84
• Swelling
A) Fluctuation test was performed by pressing the suprapatellar pouch with
one hand and feeling the impulse with the thumb and the fingers of the
other hand placed on either side of the patella or the ligamentum patellae.
B) Patellar tap was elicited by pressing the suprapatellar pouch with one hand
driving the whole of its fluid into the joint proper as to float the patella in
front of the joint. With the index finger of the other hand, the patella is
pushed backwards towards the femoral condyles with a sharp and jerky
movement. The patella can be felt to strike on the femur, which is known
as the patellar tap.
• Palpation of popliteal fossa - The patient was made to lie down prone on the table.
The knee joint was flexed and the popliteal fossa was palpated. The knee joint,
popliteal artery, areolar tissue, veins and nerves and the tendons in and around the
popliteal fossa were all palpated carefully to detect any pathology here.
• Significance of click - If the click was associated with discomfort or pain, careful
examination was done. Commonest cause of intra-articular click is OA.
• Patello-femoral and femoro-tibial components were palpated for any tenderness
or irregularity.
Movements
The movements permitted in the knee joint are mainly flexion and
extension. Minor degrees of abduction, adduction and rotations may be permitted when
the joint is partly flexed. Both active and passive movements were examined.
• Flexion & Extension: Normally, the knee can be flexed until the calf extended till
the thigh and leg form a straight line.
Clinical study 85
• Abduction & adduction: These movements are virtually absent with knee straight,
but slight degrees of abduction and adduction are possible when the knee is semi-
flexed.
• Rotation: This movement is also not possible when the knee is straight. When the
hip and knee are flexed to 90 degrees, some degree of rotation is possible.
Auscultation
During active or passive movement, the palm of one hand of the physician
was placed over the patella and crepitus was felt.
LUMBAR SPINE204
History
• Trauma: An enquiry was made whether trauma initiated the presenting complaints
or it aggravates these.
• Pain: An enquiry was made about the onset, exact site, its nature, any radiation or
presence of any referred pain. Dull and continuous pain is a feature of
inflammatory lesion of the spine, which will be aggravated by movements. A
sudden sharp pain may be complained of in case of disc prolapse during lifting
weight in the stooping position.
• Aggravating factors: Movement of the spine aggravates the pain.
• Relieving factors : Usually, rest relieves pain.
• Deformity: Scoliosis, kyphosis or lordosis.
• Stiffness of the back
Clinical study 86
Inspection
• Curvature of the spine; whether kyphosis (forward bending), lordosis (backward
bending) or scoliosis (lateral bending) was present was examined.
• Gait was examined for its normalcy or any abnormalities.
• Swelling, if present, was examined.
Palpation
• Tenderness: Thumb was pressed along the spinous processes from above
downwards along its whole extent.
• Wasting and rigidity of the erector spinae muscle was felt for.
Percussion
Percussion over the spine was sometimes performed to elicit the
tenderness.
Movements
• Movements of the lumbar spine are flexion, extension, lateral flexion and
rotations. These were tested to determine the rigidity of the spine.
1. Flexion - The patient was asked to lean forward keeping the knees
straight. The physician’s hand was placed over the spine to note the
movements of the spinous processes. The movements of the spine and hip
flexion were also noted.
2. Extension - The patient was asked to lean backwards (look up the ceiling).
3. Lateral flexion - The patient was asked to bend sideways while standing.
Clinician holds the pelvis firmly from the back.
4. Rotations: Patient was asked to sit down so as to flex his/her pelvis.
He/she was then instructed to rotate the trunk to the right and to the left.
Clinical study 87
Treatment Schedule
Group A – Shashtikashalipindaswedakarma
Poorvakarma205a
Poorvakarma of the Shashtikashalipindaswedakarma involves the
preparation of shashtikashalipindas, preparation of the patient and Abhyanga.
1. Requirements
→ Balamula (cleaned & cut) - 600gm
→ Shashtikashali (cleaned & made coarse) - 400gm
→ Goksheera - 2400ml
→ Water - 9600ml
→ Sahacharadi Taila - 50-100ml
→ Gandharvahastadi Kwatha - 15ml
→ Clean, square cloth pieces - 4 in no.
→ Twine -One roll
→ Attenders -Three
2. Preparation of shashtikashalipindas
600gm of Balamula was boiled in 9600ml of water on moderate fire and
reduced to 2400ml. This was done in the night previous to the performance of the Karma.
The decoction was filtered and half the quantity (1200ml) was kept aside. Next day
morning, the other half part of the decoction and half the quantity of cow’s milk (1200ml)
were mixed in a vessel and kept on the fire. To this, the clean & coarse Shashtikashali
(400gm) was added. The cooking was continued till the Shashtikashali assumed the form
of a semisolid paste or pudding.
Clinical study 88
The cooked shali was divided into four equal parts and each was put in
the clean, square cloth pieces. Then, one by one, each part was made into bolus. For this,
the four corners of the cloth piece is held together between the fist of the left hand and
with the right hand all the corners except one were inserted into the bolus and the one
corner left was used to cover the held part to make a tuft. Then, a twine was rounded
several times over the tuft and was tied. Likewise, other boluses were also made. The
pindas were held by this tuft (appr. 3” length) during the procedure.
3. Preparation of the patient
The patient was asked to pass his natural urges, prior to his entry into the
Panchakarma theatre. The procedure was done in between 7-10 AM. After performing
the sacred rights, the patient was asked to sit on the Taila droni. He was then
administered 15ml of Gandharvahastadi Kwatha mixed in 60ml of luke warm water.
Then, the Sahacharadi Taila was heated to luke warm and Abhyanga was performed to
the head & whole body for approximately fifteen minutes.
Pradhanakarma205b
• The remaining part of the Balamula Kwatha and Goksheera (1200ml each) were
mixed and taken into a vessel and kept on fire, which was little distant from the
Taila droni. The shashtikashalipindas were heated in this drava during the whole
process. Initiallly, all the 4 boluses were heated for 5 minutes. One attender was
posted to carry out the heating of the boluses and two others to perform the
Karma.
• Two of the heated boluses were supplied to the two attenders standing on either
side of the patient. The heat of the boluses was checked for excess heat or
insufficiency.
Clinical study 89
• Fixing the duration: The duration of the Karma was fixed 60minutes on the first
day. Then, it was increased by 5 minutes on each day to reach 90minutes on the
7th day. The Karma was performed for the same time duration on the 8th day too.
From then, it was reduced by 5 minutes per day to reach 60minutes on the 14th
day.
• The boluses were applied over the body with the right hand, while the left hand
massaged the applied part. Procedure was started from the upper part of the body
and then progressed to the lower parts. Generally, the direction of the bolus
application was in the anulomagati except over the joints where the boluses were
applied in circular direction. The attender on each side applied the boluses and
massaged every part of the body on his side, except the scalp, eyes and the
reproductive organs. Special attention was given to the affected body part.
Massage was started in the first posture of patient sitting erect with the legs
extended, then in the supine posture, then left lateral, then again supine, then right
lateral, then again supine and finally sitting. The time of massage in each of these
postures was decided on the basis of total time duration on that particular day.
• As and when the boluses used lost their warmth, they were replaced by the
boluses, which were kept for heating. The regular changing of the boluses is of
importance, as to prevent the patient feeling cool.
• By the time the massage was over, the mixture of the decoction and milk that was
on the fire would also have completely used up having been absorbed by the
pudding and transferred onto the body of the patient during the process. When the
massaging was finished, all the bolus bags were opened out and the pudding
remnants were taken and applied to the body of the patient and rubbed by the
hands acting as in the massaging process.
• The same procedure was continued for 14days.
Clinical study 90
Paschatkarma205c
The pudding sticking to the patient’s body was removed by scraping with
cut pieces of X-ray sheet (without sharp edges). The oil on the head was removed by
gentle wiping with a dry towel. The head and the body thus cleaned were again to be
anointed with Sahacharadi Taila and bathed. The interval between the application of the
oil and bath was not more than 5 minutes. For bathing, water boiled and cooled down to
comfortable warmth was used for the head and hot water for the body.
Pathya during treatment period & pariharakala
The pathyacharana is an important factor which was followed for 28days
including the treatment period & pathyacharana. The Snehapanavidhi was prescribed to
the patients. Patients were advised to take katu-tiktha-kashaya-rooksha varjitha
aharadravyas in light quantity. Rice gruel with little milk was advised as the ideal food.
Patient was advised to drink hot water only. Patient was advised to avoid sexual
intercourse, blocking of natural urges, traveling, exercise, over-speech, uneven sitting &
lying postures, exposure to wind, cold, heat and dust, anger and grief.
Group B - Bashpaswedakarma
Poorvakarma
Poorvakarma of the Bashpaswedakarma involves the preparation of
decoctions of Nirgundi & Chincha, preparation of the patient and Abhyanga.
1. Requirements
⇒ Nirgundipatra (Fresh) - 250gm
⇒ Chinchapatra (Fresh) - 250gm
⇒ Water - 8litres
⇒ Sahacharadi Taila - 50-100ml
⇒ Gandharvahastadi Kwatha - 15ml
⇒ Attenders - Two
Clinical study 91
1. Nirgundipatras and Chinchapatras were washed and boiled in 8litres of water and
reduced to 4liters.
2. The patient was asked to pass natural urges, prior to the entry into the
Panchakarma theatre. The procedure was done in between 7-10AM. After
performing the sacred rights, the patient was asked to sit on the Taila droni. He
was then administered 15ml of Gandharvahastadi Kwatha mixed in 60ml of luke
warm water. Then, the Sahacharadi Taila was heated to luke warm and Abhyanga
was performed to the head & whole body for approximately 35 minutes (5
minutes in each of the 7 postures).
Pradhanakarma
• Initially, the decoction of the Nirgundi and Chinchapatras (4litres) was kept over
the burning charcoal in the lower compartment of the Bashpaswedanayantra, in
two separate vessels. To this, again little quantity of fresh leaves was added.
• The patient, who has been anointed with the Sahacharadi Taila, was asked to lie
down on the upper compartment of the Bashpaswedanayantra. Then his whole
body except the head was covered with the doom, thereby exposing his whole
body to the decoction steam. The patient was asked to gently move his extremities
and body so as to prevent excess concentration of warmth over one part.
• The patient was continued to steam exposure until total perspiration (especially
sweat over the forehead & nose).
Paschatkarma
After the sudation, patient was withdrawn from the Swedanayantra and the
body was cleaned off the sweat by a clean towel. After rest for 10 minutes, patient was
advised to take hot water bath (heated & cooled water for the head).
Clinical study 92
Pathya during treatment period & pariharakala
The pathyacharana is an important factor which was followed for 28days
including the treatment period & pathyacharana. The Snehapanavidhi was prescribed to
the patients. Patients were advised to take katu-tiktha-kashaya-rooksha varjitha
aharadravyas in light quantity. Rice gruel with little milk was advised as the ideal food.
Patient was advised to drink hot water only. Patient was advised to avoid sexual
intercourse, blocking of natural urges, traveling, exercise, over-speech, uneven sitting &
lying postures, exposure to wind, cold, heat and dust, anger and grief.
Methods Of Assessment Of Clinical Response
Clinical parameters and functional parameters were made out to assess the
clinical response in both the groups.
Clinical Parameters
1. Subjective
• Ruk (Pain) :- Grade 0 – No Complaints
Grade 1 – Tells on Enquiry
Grade 2 – Complains Frequently
Grade 3 – Excruciating Condition
• Graha (Stiffness) :- Grade 0 – Absent
Grade 1 – Present
2. Objective
• Sparshaakshamatva :- Grade 0 – No Complaints
(Tenderness) Grade 1 – Says the joint is tender
Grade 2 – Winces the affected joint
Grade3 –Winces and withdraws the
affected joint.
Clinical study 93
• Sandhigathi-Asaamarthya :-
(Limitation of joint movement) Grade 0 – No movement
Grade 1 – Up to 50% of the full
range of joint motion
Grade 2 – 50-75% of the full
range of joint motion
Grade 3 – >75% & <full range
Grade 4 – Full Range of joint
Motion
• Shotha (Swelling) :- Grade 0 – No Complaints
Grade 1 – Slightly obvious
Grade 2 – Covers well over the bony
prominence
Grade 3 – Much elevated
• Atopa (Crepitations) :- Grade 0 – None
Grade 1 – Felt
Grade 2 – Heard
Functional parameters –
AIMS (Arthritis Impact Measurement Scale) 206 and walking time207 were
considered to assess the functional improvement.
1. Subjective – AIMS is the scale of impact due to arthritis. It sums up the grades of
various variables.
Clinical study 94
Sl. Variables Very
satisfied
Somewhat
satisfied
Neither
satisfied nor
dissatisfied
Somewhat
dissatisfied
Very
dissatisfied
01. Mobility
level
1 2 3 4 5
02. Walking and
bending
1 2 3 4 5
03. Hand and
finger
function
1 2 3 4 5
04. Arm
function
1 2 3 4 5
05. Self care
tasks
1 2 3 4 5
06. House hold
tasks
1 2 3 4 5
07. Social
activity
1 2 3 4 5
08. Support
from family
and friends
1 2 3 4 5
09. Arthritis
pain
1 2 3 4 5
10. Work 1 2 3 4 5
11. Level of
tension
1 2 3 4 5
12. Mood 1 2 3 4 5
Clinical study 95
2. Objective: - Walking time to cover 21meters was recorded and distributed into the
following grades.
Grade 0 – Up to 20seconds
Grade 1 – 21-30seconds
Grade 2 – 31-40seconds
Grade 3 – 41-50seconds
Grade 4 – 51-60seconds
All these parameters of baseline data to post-medication data (28th day)
were compared for clinical assessment of the results (assessment was also recorded on
the 14th day too).
Assessment Of Swedakarmukatha
This was done to ascertain the efficacy of both the Karmas in inducing the
benefits of Swedana in the individual groups. The following parameters were designed
basing on the Shamana-Sweda gunas explained by Sushrutha35.
• Agnideepti :- Grade 0 – No change/Absent
Grade 1 – Slight improvement/Present
Grade 2 – Good improvement
• Maardava :- Grade 0 – No change/Absent
Grade 1 – Slight improvement/Present
Grade 2 – Good improvement
• Tvakprasada :- Grade 0 – No change/Absent
Grade 1 – Slight improvement/Present
Grade 2 – Good improvement
Clinical study 96
• Tandrahaani :- Grade 0 – Absent
Grade 1 – Present
• Bhakthasradha :- Grade 0 – Absent
Grade 1 – Present
• Sandhicheshta :- Grade 0 – No movement
Grade 1 –Up to 50% of the full range of joint
motion
Grade 2 – 50-75% of the full range of joint
motion
Grade 3 – >75% & <full range
Grade 4 – Full Range of joint Motion
• Srothonirmalatva :- Grade 1 – Very satisfied
Grade 2 – Somewhat Satisfied
Grade 3 – Neither satisfied nor dissatisfied
Grade 4 – Somewhat dissatisfied
Grade 5 – Very dissatisfied
Overall Assessment Of Clinical Response
• Good Response : >60% improvement in clinical and functional
parameters
• Moderate Response : 31-60% improvement in clinical and functional
parameters
• Poor Response : 1-30% improvement in clinical and functional
parameters
• No Response : 0 % or No improvement in clinical and functional
parameters
Clinical study 97
37 patients were registered for the present study. Out of this, 7 patients
were excluded (2 drop outs and 5 not fulfilling the criteria for diagnosis); hence, their
data has not been included here. The remaining 30 patients of Sandhigatavata fulfilling
the criteria for diagnosis, were treated in the following two groups –
Group A – Shashtikashalipindasweda – 15 patients.
Group B – Abhyanga and Bashpasweda – 15 patients.
All the patients were examined before and after the treatment according to the
case sheet format given in the appendix. Both the subjective and objective changes were
recorded along with the assessment of Swedakaarmukata. The data recorded are
presented under the following heading –
I. Demographic data
II. Data related to the disease
III. Data related to over all response to the treatment
IV. Statistical analysis of the clinical and functional parameters and inter group
comparison.
V. Statistical analysis of the Swedakaarmukata.
Observation & Results 98
I. DEMOGRAPHIC DATA
A. Table No. 25. Showing Distribution of patients by age in both the treatment
groups (A & B):
Age
group
No. Of Patients.
In Group A
% No. Of Patients.
In Group B
% Total No.
Of
patients
Total
%
31-40 1 6.66 1 6.66 2 6.66
41-50 4 26.66 3 20 7 23.33
51-60 10 66.66 11 73.33 21 70
Among the 15 patients in the group A maximum number of patients fell in
the age group 51-60 i.e. 10 patients (66.66%), where as 4 patients (26.66%) fell in the age
group 41-50 and only one patient (6.66%) fell in the age group 31-40. Among the 15
patients in the group B, maximum numbers of patients, fell in the age group 51-60 i.e. 11
(73.33%), where as 3 patients (20%) fell in the age group 41-50 and only one patient
(6.66%) fell in the age group 31-40. In the study as a whole (30 patients), 2 patients
(6.66%) fell in the age group 31-40, 7 patients (23.33%) fell in the age group 41-50 and
21 patients (70%) fell in the age group 51-60.
Distribution of pts. by age
1
4
10
13
11
0246
81012
30-40 40-50 50-60
Age group
No.
of P
ts.
No. of Pts In Gr. A No. of Pts in Gr. B
Observation & Results 99
B. Table No. 26 Showing the overall response of patients in various age groups in both
the treatment groups (A & B):
Group A Group B Total Age
Group No GR MR No MR PR No GR MR PR
31-40 1 - 1 1
1 - 2 - 2 -
41-50 4 2 2 3 3 - 7 2 5 -
51-60 10 5
5 11 10 1 21 5 15 1
Among the 15 patients in Group A, the only one patient in the age group
31–40 responded moderately; whereas in the 4 patients in the age group 41–50, 2 patients
had good response (50 %) and 2 patients had moderate response (50%) and in the 10
patients in the age group 51-60, 5 patients had good response (50 %) and 5 patients had
moderate response (50 %). Among the 15 patients in Group B, the only one patient in
the age group 31-40 responded moderately; whereas in the 3 patients in the age group
41–50 all the 3 had moderate response and in the 11 patients in the age group 51–60, 10
patients had moderate response (90.09%) and one patient responded poorly (9.09 %). In
the study as a whole (30 patients), 2patients in the age group 31–40 had moderate
response; in the 7 patients in the age group 41–50, 2 patients had good response (28.57
%) and 5 patients had moderate response (71,42%) and in the 21 patients in the age group
51-60, 5 patients had good response (23.8 %), 15 patients had moderate response
(71.42%) 15 patients had moderate response and one patient responded poorly (4.76 %).
Observation & Results 100
2.A. Table No. 27. Showing the distribution of patients by sex in both the
treatment groups (A & B):
Sex No. Of Patients In
Group A
% No. Of Patients In
Group B
% Total No.
Of
Patients
Total
%
Male 7 46.66 7 46.66 14 46.66
Female 8 53.33 8 53.33 16 53.33
Among the 15 patients in the group A, 7 patients were males (46.66%) and
8 patients were females (53.33%). Among the 15 patients in the group B, 7 patients were
males (46.66%) and 8 patients were females (53.33%). In the study as a whole (30
patients), 14 patients were males (46.66%) and 16 patients were females (53.33 %).
Distribution of Pts by sex
7
8
7
8
6.5
7
7.5
8
8.5
Male FemaleSex
No. of
pts.
No. of Patients. In Gr. A
No. of Patients. In Gr. B
Observation & Results 101
B. Table No. 28. Showing the overall response of patients of both sexes in both the
treatment groups (A & B):
Group A Group B Total Sex
No GR MR No MR PR No GR MR PR
Male 7 3 4 7
7 - 14 3 11 -
Female 8 4 4 8 7 1 16 4 11 1
Among the patients in the group-A, 3 males (42. 85%) had good response
where as 4 males (57.14%) had moderate response; in the same group, 4 females (50%)
had good response and 4 females (50%) had moderate response. Among the 15 patients
in the group B, all the 7 males had moderate response, where as among the females, 7
(87.5%) had moderate response and 1 (12.5%) had poor response. In the study as a
whole (30 patients), among the 14 males, 3 (21.42%) had good response and 11 (78.57%)
had moderate response; whereas among the 16 females, 4 (25%) had good response, 11
(68.75 %) had moderate response and 1 (6.25%) had poor response.
Observation & Results 102
3.A Table No. 29. Showing the distribution of Patients by Occupation in both the
treatment in both the treatment groups (A & B):
Occupation No. Of
Patients
In Group A
% No. Of
Patients
In Group B
% Total No.
Of Patients
Total %
Sedentary 4 26.66 3 20 7 23.33
Active 9 60 6 40 15 50
Labour 2 13.33 6 40 8 26.66
Others - - - - - -
Among the 15 patients in the group A, 4 patients (26.66%) were of
sedentary, 9 patients (60%) were active and 2 patients (13.33%) were labours. Among
the 15 patients in the Group B, 3 patients (20%) were sedentary, 6 patients (40%) were
active and 6 patients (40%) were labours. In the study as a whole (30 Patients), 7 patients
(23.33%) were sedentary, 15 patients (50%) were active and 8 patients (26.66%) were
labours.
43
9
6
2
6
0 002468
10
No.of
Pts.
Sedentary Active Labour Others
Occupation
Distribution of pts by occupation
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 103
B. Table No. 30. Showing the overall Treatment Response in patients of various
occupations in both the treatment groups (A & B):
Group A Group B Total Occupation No GR MR No MR PR No GR MR PR
Sedentary 4 2 2 3 3 - 7 2 5 -
Active 9 4 5 6 6 - 15 4 11 -
Labour 2 1 1 6 5 1 8 1 6 1
Others - - - - - - - - - -
Among the 15 patients in group A, in the 4 sedentary patients, 2 patients
(50%) got good response and 2 (50%) got moderate response where as in the 9 active
patients, 4 patients (44.44%) got good response and 5 patients (55.55%) got moderate
response and in the 2 labour patients, 1 patient (50%) got good response and 1 patient
(50%) got moderate response. Among the 15 patients in the group B, all the 3 sedentary
patients got moderate response (100%) and all the active patients got moderate response
where as in the 6 labor patients, 5 patients got moderate response (83.33%) and 1 patient
got poor response (16.66%). In the study as a whole, among the 7 sedentary patients, 2
patients got good response (28.57%) and 5 patients got good response (71.42%). Among
the 15 active patients, 4 patients got good response (26.66%) and 11 patients got
moderate response and in the 8 labour patients, 1 patient got good response (12.5%), 6
patients got moderate response (75%) and 1 patient got poor response (12.5%).
Observation & Results 104
4. Table No. 31. Showing the distribution of patients by Economical status in
both the treatment groups (A& B):
Economical
status
No. Of
Patients In
Group A
% No. Of
Patients In
Group B
% Total No.
Of Patients
Total
%
Poor 3 20 7 46.66 10 33.33
Middle class 7 46.66 7 46.66 14 46.66
Aristocrat 5 33.33 1 6.66 6 20
Among the 15 patients in group A, 3 patients were poor (20%), 7 patients
were of the middle class (46.66%) and 5 patients were aristocrat (33.33%). Among the 15
patients in the group B, 7 patients were poor (46.66%), 7 patients were of middle class
(46.66%) and1 patient was aristocrat (6.66%). In the study as a whole (30 Patients), 10
patients were poor (33.33%), 14 patients were of the middle class (46.66%) and 6
patients were of aristocrat (20%).
3
7 7 7
5
1
01234567
No.ofpts
Poor Mid ArsEconomical status
Distribution of pts by economical status
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 105
Table No. 32. Showing the distribution of patients by Religion in both the treatment
groups (A&B):
Religion No. Of Patients
In Group A
% No. Of
Patients
In Group B
% Total No. Of
Patients
Total
%
Hindu 10 66.66 11 73.33 21 70
Muslim 4 26.66 4 26.66 8 26.66
Christian 1 6.66 - - 1 3.33
Among the 15 patients in group A, 10 patients were Hindus (66.66%), 4
patients were Muslims (26.66%) and 1 patient was Christian (6.66%). Among the 15
patients in group B, 11 patients were Hindus (73.33%) and 4 patients were Muslims
(26.66%). In the study as a whole (30 patients), 21 patients were Hindus (70%), 8
patients were Muslims (26.66%) and 1 patient was Christian (3.33%).
10 11
4 41 00
5
10
15
No.ofpts
Hindu Muslim Christian
Religion
Distribution of pts by religion
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 106
Table No. 33. Showing the distribution of Patients by Dietary habit in both the treatment
groups (A &B):
Dietary
habit
No. Of Patients
In Group A
% No. Of Patients
In Group B
% Total No. Of
Patients
Total
%
Vegetarian 6 40 10 66.66 16 53.33
Mixed 9 60 5 33.33 14 46.66
Among the 15 patients in group A, 6 patients were vegetarians (40%) and
9 patients were having mixed dietary habits (60%). Among the 15 patients in group B, 10
patients were vegetarians (66.66%) and 5 patients were having mixed dietary habits
(33.33%). In this study as a whole (30 patients), 16 patients were vegetarians (53.33%)
and 14 patients were having mixed dietary habits (46.66%).
6
109
5
02468
10
No.ofpts
Vegetarian MixedDietary habit
Distribution of pts by diet
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 107
7.A Table No. 34. Showing the distribution of Patients by Agni in both the treatment
groups (A & B):
Agni No. Of Patients
In Group A
% No. Of Patients
In Group B
% Total No. Of
Patients
Total
%
Manda 7 46.66 9 60 16 53.33
Teekshna - - - - - -
Vishama 5 33.33 4 26.66 9 30
Sama 3 20 2 13.33 5 16.66
Among the 15 patients in group A, 7 patients were having Manda agni
(46.66%), 5 patients were having vishama agni (33.33%) and 3 patients were having
sama agni (20%). Among the 15 patients in group B, 9 patients were having Manda agni
(60%), 4 patients were having vishama agni (26.66%) and 2 patients were having sama
agni (13.33%). In the study as a whole, 16 patients were having manda agni (53.33%)
patients were having vishama agni (30%) and 5 patients were having sama agni
(16.66%). No patients reported with Teekshna agni in this study.
79
0 0
54
32
02468
10
Noofpts
Md Tk Vs SAgni
Distribution of pts by agni
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 108
B. Table No. 35. Showing the overall treatment response in Patients by of all types of
Agni in both the treatment groups:
Group A Group B Total Agni No GR MR No MR PR No GR MR PR
Manda 7 3 4 9 8 1 16 3 12 1
Teekshna - - - - - - - - - -
Vishama 5 2 3 4 4 - 9 2 7 -
Sama 3 2 1 2 2 - 5 2 3 -
In the group A, among the 7 patients of Manda agni, 3 patients had good
response (42.85%) and 4 patients had moderate response (57.14%) whereas among the 5
patients of vishama agni, 2 patients had good response (40%) and 3 patients had
moderate response (60%) and among the 3 patients of sama agni, 2 patients had good
response (66.66%) and 1 patient had moderate response (33.33%). In group B, among the
9 patients of manda agni, 8 patients had moderate response (88.88%) and 1 patient had
poor response (11.11%) where as all the 4 patients of vishama agni responded moderately
and both the patients of sama agni responded moderately. In the study as a whole (30
patients), among the 16 patients of manda agni, 3 patients had good response (18.75%),
12 patients had moderate response (75%) and 1 patient had poor response (6.25 %)
whereas among the 9 patients of vishama agni, 2 patients had good response (22.22%)
and 7 patients had moderate response (77.77%) and among the 5 patients of sama agni 2
patients had good response (40 %) and 3 patients had moderate response (60%).
Observation & Results 109
8. A. Table No. 36. Showing the distribution of patients by koshta in both the treatment
groups
Koshta No. Of Patients
In Group A
% No. Of Patients
In Group B
% Total No. Of
Patients
Total
%
Madhya 5 33.33 4 26.66 9 30
Mridu 1 6.66 1 6.66 2 6.66
Krura 9 60 10 66.66 19 63.66
Among the 15 patients in group A, 5 patients were having Madhya koshta
(33.33%), 1 patient was having Mridu koshta (6.88%) and 9 patients were having Krura
koshta (60%). Among the 15 patients in group B, 4 patients were having Madhya koshta
(26.66%), one patient was having Mridu koshta (6.66%) and 10 patients were having
Krura koshta (66.66%). In the study as a whole (30 patients), 9 patients were having
Madhya koshta (30%), 2 patients were having Mridu koshta (6.66%), and 19 patients
were having Krura koshta (63.66%).
54
1 1
910
02468
10
No.ofpts
Madhya Mridu Krura
Koshta
Distribution of pts by koshta
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 110
B. Table No. 37. Showing the overall treatment response in patients of All
types of Koshta in both the treatment groups (A & B):
Group A Group B Total Koshta
No GR MR No MR PR No GR MR PR
Madhya 5 4 1 4
4 - 9 4 5 -
Mridu 1 - 1 1 1 - 2 - 2 -
Krura 9 3 6 10 9 1 19 3 15 1
In group A, among the 5 patients of Madhya koshta, 4 patients got good
response (80%) and 1 patient got moderate response (20%) where as the one patient of
Mridu koshta got moderate response and among the 9 patients of Krura koshta, 3 patients
got good response (33.33%) and 6 patients got moderate response (66.67%). In groupB,
all the 4 patients of Madhya koshta got moderate response and the one patient of Mridu
koshta got moderate response, whereas among the 10 patients of Krura koshta, 9 patients
got moderate response (90%) and one patient got poor response (10%). In the study as a
whole (30 patients), among the 9 patients of Madhya koshta, 4 patients got good response
(44.44%) and 5 patients got moderate response (55.55%) where as both the 2 patients of
Mridukoshta got moderate response and among the 19 patients of Krura koshta, 3 patients
got good response (15.75%), 15 patients got moderate response (78.94%) and 1 patient
got poor response (5.26%).
Observation & Results 111
9. Table No. 38. Showing the distribution of Patients by Nidra in both the
treatment groups (A & B):
Nidra No. Of Patients
In Group A
% No. Of Patients
In Group B
% Total No. Of
Patients
Total
%
Sukha - - - - - -
Alpa 9 60 11 73.33 20 66.66
Ati - - 1 6.66 1 3.33
Vishama 6 40 3 20 9 30
Among the 15 patients in group A, 9 patients had alpa nidra (60%) and 6
patients had vishama nidra (40%). Among the 15 patients in group B, 11 patients had
alpa nidra (73.33%), 1 patient had ati nidra (6.66%) and 3 patients had vishama nidra
(20%). In the study as a whole (30 patients), 20 patients had alpa nidra (66.66%), one
patient had ati nidra (3.33%) and 9 patients had vishana nidra (30%). No patient reported
with sukha nidra in this study.
00
911
0 1
63
0 2 4 6 8 10 12No. of pts
Sk
Alpa
Ati
Vs
nidr
a
Distribution of pts by nidra
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 112
Table No. 39. Showing the distribution of patients by Vyasana in both the treatment
groups (A & B):
Vyasana No. Of Patients
In Group A
% No. Of Patients
In Group B
% Total No.
Of
Patients
Total
%
Smoking 2 13.33 1 6.66 3 10
Tobacco 9 60 5 33.33 14 46.66
Alcohol 3 20 6 40 9 30
Others - - - - - -
None 1 6.66 3 20 4 13.33
Among the 15 Patients in group A, 2 patients had smoking habit (13.33%),
9 patients had tobacco habit (60%), 3 patients had alcohol habit (20%) and 1 patient had
no habits (6.66%). Among the 15 patients in group B, 1 patient had smoking habit
(6.66%), 5 patients had tobacco habit (33.33%), 6 patients had alcohol habit (40%) and 3
patients had no habits (20%). In the study as a whole, 3 patients had smoking habit
(10%), 14 patients had tobacco habit (46.66%), 9 patients had smoking habit (30%) and 4
patients had no habits (13.33%). No patient reported in this study had any other habits.
21
9
5
3
6
0 01
3
0
2
4
6
8
10
No.ofpts
Smk Tbc Alc Oth NnVyasana
Distribution of pts by Vyasana
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 113
10. Table No. 40. Showing the distribution of Patients by Deha prakrithi in
both the treatment groups ( A & B ):
Deha
prakriti
No. Of
Patients In
Group A
% No. Of
Patients In
Group B
% Total No. Of
Patients
Total
%
Vata 2 13.33 2 13.33 4 13.33
Pitta - - - - - -
Kapha 1 6.66 - - 1 3.33
Vata-pitta 6 40 7 46.66 13 43.33
Vata-kapha 5 33.33 3 20 8 26.66
Pitta-kapha 1 6.66 3 20 4 13.33
Sannipataja - - - - - -
Among the 15 patients in group A, 2 patients were of Vata prakriti
(13.33%), 1 patient of Kapha prakriti (6.66 %), 6 patients of Vata – Pitta prakriti (40%), 5
patients of Vata–kapha prakriti (33.33%) and 1 patient of Pitta-Kapha prakriti (6.66%).
Among the 15 patients in group B, 2 patients were of Vata prakriti (13.33%), 7 patients
of Vata-pitta prakriti (46.66%), 3 patients of Vata-kapha prakriti and 3 patients of Pitta-
kapha prakriti (20%). In the study as a whole (30 patients), 4 patients were of Vata
prakriti (13.33%), 1 patient of Kapha prakriti (3.33%), 13 patients of Vata–pitta prakriti
(43.33%), 8 patients of Vata–kapha prakriti (26.66%) and 4 patients of Pitta–kapha
prakritti (13.33%). No patients reported with Pitta / sannipatha prakriti in this study.
2 2
0 01
0
67
5
3
1
3
0 001234567
No.ofpts
V P K VP VK PK SPrakriti
Distribution of pts by deha prakriti
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 114
B. Table No. 41. Showing the overall Treatment Response in patients of all types of
Dehaprakrithi in both the treatment groups ( A & B):
Group A Group B Total Deha prakriti No GR MR No MR PR No GR MR PR
Vata 2 1 1 2 1 1 4 1 2 1
Pitta - - - - - - - - - -
Kapha 1 - 1 - - - 1 - 1 -
Vata-pitta 6 3 3 7 7 - 13 3 10 -
Vata-kapha
5 2 3 3 3 - 8 2 6 -
Pitta-kapha
1 1 - 3 3 - 4 1 3 -
Sannipataja
- - - - - - - - - -
In group A, among the 2 patients of vata prakriti, 1 patient got good
response (50%) and 1 patient got moderate response (50%). The patient of kapha prakriti
got moderate response. Among 6 patients of vata-pitta prakriti, 3 patients got good
response (50%) and 3 patients got moderate response (50%). Among 5 patients of vata-
kapha prakriti, 2 patients got good response (40%) and 3 patients got moderate response
(60%). The patient of pitta-kapha prakriti got good response. In group B, among the 2
patients of vata prakriti, 1 patient got moderate response (50%) and 1 patient got poor
response (50%). All the 7 patients of vata–pitta prakriti got moderate response, all the 3
patients of vata-kapha prakriti got moderate response and all the 3 patients of pitta–kapha
prakriti got moderate response. In the study as a whole (30 patients), among the 4
patients of vata prakriti, 1 patient got good response (25%), 2 patients got moderate
response (50%) and 1 patient got poor response (25%). The only one patient of kapha
prakriti got moderate response. Among the 13 patients of vata-pitta prakriti, 3 patients got
good response (23.07%) and 10 patients got moderate response (76.92%). Among the 8
patients of vata–kapha prakriti, 2 patients got good response (25%) and 6 patients got
good response (75 %). Among the 4 patients of pitta–kapha prakriti, 1 patient got good
response (25%) and 3 patients got moderate response (75%).
Observation & Results 115
11. Table No. 42. Showing the distribution of patients by Satmya in both the
treatment groups (A & B):
Satmya No. Of Patients
In Group A
% No. Of Patients
In Group B
% Total No. Of
Patients
Total
%
Rooksha 13 86.66 15 100 28 93.33
Snigdha 2 13.33 - - 2 6.66
Among the 15 patients in group A, 13 patients were of rooksha satmya
(86.66%) and 2 patients were of snigdha satmya (13.33%). All the patients of group B,
were of rooksha satmya. In the study as a whole (30 patients), 28 patients were of
rooksha satmya (6.66%) and 2 patients were of snigdha satmya.
1315
2 00
5
10
15
No.of
pts.
Rooksha SnigdhaSatmya
Distribution of pts by satmya
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 116
II. DATE RELATED TO THE DISEASE
1. CHIEF COMPLAINTS:
A. RUK
A. 1. Table No. 43. Showing the distribution of patients by different grades of
RUK in both the treatment groups (A & B):
Ruk No. Of Patients
In Group A
% No. Of Patients
In Group B
% Total No. Of
Patients
Total
%
Grade 0 - - - - - -
Grade 1 - - - - - -
Grade 2 7 46.66 6 40 13 43.33
Grade 3 8 53.44 9 60 17 56.66
Among the 15 patients in group A, 7 patients had the ruk of grade–2
(46.66 %) and 8 patients had the ruk of grade –3 (53.44%) before the treatment. Among
the 15 patients in group B, 6 patients had the ruk of grade –2 (40%) and 9 patients had the
ruk of grade 3 (60%). Before the treatment in the study as a whole (30 patients), 13
patients had the ruk of grade–2 (43.33%) before the treatment and 17 patients had the ruk
of grade-3 (56.66%). Before the treatment, no patients reported with grade–0 and grade–1
pains.
0 0 0 0
76
89
0
2
4
6
8
10
No.ofpts
Gr 0 Gr 1 Gr 2 Gr 3Grades of Ruk
Distribution of pts by diff. grades of Ruk
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 117
A. 2. Table No. 44. Showing the overall treatment response in patients of different grades
of Ruk in both the treatment groups (A & B):
Group A Group B Total Ruk
No GR MR No MR PR No GR MR PR
Grade 0 - - - -
- - - - - -
Grade 1 - - - - - - - - - -
Grade 2 7 4 3 6 5 1 13 4 8 1
Grade 3 8 3 5 9 9 - 17 3 14 -
In the group A, among the 7 patients of Ruk grade–2, 4 patients got good
response (57.14 %) and 3 patients got moderate response (42.85 %); among the 8 patients
of Ruk grade–3, 3 patients good response (37.5 %) and 5 patients got moderate response
(62.5 %). In the group B, among the 6 patients of Ruk grade–2, 5 patients got moderate
response (83.33%) and 1 patient got poor response (16.66%); all the patients of Ruk
grade–3 got moderate response. In the study as a whole (30 patients), among 13 patients
of Ruk grade–2, 4 patients got good response (30.76%), 8 patients got poor response
(7.69%); whereas among the 17 patients of Ruk grade–3, 3 patients got good response
and 14 patients got moderate response.
Observation & Results 118
B.GRAHA
B. 1. Table No. 45. Showing the distribution of patients by different grades of
Graha in both the treatment groups (A& B):
Graha No. Of Patients
In Group A
% No. Of Patients
In Group B
% Total No. Of
Patients
Total
%
Grade 0 - - - - - -
Grade 1 15 100 15 100 30 100
All the patients (in groups A & B), had grade–1 graha (100%) before the
treatment.
0 0
15 15
0
5
10
15
No. Ofpts
Grade 0 Grade 1Graha
Distribution of pts by DIff. grades of graha`
No. of Patients. In Gr. A No. of Patients. In Gr. B
Observation & Results 119
B. 2. Table No. 46. Showing the overall Treatment Response in Patients of different
grades of Graha in both the treatment groups (A& B):
Group A Group B Total Graha
No GR MR No MR PR No GR MR PR
Grade 0 - - - -
- - - - - -
Grade 1 15 7 8 15 14 1 30 7 22 1
In group A among the 15 patients of grade–1 Graha, 7 patients got good
response (46.66%) and 8 patients got moderate response (53.33 %). In group B among
the 15 patients of grade–1 Graha, 14 patients got moderate response (93.33%) and 1
patient got poor response (6.66%). In the study as a whole (30 patients), among the 30
patients of grade–1 Graha, 7 patients got good response (23.33%), 22 patients got
moderate response (73.33%) and 1 patient got poor response (3.33%).
Observation & Results 120
C. SPARSHAAKSHAMATVA
B. Table No. 47. Showing the distribution of patients by different grades of Sparsha
akshamatva in both the treatment groups (A &B):
Sparsha
akshamatva
No. Of Patients
In Group A
% No. Of Patients
In Group B
% Total No. Of
Patients
Total
%
Grade 0 3 20 4 26.66 7 23.33
Grade 1 3 20 4 26.66 7 23.33
Grade 2 9 60 7 46.66 16 53.33
Grade 3 - - - - - -
Among the 15 patients in group A, 3 patients had Sparsha akshamatva of
grade–0 (20%), 3 patients had Sparsha akshamatva of grade–1 (20%) 3 patients had
Sparsha akshamatva of grade–1(20%) and 9 patients had Sparsha akshamatva of grade–2
(60%) before the treatment. Among the 15 patients in group B, 4 patients had Sparsha
akshamatva of grade–0 (26.66%), 4 patients had Sparsha akshamatva of grade–1
(26.66%) before the treatment. In the study as a whole (30 patients), 7 patients had
Sparsha akshamatva of grade 0 (23.33%), 7 patients had Sparsha akshamatva of grade–1
(23.3%) and 16 patients had Sparsha akshamatva of grade-2 (53.33%) before the
treatment. No patients reported with Group 3 Sparsha akshamatva in this study.
34
34
97
0 00
2
4
6
8
10
No. of pts.
Gr 0 Gr 1 Gr 2 Gr 3Grades
Distribution of pts by Diff. grades of sparsha akshamatwa
No. of Pts. In Gr. A No. of Pts. In Gr. B
Observation & Results 121
C. 2. Table No. 48. Showing the overall Treatment Response in Patients of different
grades of Sparsha Akshamatva in both the treatment groups (A & B):
Group A Group B Total Sparsha
akshama
tva No GR MR No MR PR No GR MR PR
Grade 0 3 1 2 4 3 1 7 1 5 1
Grade 1 3 2 1 4 4 - 7 2 5 -
Grade 2 9 4 5 7 7 - 16 4 12 -
Grade 3 - - - - - - - - - -
In the group A, among the 3 patients of grade-0, 1 patient got good
response (33.33%) and 2 patients got moderate response (66.66%); whereas among the 3
patients of grade–1, 2 patients got good response (66.66%) and 1 patient got moderate
response (33.33%) and among the 4 patients of grade–2, 4 patients got good response
(44.44%) and 5 patients got moderate response (55.55%). In the group B, among the 4
patients of grade–0, 3 patients got moderate response (75%) and 1 patient got poor
response (25%) whereas all the patients of grade–1 and grade–2 got moderate response.
In the study as a whole (30 patients), among the 7 patients of grade–0, 1 patient got good
response (14.28%), 5 patients got moderate response (71.42%) and 1 patient got poor
response (14.28%); where as among the 7 patients of grade–1, 2 patients got good
response (28.57%) and 5 patients got moderate response (71.42%); among the 16 patients
of grade–2,4 patients got good response (25%) and 12 patients got moderate response
(75%).
Observation & Results 122
D.SANDHIGATHIASAAMARTHYA
D.1. Table No. 49. Showing the distribution of patients by different grade of
Sandhigati asaamarthya in both the treatment groups (A & B):
Sandhigati
asaamarthya
No. Of Patients
In Group A
% No. Of
Patients In
Group B
% Total No.
Of Patients
Total
%
Grade 0 - - - - - -
Grade 1 10 66.66 7 46.66 17 56.66
Grade 2 5 33.33 8 53.33 13 43.33
Grade 3 - - - - - -
Grade 4 - - - - - -
Among the 15 patients in group A, 10 patients had Sandhigati asaamarthya
of grade-1 (66.66%) and 5 patients had Sandhigati asaamarthya of grade–2 (33.33%)
before the treatment. Among the 15 patients in group B, 7 patients had Sandhigati
asaamarthya of grade–1 (46.66%) and 8 patients had Sandhigati asaamarthya of grade–2
(53.33%). Before the treatment, in the study as a whole (30 patients), 17 patients had
Sandhigati asaamarthya of grade–1 (56.66%) and 13 patients had Sandhigati asaamarthya
of grade–2 (43.33 %). No patients reported with grades-0, 3&4 Sandhigati asaamarthya
before the treatment in this study.
Distribution of pts by Diff. gds. of SGA
0
10
5
0 00
78
0 00
2
4
6
8
10
12
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4Grades
No.
of p
ts.
No. of Pts. In Gr. A No. of Pts. In Gr. B
Observation & Results 123
D. 2. Table No. 50. Showing the overall Treatment Response in patients of
different Grades of Sandhigati asaamarthya in both the treatment groups (A & B):
Group A Group B Total Sparsha
akshama
tva No GR MR No MR PR No GR MR PR
Grade 0 - - - - - - - - - -
Grade 1 10 4 6 7 7 - 17 4 13 -
Grade 2 5 3 2 8 7 1 13 3 9 1
Grade 3 - - - - - - - - - -
Grade 4 - - - - - - - - - -
In the group A, among the 10 patients with grade–1, 4 patients got good
response (40%) and 6 patients got moderate response (60%) where as among the 5
patients with grade–2, 3 patients got good response (60 %) and 2 patients got moderate
response (40%). In the group B, among the 7 patients with grade–1 all got moderate
response, while among the 8 patients with grade–2, 7 patients got moderate response
(87.5%) and 1 patient got poor response (12.5%). In the study as a whole (30 patients),
among the 17 patients of grade–1, 4 patients got good response (23.52%) and 3 patients
got moderate response (76.47%); where as among the 13 patients with grade 2, 3 patients
got good response (23.07%), 9 patients got moderate response (69.28%) and 1 patient got
poor response (7.69%).
Observation & Results 124
E. ATOPA
E. 1. Table No 51. Showing the distribution of patients by different grades of
Atopa with both the treatment groups (A & B):
Atopa No. Of Patients
In Group A
% No. Of Patients
In Group B
% Total No. Of
Patients
Total
%
Grade 0 4 26.66 3 20 7 23.33
Grade 1 10 66.66 12 80 22 73.33
Grade 2 1 6.66 - - 1 3.33
Among the 15 patients in group A, 4 patients had grade-0 Atopa (26.66%),
10 patients had grade-2 Atopa (6.66%) before the treatment. Among the 15 patients in
group B, 3 patients had grade-0 Atopa (20%) and 12 patients had grade-1 Atopa (80%)
before the treatment. In the study as a whole (30 patients), 7 patients had grade-0 Atopa
(23.33%), 22 patients had grade-1 Atopa (73.33%) and 1 patient had grade-2 Atopa
(3.33%) before the treatment.
43
1012
1 002
46
81012
No.of
pts.
Grade 0 Grade 1 Grade 2Grades
Distribution of pts. by Diff. gds of Atopa
No. of Pts. In Gr. A No. of Pts. In Gr. B
Observation & Results 125
E. 2. Table No. 52. Showing the overall treatment response in patients of different grades
of Atopa in both the treatment groups (A & B):
Group A Group B Total Atopa
No GR MR No MR PR No GR MR PR
Grade 0 4 2 2 3 2 1 7 2 4 1
Grade 1 10 5 5 12 12 - 22 5 17 -
Grade 2 1 - 1 - - - 1 - 1 -
In the group A, among the 4 patients with grade-0 Atopa, 2 patients had good
response (50%) and 2 patients had moderate response (50%); whereas among the 10
patients with grade-2 Atopa had moderate response. In the group B, among the 3 patients
with grade-0 Atopa, 2 patients had moderate response (66.66%), 1 patients had moderate
response (33.33%); where as among the 12 patients with grade-1 Atopa all had moderate
response. In the study as a whole, among the 7 patients with grade-0 Atopa, 2 patients
had good response (28.57%) and 4 patients had moderate response (57.14%) and 1
patient had poor response (14.28%); whereas among the 22 patients with grade-1 Atopa,
5 patients had good response (22.72%) and the 17 patients had moderate response
(72.72%) and the one patient with grade-2 Atopa had moderate response.
Observation & Results 126
F. SHOPHA
F. 1. Table No. 53. Showing the distribution of patients by different gradings of
Shopha in both the treatment groups (A & B):
Shopha No. Of Patients
In Group A
% No. Of
Patients In
Group B
% Total No.
Of Patients
Total
%
Grade 0 5 33.33 4 26.66 9 30
Grade 1 7 46.66 5 33.33 12 40
Grade 2 2 13.33 6 40 8 26.66
Grade 3 1 6.66 - - 1 3.33
Among the 15 patients in group A, 5 patients had grade-0 Shopha
(33.33%), 7 patients had grade-1 Shopha (46.66%), 2 patients had grade-1 Shopha
(13.33%) and 1 patient had grade-3 Shopha (6.66%) before the treatment. Among the 15
patients in group B, 4 patients had grade-0 Shopha (26.66%), 5 patients had grade-1
Shopha (33.33%) and 6 patients had grade-2 Shopha (40%) before the treatment. In the
study as a whole (30 patients), 9 patients had grade 0 Shopha (30%), 12 patients had
grade-1 Shopha (40%), 8 patients had grade-2 shopha (26.66%) and 1 patient had grade-3
Shopha (3.33%) before the treatment.
54
7
5
2
6
100
1234567
No.of
pts.
Grade 0 Grade 1 Grade 2 Grade 3Grades
Distribution of pts. by Diff. gds of shopha
No. of Pts. In Gr. A No.of Pts. In Gr. B
Observation & Results 127
F. 2. Table No. 54. Showing the overall treatment response in patients of different grades
of shopha in both the treatment groups (A & B):
Group A Group B Total Shopha
No GR MR No MR PR No GR MR PR
Grade 0 5 2 3 4 3 1 9 2 6 1
Grade 1 7 3 4 5 5 - 12 3 9 -
Grade 2 2 2 - 6 6 - 8 2 6 -
Grade 3 1 - 1 - - - 1 - 1 -
In the group A, among the 5 patients with grade-0, 2 patients got good
response (40%) and 3 patients got moderate response (60%); whereas among the 7
patients with grade-1, 3 patients got good response (42.85%) and 4 patients got moderate
response (57.14%) and the 2 patients with grade-2 got good response and 1 patient with
grade-3 got moderate response. In the group B, among the 4 patients with grade-0, 3
patients got moderate response (75%) and 1 patient got poor response (25%); whereas all
the 5 patients with grade-1 and all the 6 patients with grade-2 got moderate response. In
the study as a whole (30 patients), among the 9 patients with grade-0, 2 patients got good
response (22.22%), 6 patients got moderate response (66.66%) and 1 patient got poor
response (11.11%); whereas among the 12 patients with grade-1, 3 patients got good
response (25%) and 9 patients got moderate response (75%); among the 8 patients with
grade-2, 2 patients got good response (25%) and 6 patients got good response (75%) and
the only 1 patient with grade-3 got moderate response.
Observation & Results 128
G. Table No. 55. Showing the distribution of patients by chief complaints in the
study as a whole (30 patients)
Sl. Presenting complaint No. of Patients %
1 Prasarana akunchanayoho savedana
pravritti
27 90
2 Ruk 30 100
3 Vatapoorna dritisparsha 4 13.33
4 Shopha 21 70
5 Sandhigraha 30 100
6 Sandhigati asaamarthya 30 100
7 Sparsha akshamatva 23 76.66
8 Atopa 23 76.66
Among the 30 patients included in this study, all the patients had the
symptoms Ruk, Sandhi graha and Sandhigati asaamarthya. 27 patients had the symptom
prasarana akunchanayoho savedana pravritti (90%). Only 4 patients had the symptom
Vatapoorna dritisparsha (13.33%) whereas 21 patients had the symptom Shopha (70%)
and 23 patients had the symptom Sparsha akshamatva (76.66%) and an equal number of
patients had the symptom Atopa (76.66%).
Distribution of pts. by chief complaints27
30
4
21
30 30
23 23
0
5
10
15
20
25
30
35
PAS Ruk VPD Shopha SG SGA SPA Atopa
No. of Patients
Observation & Results 129
2. A. Table No. 56. Showing the distribution of patients by duration of the disease in
both the treatment groups (A & B)
Duration No. Of Patients
In Group A
% No. Of
Patients In
Group B
% Total No.
Of Patients
Total
%
>2 years (A) 4 26.66 1 6.66 5 16.66
1-2years (B) 6 40 12 80 18 60
<1year (C) 5 33.33 2 13.33 7 23.33
Among the 15 patients in group A, 4 patients had a duration > 2 years
(26.66%), 6 patients had duration 1-2 years (40%) and 5 patients had a duration < 1 year
(33.33%). Among the 15 patients in group B, 1 patient had a duration > 2 years (6.66%),
12 patients had a duration 1-2years(80%) and 2 patients had a duration < 1 year
(13.33%). In the study as a whole (30 patients), 5 patients had a duration > 2 years
(16.66%), 18 patients had a duration 1-2 years (60%) and 7 patients had a duration < 1
year (23.33%).
2. B. Table No. 57. Showing the overall treatment response in patients of various
durations in both the treatment groups (A & B):
Group A Group B Total Duration
No GR MR No MR PR No GR MR PR
>2 years
(A)
4 1 3 1 1 - 5 1 4 -
1-2years
(B)
6 4 2 12 12 - 18 4 14 -
<1year
(C)
5 2 3 2 1 1 7 2 4 1
Observation & Results 130
In the group A, among the 4 patients with > 2 years duration, only 1
patient had good response (25%) while 3 patients had moderate response (75%); among
the 6 patients with 1-2 years duration, 4 patients had good response (66.66%) while 2
patients had moderate response (33.34%); among the 5 patients with < 1 year duration, 2
patients had good response (40%) while 3 patients had moderate response (60%). In the
group B, the only one patient with > 2 years got moderate response and all the 12 patients
with 1-2 years duration got moderate response while among the 2 patients with < 1 year
duration, 1 patient got poor response (50%) and 1 patient got poor response (50%). In the
study as a whole (30 patients), among the 5 patients with > 2 years duration, 1 patient got
good response (20%) and 4 patients got moderate response (80%); among the 18 patients
with 1-2 years duration, 4 patients got good response (22.22%) and 14 patients got
moderate response (77.77%); among the 7 patients with < 1 year duration, 2 patients got
good response (28.57%), 4 patients got moderate response (57.14%) and 1 patient got
poor response (14.28%).
3.A Table No. 58. Showing the distribution of patients by mode of on set in both
the treatment groups (A &B):
Mode of
onset
No. Of Patients
In Group A
% No. Of
Patients In
Group B
% Total No.
Of Patients
Total
%
Chronic 10 66.66 12 80 22 73.33
Insidious 3 20 2 13.33 5 16.66
Acute - - 1 6.66 1 3.33
Traumatic 2 13.33 - - 2 6.66
Observation & Results 131
Among the 15 Patients in group A, 10 patients had chronic onset
(66.66%), 3 patients had insidious onset (20 %) and 2 patients had traumatic onset
(13.33%). Among the 15 patients in group, 12 patients had chronic onset (80%), 2
patients had insidious onset (13.33%) and 1 patient had acute onset (6.66%). In the study
as a whole (30 patients), 22 patients had chronic onset (73.33%), 5 patients had insidious
onset (73.33%), 1 patient had acute onset (3.33%) and 2 patients had traumatic onset
(6.66 %).
C. Table No. 59. Showing the overall Treatment Response in patients of various
modes of onset in both the treatment groups (A & B):
Group A Group B Total Mode of
onset No GR MR No MR PR No GR MR PR
Chronic 10 5 5 12 12 - 22 5 17 -
Insidious 3 1 2 2 2 - 5 1 4 -
Acute - - - 1 - 1 1 - - 1
Traumatic 2 1 1 - - - 2 1 1 -
In the group A, among 10 patients of chronic onset, 5 patients got good
response (50%) and 5 patients got moderate response (50%); among the 3 patients of
insidious onset, 1 patient got good response (33.33%) and 2 patients got moderate
response (66.66%); among the 2 patients of traumatic onset, 1 patient got good response
(50%) and 1 patient got moderate response (50%). In the group B, all the 12 patients of
chronic onset and both the patients of insidious onset got moderate response, while the 1
patient of acute onset got poor response. In the study as a whole (30 patients), among the
22 patients of chronic onset, 5 patients got good response (22.72%) and 17 patients got
moderate response (77.27%); among the 5 patients of insidious onset, patient got good
Observation & Results 132
response (80%) and 4 patients got moderate response (80%) the only one patient of acute
onset got poor response while among the two patients of traumatic onset one patient got
good responses (50%) and one patient got moderate response (50%).
4.1 A. Table No. 60. Showing the distribution of patients by the different joints
affected in both the treatment groups (A & B):
Joint
affected
No. Of Patients
In Group A
% No. Of Patients
In Group B
% Total No. Of
patients
Total
%
Knee 13 86.66 12 80 25 83.33
Lumbar spine 2 13.33 3 20 5 16.66
Among the 15 patients in group A, 13 patients had their knee joint affected
(86.66%) and 2 patients had their lumbar spine affected (13.33%).
Among the 15 patients in group B, 12 patients had their knee joint affected (80%) and 3
patients had their lumbar spine affected (20%). In the study as a whole, 25 patients had
their knee joint affected (83.33%) and 5 patients had their lumbar spine affected
(16.66%).
13 12
2 3
02468
101214
No.of
pts.
Knee Lumbar spineJoint
Distribution of pts. by joints affected
No. of Pts. In Gr. A No. of Pts. In Gr. B
Observation & Results 133
1.B. Table No. 61. Showing the overall Treatment Response in Patients of
various joint involvement in both the treatment groups ( A & B ):
Group A Group B Total Joint
affected
No GR MR No MR PR No GR MR PR
Knee 13 6 7 12
12 - 25 6 19 -
Lumbar
spine
2 1 1 3 2 1 5 1 3 1
In the group A, among the 13 patients with knee joint involvement, 6
patients got good response (46.15%) and 7 patients got moderate response (53.84 %)
where as among the 2 patients with lumbar involvement one patient got good response
(50 %) and 1 patient got moderate response (50%). In the group B, among the 12
patients with knee involvement, all got moderate response where as among the 3 patients
with lumbar involvement, 2 patients got moderate response (66.66 %) and 1 patient got
poor response (33.33 %). In the study as a whole (30 patients), among the 25 patients
with knee involvement, 6 patients got good response (24 %) and 19 patients got moderate
response (76 %) and among the 5 patients with lumbar spine involvement, 1 patient got
good response (20%), 3 patients got moderate response (60%) and 1 patient got poor
response (20%).
Observation & Results 134
4.2 Table No. 62. Showing the distribution of patients by the type of Knee joint
involvement in both the treatment Groups (A & B):
Type of joint
involvement
No. Of Patients
In Group A
% No. Of
Patients In
Group B
% Total No.
Of Patients
Total
%
Unilateral 9 69.23 8 66.66 17 68
Bilateral 4 30.76 4 33.33 8 32
Among the 13 patients of knee involvement in group A, 9 patients had
unilateral joint involvement (69.23%) while 4 patients had bilateral joint involvement
(30.76%). Among the 12 patients of knee involvement in group B, 8 had unilateral joint
involvement (66.66%) and 4 patients had bilateral involvement (33.33%). In the study,
among the 25 patients of knee involvement, 17 patients had unilateral involvement (68%)
and 8 patients had bilateral involvement (32%).
5.1. A Table No. 63. Showing the distribution of Patients by various Aharaja
Vatakopa Nidanas in both the treatment groups (A & B):
Aharaja
nidana
No. Of Patients
In Group A
% No. Of
Patients In
Group B
% Total No.
Of Patients
Total
%
Tikta rasa 3 20 1 6.66 4 13.33
Kashaya rasa 4 26.66 5 33.33 9 30
Katu rasa 14 93.33 15 100 29 96.66
Alpa bhojana 6 40 11 73.33 17 56.66
Pramita
bhojana
2 13.33 1 6.66 3 10
Rooksha
bhojana
11 73.33 13 86.66 24 80
Observation & Results 135
Among 15 patients in group A, 3 patients had tikta rasa atisevana (20%), 4
patients had kashaya rasa atisevana (26.66%), 14 patients had katu rasa atisevana
(93.33%), 6 patients had alpa bhojana (40%), 2 patients had pramita bhojana (13.33%)
and 11 patients had rooksha bhojana (73.33%). Among 15 patients in group B, 1 patient
had tikta rasa atisevana (6.66%), 5 patients had kashaya rasa atisevana (33.33%), 15
patients had katu rasa atisevana (100%), 11 patients had alpa bhojana (73.33%), 1 patient
had pramita bhojana (6.66%) and 13 patients had rooksha bhojana (86.66%). In the study
as a whole (30 patients), 4 patients had tikta rasa atisevana (13.33%), 9 patients had
kashaya rasa atisevana (30%), 29 patients had katu rasa atisevana (96.66%), 17 patients
had alpa bhojana (56.66%), 3 patients had pramita bhojana (10%) and 24 patients had
rooksha bhojana (80%).
Distribution of pts. by aharaja nidana
3 4
14
6
2
11
1
5
15
11
1
13
02468
10121416
TkR KsR KtR AlBh PrBh RkBhNidana
No.
of p
ts.
No. of Pts. In Gr. A No. of Pts. In Gr. B
Observation & Results 136
5.1.B Table No. 64. Showing the overall Treatment Response in Patients having various
Aharaja Vatakopa nidana in both the treatment groups:
Group A Group B Total Aharaja nidana
No GR MR No MR PR No GR MR PR
Tikta rasa 3 2 1 1
1 - 4 2 2 -
Kashaya rasa
4 3 1 5 5 - 9 3 6 -
Katu rasa 14 7 7 15 14 1 29 7 21 1
Alpa bhojana
6 2 4 11 11 - 17 2 15 -
Pramita bhojana
2 1 1 1 1 - 3 1 2 -
Rooksha bhojana
11 5 6 13 12 1 24 5 18 1
In group A, among 3 patients having tikta rasa nidana, 2 patients got good
response (66.66%) and 1 patient got moderate response (33.33%); among 4 patients
having kashaya rasa nidana, 3 patients got good response (75%) and 1 patient got
moderate response (25%); among 14 patients having katu rasa nidana, 7 patients got good
response (50%) and 7 patients got moderate response (50%); among 6 patients having
alpa bhojana nidana, 2 patients got good response (33.33%) and 4 patients got moderate
response (66.66%) ; among 2 patients having pramita bhojana, 1 patient got good
response (50%) and 1 patient got moderate response (50%) ; among 11 patients having
rooksha bhojana nidana, 5 patients had good response (45.45%) and 6 patients had
moderate response (54.54%).
Observation & Results 137
In group B, the one patient having tikta rasa nidana got moderate response and all
the 5 patients having kashaya rasa nidana got moderate response; among the 15 patients
having katu rasa nidana, 14 patients got moderate response (93.33%) and 1 patient got
poor response; all the 11 patients having pramita bhojana nidana got moderate response;
among the 13 patients having rooksha bhojana nidana, 12 patients got moderate response
(92.3%) and 1 patient got poor response (7.69%).
In the study as a whole (30 patients), among the 4 patients of tikta rasa nidana, 2
patients got good response (50%) and 2 patients got moderate response (50%); among the
9 patients of kashaya rasa nidana 3 patients got good response (33.33%) and 6 patients
got moderate response (66.66%); among the 29 patients of katu rasa nidana, 7 patients
got good response (24.13%), 21 patients got moderate response (72.41%) and 1 patient
got poor response (3.44%); among the 17 patients of alpa bhojana nidana, 2 patients got
good response (11.76%) and 15 patients got moderate response (88.23%): among the 3
patients of pramita bhojana, 1 patient got good response (33.33%) and 2 patients got
moderate response (66.66%); among the 24 patients of rooksha bhojana, 5 patients got
good response (20.83%) , 18 patients got moderate response (75%) and 1 patient got poor
response (4.16 %).
Observation & Results 138
5.2.A Table No. 65. Showing the distribution of patients by various Viharaja Vatakopa nidanas in both the treatment groups (A & B):
Viharaja nidana
No. Of Patients In Group A
% No. Of Patients In Group B
% Total No. Of Patients
Total %
Vega dharana 9 60 13 86.66 22 73.33
Vega udeerana
- - 9 60 9 30
Ati vyavaya - - 2 13.33 2 6.66
Nisha jagarana
11 73.33 10 66.66 21 70
Atyucha bhashana
2 13.33 2 13.33 4 13.33
Ativyayama 11 73.33 12 60 23 76.66
Among 15 patients in group A, 9 patients had Vega dharana (60%), 11
patients had Nisha jagarana (73.33%), 2 patients had Athyucha bhashana (13.33%) and
11 patients had Ativyayama (73.33%). Among 15 patients in group B, 12 patients had
Vega dharana (86.66%), 9 patients had Vega udeerana (60%), 2 patients had Ati vyavaya
(13.33%), 10 patients had Nisha jagarana (66.66%), 2 patients had Athyucha bhashana
(13.33%) and 12 patients had Ativyayama (80%). In the study as a whole, 22 patients
had Vega dharana (73.33%), 9 patients had Vega udeerana (30%), 2 patients had Ati
vyavaya (6.66%), 21 patients had Nisha jagarana (70%), 4 patients had Athyucha
bhashana (13.33%) and 23 patients had Ativyayama (76.66 %).
9
13
0
9
02
1110
2 2
1112
0
2
4
6
8
10
12
14
No.of
pts.
Vg Dh Vg Ud A Vyv Ns Jg At U Bh A Vy
Nidana
Distribution of pts. by viharaja nidana
No. of Pts. In Gr. A No. of Pts. In Gr. B
Observation & Results 139
5.2.B Table No. 66. Showing the overall treatment response in patients having various
Viharaja Vatakopa Nidanas in both the treatment groups (A & B):
Group A Group B Total Viharaja
nidana No GR MR No MR PR No GR MR PR
Vega
dharana
9 4 5 13 12 1 22 4 17 -
Vega
udeerana
- - - 9 9 - 9 - 9 -
Ati
vyavaya
- - - 2 2 - 2 - 2 -
Nisha
jagarana
11 5 6 10 10 - 21 5 16 -
Athyucha
bhashana
2 1 1 2 2 - 4 1 3 -
Ativyaya
ma
11 5 6 12 11 1 23 5 17 1
In the group A, among 9 patients of Vega dharana nidana, 4 patients had
good response (44.44%) and 5 patients had moderate response (55.55%); among the 11
patients of Nisha jagarana, 5 patients had good response (45.45%) and 6 patients had
moderate response (54.54%); among the 2 patients of Athyucha bhashana, one patient
had good response (50%) and 1 patient had moderate response (50%); among the 11
patients of Ativyayama, 5 patients got good response (45.45%) and 6 patients got
moderate response (54.54%). In the group B, among 13 patients of Vega dharana nidana,
12 patients had good response (92.3%) and 1 patient had moderate response (7.69%); all
the 9 patients of Vega udeerana and both the patients of Ati vyavaya, patients of Nisha
jagarana and both the patients of Athyucha bhashana had moderate response; among the
12 patients of Ativyayama, 11 patients had moderate response (91.66%) and 1 patient had
Observation & Results 140
poor response (8.33%). In the study as a whole (30 patients), among the 22 patients of
Vega dharana nidana, 4 patients had good response (18.18%), 17 patients had moderate
response (77.27%) and 1 patient had poor response (4.54%); all 9 patients of Vega
udeerana and 2 patients of Ati vyavaya had moderate response; among the 21 patients of
Nisha jagarana, 5 patients had good response (23.8%) and 16 patients had moderate
response (76.19%); among the 4 patients of Athyucha bhashana, 1 patient had good
response (25%) and 3 patients had moderate response (75%) ; among the 23 patients of
Ativyayama, 5 patients got good response (21.73%), 17 patients got moderate response
(73.91%) and 1 patient got poor response (4.34 %).
5.3 Table No. 67. Showing the distribution of Patients by various Manasika
Vatakopa nidanas in both the treatment groups (A &B):
Manasika
nidana
No. Of Patients
In Group A
% No. Of
Patients In
Group B
% Total No.
Of Patients
Total
%
Bhaya 1 6.66 4 26.66 5 16.66
Shoka 4 26.66 2 13.33 6 20
Chinta 11 73.33 10 66.66 21 70
Among the 15 patients in group A, only 1 patient had bhaya (6.66%), 4
patients had shoka (26.66%) and 11 patients had chinta (73.33%). Among the 15 patients
in group B, 4 patients had bhaya (26.66%), 2 patients had shoka (13.33%) and 10 patients
had chinta (66.66%). In the study as a whole (30 patients), 5 patients had bhaya
(16.66%), 6 patients had shoka (20%), and 21 patients had chinta (70%).
Observation & Results 141
6. Table No. 68. Showing the distribution of Patients by radiological
interpretations in both the treatment groups:
Radiological
interpretation
No. Of Patients
In Group A
% No. Of
Patients In
Group B
% Total
No.
Total
%
Incr. 3 20 - - 3 10
Decr. 9 60 12 80 21 70
Joint
space
Unalt. 3 20 3 20 6 20
Sub. Bon. Scl. 3 20 1 6.66 4 13.33
Osteophytes 15 100 13 86.66 28 93.33
Peri.Art.Oss. 2 13.33 - - 2 6.66
Alt. Bne. End - - - - - -
Among the 30 patients in this study, 3 patients had their affected joint
space increased (10%), 21 patients had their affected joint space reduced (70%), 6
patients had their affected joint space unaltered (10%), 4 patients had subchondral bony
sclerosis (13.33%), 28 patients had osteophytes formation (93.33%), 2 patients had
periarticular ossicles (6.66%) and no patient had altered bone end.
Observation & Results 142
III. Data Related to Overall Response to the treatment: -
Table No. 69. Showing the distribution of patients according to response.
Response No. Of Patients
In Group A
% No. Of
Patients In
Group B
% Total No.
Of Patients
Total
%
Good 7 46.66 - - 7 23.33
Moderate 8 53.33 14 93.33 22 73.33
Poor - - 1 6.66 1 3.33
No response - - - - - -
In group A, 7 patients (46.66%) had good response to the treatment (>
60% improvement in all the parameters) and 8 patients (53.33%) had moderate Response
to the treatment (31-60% improvement in all the parameters). In group B, 14 patients
(93.33%) had moderate response to the treatment and one patient (6.66%) had poor
response to the treatment (1-30% in all the parameters). In the study as a whole, 7
patients (23.33%) had good response, 22 patients (73.33%) had moderate response and 1
patient (3.33%) had poor response.
7
0
8
14
0 1 0 0024
68
101214
No.ofpts
GR MR PR NoResponse
Overall response to the treatment
No. of Pts. In Gr. A No. of Pts. In Gr. B
Observation & Results 143
IV. Statistical analysis of the clinical and functional parameters & Intergroup comparison Table No. 70. Showing the before and after treatment values of all parameters in Gr. A.
Clinical parameters Functional parameters
Ruk Graha Sp. Ak.
SGA Atopa Sopha AIMS Score
Walk time
Sl. No.
OPD No.
B A B A B A B A B A B A B A B A
01. 3575 2 0 1 0 1 0 1 3 1 0 0 0 37 18 3 2 02. 3565 2 0 1 0 0 0 1 3 1 1 0 0 38 18 2 1 03. 3529 3 1 1 0 2 1 1 2 1 1 1 0 46 23 4 3 04. 3560 3 2 1 1 2 1 1 2 2 1 3 2 48 27 4 3 05. 3790 3 1 1 0 2 1 1 3 1 0 1 1 34 21 4 3 06. 3818 3 2 1 1 2 1 1 2 1 1 1 0 41 23 3 3 07. 3914 2 1 1 0 2 1 2 3 1 0 1 0 38 23 3 2 08. 3961 2 1 1 1 1 0 2 2 0 0 1 0 37 25 3 2 09. 3973 2 1 1 0 0 0 2 3 0 0 0 0 31 21 3 3 10. 4003 3 2 1 0 2 0 1 3 1 0 2 1 32 22 4 3 11. 3588 2 1 1 0 2 1 1 3 1 0 0 0 42 21 4 3 12. 4502 3 1 1 0 2 1 2 3 1 0 1 0 31 21 3 2 13. 434 3 2 1 0 1 0 2 3 0 0 0 0 29 20 3 3 14. 4047 3 1 1 0 0 0 1 3 0 0 2 1 33 21 4 2 15. 3527 2 1 1 0 2 1 1 3 1 1 1 0 43 24 3 2 Table No. 71. Showing before and after treatment values of all parameters in Gr. B.
Clinical parameters Functional parameters
Ruk Graha Sp. Ak.
SGA Atopa Sopha AIMS Score
Walk time
Sl. No.
OPD No.
B A B A B A B A B A B A B A B A 16 380 2 1 1 0 0 0 2 3 0 0 0 0 38 30 4 4 17 1045 3 2 1 0 2 1 1 2 1 0 1 1 40 35 4 3 18 1044 3 2 1 0 2 1 1 2 1 1 2 1 37 30 3 2 19 989 3 2 1 0 0 0 1 3 0 0 0 0 39 30 3 3 20 1223 3 2 1 0 1 0 1 2 1 0 2 1 35 27 4 3 21 832 2 1 1 1 2 1 1 2 1 0 1 0 37 28 3 3 22 3526 2 1 1 0 2 1 1 2 1 1 1 1 32 25 3 2 23 1105 3 2 1 0 0 0 1 2 1 0 0 0 30 23 3 3 24 1230 2 1 1 0 1 1 2 3 1 0 2 1 33 24 3 3 25 732 2 1 1 0 2 1 2 3 1 0 2 1 35 27 3 2 26 1046 3 2 1 0 2 1 2 3 1 1 2 0 26 21 3 2 27 4658 3 2 1 0 2 1 2 3 1 1 2 1 37 33 4 4 28 400 3 2 1 1 0 0 2 2 0 0 0 0 37 33 4 4 29 4515 3 2 1 0 1 1 2 3 1 1 1 0 36 29 4 4 30 2071 2 1 1 1 1 0 2 3 1 1 1 0 39 33 3 3
Observation & Results 144
Table No. 73. Showing the individual study of group-A
Parameters Mean S.D S.E t-value p-value Remarks Ruk 1.4 0.507 0.131 10.68 <0.001 H.S. Graha 0.8 0.414 0.106 7.54 <0.001 H.S. Sparsha akshamatva 0.866 0.516 0.133 6.511 <0.001 H.S. Sandhigati asamarthya 1.4 0.632 0.163 8.588 <0.001 H.S. Shopha 0.6 0.507 0.131 4.58 <0.001 H.S. Atopa 0.466 0.516 0.133 3.503 <0.02 H.S. AIMS 15.466 4.867 1.256 12.313 <0.001 H.S. Walking time 0.866 0.516 0.133 6.511 <0.001 H.S. Table No. 74. Showing the individual study of group-B
Parameters Mean S.D S.E t-value p-value Remarks Ruk 1.0 - - - - H.S. Graha 0.866 0.351 0.0901 9.611 <0.001 H.S. Sparsha akshamatva 0.6 0.507 0.1309 4.58 <0.001 H.S. Sandhigati asamarthya 1.0 0.377 0.097 10.309 <0.001 H.S. Shopha 0.666 0.617 0.159 4.188 <0.01 H.S. Atopa 0.666 0.617 0.159 4.188 <0.01 H.S. AIMS 6.866 1.726 0.445 15.429 <0.001 H.S. Walking time 0.4 0.507 0.131 3.053 <0.01 H.S. Table No. 75. Showing the inter group comparison.
Parameters Group Mean S.D S.E P.S.E t-value
p-value
Remarks
A 1.133 0.639 0.156Ruk B 1.6 0.507 0.131
0.211 2.213 <0.05 HS
A 0.2 0.414 0.106Graha B 0.133 0.351 0.091
0.139 0.482 >0.05 NS
A 2.666 4.336 1.119Sparsha akshamatva B 0.6 0.507 0.131
1.126 1.834 >0.05 NS
A 2.733 0.457 0.118Sandhigati asamarthya B 2.533 0.516 0.133
0.177 1.129 >0.05 NS
A 0.333 0.617 0.159Shopha B 0.466 0.516 0.133
0.207 0.642 >0.05 NS
A 0.266 0.457 0.118Atopa B 0.4 0.507 0.130
0.175 0.765 >0.05 NS
A 21.866 2.416 0.623AIMS B 28.533 4.085 1.054
1.224 5.359 <0.001 HS
A 2.46 0.639 0.165Walking time B 3.0 0.755 0.195
0.255 0.534 >0.05 NS
Observation & Results 145
Among the groups A and B the parameters ‘Ruk’ and ‘AIMS score’ shows
high significance and other parameters are not significant in the comparative study (as by
using unpaired t-test, p-value is <0.05). The AIMS sore shows high significance than the
Ruk and the AIMS score is more uniform in the group-A than group-B after the treatment
(by using the co-efficient of variation.
To know the effect on the parameters individually in the groups, we used
the paired t-test; assume that the treatment is not responsible for changes in the
observations of parameters before and after the treatment. In group-A the parameters
Ruk, Sparsha akshamatva, Shopha and walking time shows high significance than the
group-B by comparing the t-values. The parameters Ruk, Sparsha akshamatva, Shopha
and walking time approximately had the same variation in the group-A when compared
to group-B. The mean effect of AIMS scores and variation in group-A is more as
compared to group-B and it showed uniform effect after the treatment in patients. In
group-A Atopa is not having constant effect. In group-B the variation due to the
treatment is zero in the parameter Ruk. Again AIMS score in group-B showed uniform
effect.
Observation & Results 146
V. Statistical analysis of Swedakaarmukata
Table No. 72A. Chart showing the before and after values of Sweda kaarmukata parameters.
Agnideepti Bhakta shraddha
Tandra hani
Sandhi cheshta
Sroto nirmalatwa
Mardava Twak prasada
Sl. No.
B A B A B A B A B A B A B A 01. 0 2 0 1 0 1 1 3 3 1 0 1 0 2 02. 0 2 0 1 0 1 1 3 3 1 0 2 0 2 03. 0 2 1 1 0 1 1 2 3 2 1 2 1 2 04. 1 2 1 1 0 1 1 2 4 3 0 2 0 2 05. 1 2 1 1 0 1 1 2 4 2 1 2 1 2 06. 1 2 1 1 0 1 1 2 3 2 1 2 0 1 07. 0 2 0 1 1 1 2 3 4 2 1 2 1 2 08. 1 2 1 1 0 1 2 2 4 2 0 1 0 1 09. 0 1 0 1 0 1 2 3 3 2 0 1 0 1 10. 1 2 0 1 0 1 1 2 3 1 0 1 0 1 11. 0 2 0 1 0 1 1 2 3 2 0 1 0 0 12. 1 2 1 1 0 1 1 3 3 2 0 1 0 1 13. 0 1 0 1 0 1 2 3 3 2 0 1 0 1 14. 1 2 1 1 0 1 1 3 4 2 1 2 1 1 15. 0 2 0 1 0 1 1 2 3 2 0 1 0 1 Table No. 72B. Chart showing the before and after values of Sweda kaarmukata parameters.
Agnideepti Bhakta shraddha
Tandra hani
Sandhi cheshta
Sroto nirmalatwa
Mardava Twak prasada
Sl. No.
B A B A B A B A B A B A B A 16. 0 1 0 1 0 1 2 3 3 3 0 0 0 0 17. 0 1 0 1 0 1 1 2 4 2 1 1 1 2 18. 0 1 0 1 0 1 1 3 4 2 1 1 1 2 19. 0 1 0 1 0 1 1 3 3 2 0 1 0 2 20. 1 1 1 1 0 1 1 2 3 2 0 1 0 0 21. 0 1 0 1 0 1 1 2 3 2 1 1 1 2 22. 0 1 0 1 0 1 1 2 3 3 0 1 0 1 23. 0 1 0 1 0 1 1 2 3 2 0 1 0 1 24. 0 1 0 1 0 1 2 3 3 3 0 0 0 1 25. 0 2 0 1 0 1 2 3 3 2 0 1 0 1 26. 0 1 0 1 0 0 2 3 3 3 0 0 0 1 27. 0 1 0 1 0 1 2 3 4 3 0 1 0 1 28. 0 1 0 1 0 1 2 3 3 3 0 1 0 1 29. 0 1 0 1 0 1 2 3 3 3 0 0 0 1 30. 0 1 1 1 0 1 2 3 3 2 0 1 0 0
Observation & Results 147
Table No. 76A. Showing the study of Sweda kaarmukata parameters Parameters Mean S.D S.E t-value p-value Remarks Agnideepti 1.866 0.351 0.0908 10.664 <0.001 H.S. Bhakta shraddha 0.533 0.516 0.133 4.00 <0.01 H.S. Tandrahani 0.933 0.258 0.066 14.13 <0.001 H.S. Sandhi cheshta 1.133 0.1516 0.133 8.518 <0.001 H.S. Srotonirmalatva 1.866 0.516 0.133 14.03 <0.001 H.S. Mardava 1.466 0.516 0.133 11.02 <0.001 H.S. Twak prasada 1.33 0.617 0.159 8.383 <0.001 H.S. Table No. 76B. Showing the study of Sweda kaarmukata parameters. Parameters Mean S.D S.E t-value p-value Remarks Agnideepti 1.066 0.256 0.066 16.00 <0.001 H.S. Bhakta shraddha 0.866 0.351 0.0903 9.537 <0.001 H.S. Tandrahani 0.866 0.351 0.0908 9.537 <0.001 H.S. Sandhi cheshta 2.26 0.351 0.0908 12.47 <0.001 H.S. Srotonirmalatva 2.466 0.516 0.133 18.54 <0.001 H.S. Mardava 0.733 0.457 0.118 6.211 <0.001 H.S. Twak prasada 1.066 0.153 0.153 6.967 <0.001 H.S.
To know the Swedakaarmukata in both the groups the parameters were
analyzed. In group-A the parameter Agni deepti showed more significance than the other
parameters and also it differs from the group-B, by comparing the t-values. The
parameter Agni deepti had uniform effect in group-A but in group-B the parameter
Srotonirmamatva had uniform effect. The mean effect of the parameter Sandhi cheshta in
group-A and the parameter Tandra haani was more and same in both the groups. The
variation in Sandhi chesta in group-A was more whereas the parameters Srotonirmalatva
and Mardava had the same mean effect. The parameter Twak prasada in group-B had
more variation whereas the parameters Tandra haani and Mardava had the same
variations.
Observation & Results 148
Discussions on this study are made under the following headings:
1. Sandhigatavata vis-à-vis Osteoarthritis
2. Role of Snehana and Swedana in the management of Sandhigatavata
3. Clinical study
4. Probable mechanism of action of Swedana
5. Discussion on Shashtikashalipindasweda
Sandhigatavata vis-à-vis Osteoarthritis
Sandhigatavata is the most common joint disorder worldwide. It is a
disorder caused by the localization of the vitiated Vata dosha in the asthi sandhis of the
body. It is one among the many Vatavyadhis described by all the acharyas of Ayurveda.
It comes under the various Gatavatas explained in Vatavyadhi prakarana. It is
characterized by the symptoms pertaining to the asthi sandhis like sandhi shoola, sandhi
shopha etc.
Osteoarthritis is a disease coming under the arthritis group of diseases
described by the modern science, which is almost identical to Sandhigatavata in etiology,
pathology and clinical features. Hence, the discussion is made here step by step starting
from the shareera to the roopa.
Sandhis are the union of the asthis and in them are located the Sleshaka
Kapha and Sleshmadhara kala, both of which lubricate the sandhis, thereby reducing the
friction during various joint movements. Various snayus and peshis are responsible for
the compactness of the joints and support in their functions. Also, several marmas are
located in the Sandhis whose protection is inevitable in maintaining the normal functions
Discussion 149
of these sandhis. Role of Vyanavata is most important in the movements of the joints.
The human skeleton is designed with a number of individual bones that are articulated at
joints to allow movements in different directions, angles and positions. Knee functions as
a hinge joint, but the articulation is far more complex than other hinge joints. Seven
major ligaments and flexor & extensor muscles support the movements of the knee joint.
The five lumbar vertebrae are the largest of the vertebrae and those are interconnected
and stabilized by the deep muscles of the spine. The synovial fluid in the synovial joint
serves as a lubricant, a shock absorber and a nutrient carrier.
Functions of the Sleshaka Kapha and Sleshmadhara kala described in
Ayurveda can be co-related to that of the synovial fluid that lubricates the knee joint and
the intervertebral disc that reduces the friction between the vertebrae. The marmas can be
considered as the various points of nervous, vascular and muscular system, which are
vital in the functioning of the joints. Functions of the peshis and snayus are exactly
identical to that of the muscles and ligaments related to the joints.
From the nidana point of view, Ayurveda had highlighted all the Vata
prakopakara nidanas in the generation of Sandhigatavata. Vardhakya avastha
characterized by dhatu kshaya leads to reduced sneha bhava in the body, which in turn,
vitiates the Vata dosha and reduces the Kapha, thereby resulting in karma hani of the
sandhis. Also, dhatusaithilya is another feature in vardhakya, which reflects in peshis and
snayus thereby reducing their functional efficiency in supporting the joints. This is a
major risk factor for Sandhigatavata. Age is the most powerful risk factor for
Osteoarthritis. More than 80% of the people over the age of 60 have radiological
evidence of Osteoarthritis in the joints.
Discussion 150
Various physical activities such as pradhavana, bharaharana and
abhighatas due to prapatana, marma abhighata, dukha shayya and dukha asana are
important nidanas for Sandhigatavata. Repetitive movements may lead to excessive strain
leading to erosion and joint damage. Trauma to the joint enhances the occurrence of
arthritis.
Sthoulya is another causative factor for Sandhigatavata. The meda avarana
of the Vata is the mechanism causing the inter-relationship between Sthoulya and
Vatavyadhis. Obese persons have a high risk of Osteoarthritis. The relative risk for
developing Osteoarthritis, in the population belonging to the highest quintile for body
mass index at the baseline examination is very high.
Another point noteworthy here is that Sandhigatavata being one among the
Gatavatas is caused due to the factors vitiating Vata alone, but the nidanas specific to the
localization of Vata in Sandhis also have some role in the production of the disease. The
dhatu kshaya samprapti characterized by the functional deterioration of the Vata dosha
can be co-related with the degenerative changes in the joints associated with ageing
which causes the cartilage degradation; whereas the marga avaranajanya samprapti
initiated by the nidana ghataka Sthoulya involving the avarana of Vata by Kapha and
medas can be co-related with the complications of obesity leading to excessive pressure
on the weight bearing joints.
The lakshanas of Sandhigatavata, viz., vedanayukta pravritti of sandhis,
shopha (vatapoorna dritisparshavat), atopa and sandhigati asaamarthya are explained by
various textbooks of Ayurveda. Modern science has listed the same features along with
other symptoms pertaining to individual joints. Also tenderness and joint stiffness
Discussion 151
(implied by the restriction of joint movements) find special mentioning in Modern
science. Acharyas of Ayurveda have not mentioned that particularly any one sandhi only
gets affected with Sandhigatavata. Modern science has mentioned that any joint can get
affected with Osteoarthritis. In this view, they have considered the condition of Lumbar
spondylosis also as the Osteoarthritis of the intervertebral joints.
Role of Snehana and Swedana in the management of Sandhigatavata
Snehana and Swedana are both described as Poorva karmas and also find
place among the Shad upakramas. The upakrama of Vata dosha emphasizes the necessity
of these two karmas in correcting the vitiated Vata dosha. Snehana corrects the shuska
dhatus that are the root cause for the Vata vitiation and imparts strength to the body and
agni. Swedana relieves all types of Vata symptoms such as toda, ruk, ayama, shotha,
stambha etc. and smoothens the body part. Repetitive uses of these two karmas are
essential for the total control of Vata and restoration of its normal functions.
Sandhigatavata is a disease of the madhyama rogamarga involving the
asthi sandhis of the body. Asthis are the ashraya of the Vata dosha and the vitiation of
Vata hampers the nourishment of asthis, thereby reflecting in Sandhis also. Such a mal-
nourishment involves the reduction of the Sleshaka Kapha and deterioration of the
Sleshmadharakala. Snehana provides the sneha bhava needed for the nourishment of
these. Also, this controls the vitiated Vata.
Swedana relieves the stambha and gourava related to the joints and related
structures involved in the joint movements. Stambha means stiffness. This attribute is a
resultant of excess seetha guna and also influence of factors such as samanavata,
Discussion 152
sleshakakapha, ama, mamsa, vasa & medas is contributory to the production of stambha.
Samanavata is rooksha gunapradhana and hence if vitiated does excessive shoshana of
shareera there by producing contractures and stiffness. Sleshakakapha is snigdha and
pichila and hence if decreased (kshaya) results in less lubrication of joints causing
stiffness. Swedakarma being snigdha and ushna corrects both these deranged dosha
ghatakas and relieves stiffness. Thus it is very clear that both these karmas are inevitable
in the management of Sandhigatavata.
Clinical Study
Patients of Sandhigatavata were selected the OPD & IPD of Shri D.G.M.
Ayurvedic Medical college by pre-set inclusion and exclusion criteria. Data of 30 patients
who had satisfied the diagnostic criteria, underwent the treatment and reported for the
follow-up are discussed here. The patients were randomly distributed into two groups and
the patients of group-A were administered Shashtikashalipindaswedakarma and the
patients of group-B were administered Abhyanga & Bashpaswedakarma.
Gandharvahastadi Kwatha was administered to the patients of both the groups just prior
to the karma on every day of Swedana. This was done so as to prevent the accumulation
of shareera kleda or abhishyanda which might be produced as a result of swedana.
Sahacharadi taila was used for Abhyanga in both the groups. Patients of both the groups
were advised to take hot water bath after the karma every day and also were advised the
same pathya acharana.
The laboratory investigations like ESR, TC, DC, Hb% and RBS were
performed to rule out the associated systemic diseases. The radiology of the affected joint
Discussion 153
was performed in each and every patient. After scrutinizing the whole literature of
Ayurveda and Modern Medicine, Ruk and Graha were fixed as the subjective parameters
for clinical assessment; Sparsha akshamatva, Sandhigati asaamarthya, Shopha and Atopa
were fixed as the objective parameters for clinical assessment. The subjective parameter
for functional assessment was the total score of the AIMS and the objective parameter for
the functional assessment was the walking time (to cover 21meters).
Most of the patients in this clinical study belonged to the age group 50-60
(70%) thereby supporting the association of vardhakya avastha and Sandhigatavata.
23.33% of the patients belonged to the age group 40-50 and 6.66% of the patients
belonged to the age group 30-40. 50% of the patients belonged to the active group of
occupational status and 26.66% of the patients belonged to the labour group. This
strengthens the viewpoint that this disease is triggered by excessive physical demand on
the joint. 53.33% of the patients were females and 46.66% of the patients were males
supporting the male to female incidence ratio of 1:1.
46.66% of the patients were of the middle class and 33.33% were of the
poor class and 20% were of the aristocrat and this observation is inconclusive to make
any comments. 70% of the patients were Hindus, 26.66% were Muslims and 3.33% were
Christians. This is reflective of the geographical dominance of the religion and do not
have any association with the disease. 53.33% of the patients were vegetarians and
46.66% were of the mixed diet and this is reflective of the diet habit prevalent in the
society. 46.66% of the patients were having tobacco chewing as a habit, 30% were
having alcohol intake as a habit and 10% had smoking habit; this has no association with
the disease state.
Discussion 154
43.33% of the patients were of the Vata-pitta prakriti, 26.66% of the
patients were of the Vata-kapha prakriti, 13.33% of the patients were of the Pitta-kapha
prakriti, 13.33% of the patients were of the Vata prakriti and 3.33% of the patients were
of the Kapha prakriti. 93.33% of the patients were of the rooksha satmya and 6.66% were
of the snigdha satmya, which is reflective of the nature of the diet. This also may have
contributed to the Vata kopa. 76.66% of the patients were having ati vyayama as a nidana
and 96.66% of the patients were having katurasa bhojana.
83.33% of the patients were having Sandhigatavata of the knee joint and
16.66% of the patients were having Sandhigatavata of the lumbar spine. Among the cases
of Sandhigatavata of the knee, 68% was unilateral involvement and 32% was bilateral
involvement. All the patients had the complaints Ruk, graha and Sandhigati asaamarthya,
while 76.66% had Sparsha akshamatva and Atopa, 90% reported with Prasaarna
aakunchanayoho savedana pravritti, 70% with Shopha and 13.33% with Vatapoorna
dritisparsha.
Response to the treatment
Group-A
1) Ruk: - 53.44% of the patients reported with grade 3 ruk and 46.66% reported
with grade 2 ruk. 57.14% of the grade 2 got good response and 42.85% got
moderate response. 37.5% of the grade 3 got good response and 62.5% got
moderate response. In the statistical analysis, the parameter showed high
significance (p-value<0.001) and corresponding t-value10.68.
2) Graha: - All the patients of group-A presented with Sandhigraha(100%). Among
them 46.66% got good response and 53.33% got moderate response. In the
statistical analysis Graha showed high significance (p-value<0.001) and
corresponding t-value 7.54.
Discussion 155
3) Sparsha akshamatva: - 20% of the patients reported with grade 0 tenderness
whereas 20% reported with grade 1 tenderness and 60% reported with grade 2
tenderness. 33.33% of grade 0 got good response and 66.66% of grade 0 got
moderate response. 66.66% of grade 1got good response and 33.33% got
moderate response. 44.44% of grade 2 got good response and 55.55% got
moderate response. In the statistical analysis the parameter showed high
significance (p-value<0.001) and corresponding t-value 6.511.
4) Sandhigati asaamarthya: - 66.66% of the patients reported with grade 1
Sandhigati asaamarthya and 33.33% of the patients reported with grade 2
Sandhigati asaamarthya. 40% of the patients with grade 1 got good response and
60% got moderate response. 60% of the patients with grade 2 got good response
and 40% got moderate response. In the statistical analysis the parameter showed
high significance (p-value<0.001) with corresponding t-value 8.588.
5) Shopha: - 33.33% of the patients reported with grade 0 Shopha, 46.66% with
grade 1, 13.33% with grade 2 and 6.66% with grade 3. 40% of the patients with
grade 0 got good response and 60% got moderate response. 42.85% of the
patients with grade 1 got good response and 57.14% got moderate response. 100%
of the patients with grade 2 got good response and 100% of the patients with
grade 3 got moderate response. In the statistical analysis the parameter Shopha
showed high significance (p-value<0.001) with corresponding t-value 4.58.
6) Atopa: - 26.66% of the patients reported with grade 0 atopa, 66.66% with grade 1
and 6.66% with grade 2. 50% of the patients with grade 0 showed good response
and 50% got moderate response. 50% of the patients with grade 1 showed good
Discussion 156
response and 50% showed moderate response. 100% of patients with grade 2
showed moderate response. In the statistical analysis the parameter showed high
significance (p-value<0.02) with corresponding t-value 3.503.
7) AIMS score: - The functional parameter AIMS score showed high significance
(p-value<0.001) with corresponding t-value 12.313.
8) Walking time: - The functional parameter walking time (to cover 21meters)
showed high significance (p-value<0.001) with corresponding t-value 6.511.
Group-B
1) Ruk: - 40% of the patients had grade 2 ruk and 60% had grade 3 ruk. 83.33% of
the patients with grade 2 ruk got moderate response and 16.66% got poor
response. All the patients of grade 3 got moderate response.
2) Graha: - All the patients had grade 1 graha. 93.33% of the patients got moderate
response and 6.66% got poor response. In the statistical analysis the parameter
showed high significance (p-value<0.001) with corresponding t-value 9.611.
3) Sparsha akshamatva: - 26.66% of the patients had grade 0 tenderness, 26.66%
had grade 1 and 46.66% had grade 2. 75% of the patients of the grade 0 got
moderate response and 25% got poor response. All the patients of grade 1 got
moderate response. In the statistical analysis the parameter showed high
significance (p-value<0.001) with corresponding t-value 4.58.
4) Sandhigati asaamarthya: - 46.66% of the patients gad grade 1 and 53.33% had
grade 2. All the patients with grade 1 got moderate response while 87.5% with
grade 2 got moderate response and 12.5% got poor response. In the statistical
analysis this parameter showed high significance (p-value<0.001) with
corresponding t-value 10.309.
Discussion 157
5) Shopha: - 26.66% had grade 0 shopha, 33.33% had grade 1 and 40% had grade 2.
75% of the patients with grade 0 got moderate response and 25% got poor
response. All the patients with grade 1 & 2 got moderate response. In the
statistical analysis this parameter showed high significance (p-value<0.01) with
corresponding t-value 4.188.
6) Atopa: - 20% of the patients had grade 0 atopa and 80% had grade 1. 66.66% of
the patients with grade 0 got moderate response and 33.33% got poor response.
All the patients with grade 1 got moderate response. In the statistical analysis, this
parameter showed high significance (p-value<0.01) with corresponding t-value
4.188.
7) AIMS score: - This functional parameter showed high significance (p-
value<0.001) with corresponding t-value 15.429.
8) Walking time: - This functional parameter showed high significance (p-
value<0.01) with corresponding t-value 3.053.
Intergroup comparison was done and the parameters Ruk and AIMS score
were highly significant in group-A (P-value<0.05 & p-value<0.001 respectively). The
AIMS score showed high significance than the Ruk and the AIMS score was more
uniform in the group-A than the group-B. Also in the group-A 46.66% of the patients had
good response and 53.33% had moderate response. But in the group-B no patients had
good response, 93.33% of the patients had moderate response and 6.66% had poor
response. Hence, it is clear that the Shashtikashalipindaswedakarma group responded
more in comparison with the Abhyanga & Bashpa sweda group.
Discussion 158
Observations on Swedana
In the present study, apart from the routine observations on the karma like
samyak swinna, ati swinna, mithya swinna etc. observations were made for knowing the
benefits imparted by the Swedakarma. For this, the Shaman sweda gunas explained by
Sushruta were selected as the parameters. Gradings were designed and observations
recorded before the treatment (Day 0), after the course of Swedana (Day 14) and after the
pariharakala (Day 28). The readings of Day 0 and Day 28 were subjected to statistical
analysis.
Both the karmas produced high significance in the parameter Agni deepti
(p-value<0.001 & p-value<0.001 respectively in group-A & group-B). The parameter
Bhakta shradha also showed high significance in both the groups (p-value<0.01 & p-
value<0.001 respectively in group-a & group-b). Both the karmas produced high
significance in the parameter Tandra haani also (p-value<0.001 & p-value<0.001
respectively in group-a & group-b). The parameters Sandhi cheshta, Sroto nirmalatva,
Mardava and Twak prasada also showed high significance in both the groups (p-
value<0.001).
Probable Mechanism of Action of Swedana
Mechanism of action of Swedana will be discussed under the following
headings: -
1) application of heat,
2) Physical effect of massage and
3) Therapeutic effects of medicaments used.
Discussion 159
1) Application of heat : - Application of heat on an unctuous area causes the generation
of a temperature gradient across the cell membrane. Besides facilitating the diffusion of
liquid substances through the cell membrane, this plays key role in the formation of
lipoid vesicles from the dropouts in the membrane in areas of flow temperature. This
causes an expansion in the cell volume as well as surface area. But it cannot expand
freely especially in the peripheral direction as it is bound by other cells around. This
makes the blebbing of cell membrane inside.
The temperature gradient caused by the heat further helps in blebbing in
this particular direction. These lipoid vesicles or blebs gets detached from the cell
organelle or other side of membrane and remain there till a critical surface is reached.
This membrane then blebs out and spread further, thus providing nourishment to the
tissues.
The chief beneficial effects of any kind of thermal therapy are due to the
increase in the circulation and local metabolic process with the relaxation of the
musculature. Application of heat causes relaxation of muscles and tendons, improves the
blood supply and activates the local metabolic processes which are responsible for the
relief of pain, swelling, tenderness and stiffness.
Routine application of heat preceding the application of massage renders
the applied area less painful than when the heat is not applied.
The medicaments used in the Pinda sweda seems to be calculated for
forming a suitable and effective medium for application of heat to the body in the process
of Pinda sweda. This may be the reason for the advantageous effect of
Shashtikashalipindaswedakarma over the Bashpaswedakarma where only the steam
vapours provide the heat.
Discussion 160
2) Physical effect of the massage: - It stimulates the sensory nerve endings thereby
producing relaxation. It produces a hyperaemic effect causing the arterioles to dilatate
and thereby achieving more circulation. Also, the venous and lymphatic return is assisted.
Massage causes movements of the muscles thereby accelerating the blood supply, which
in turn relieves the muscular fatigue. The application of massage may cause displacement
of the exudates and thus may relieve tension and pain. In Bashpasweda massage is
performed only as a part of the Abhyanga procedure. But in
Shashtikashalipindaswedakarma massage is performed during the pre-operative and post-
operative Abhyanga and also during the performance of Pindasweda. This may have
contributed to the advantageous effect of Shashtikashalipindaswedakarma.
3) Therapeutic effects of the medicaments used: - Drugs in oils and other lipid- soluble
carriers can penetrate the epidermis. The movement is slow, particularly through the
layers of cell membranes in the stratum corneum. But once the drug reaches the
underlying tissues it will be absorbed into the circulation. Placing a drug in a solvent that
is lipid soluble can assist its movement through the lipid barriers.
The constituent methionine in the Shashtikashali might be the responsible
active compound for the medicinal quality. Methionine is the only common amino acid
with either linkage and is an important donor of active methyl groups. Cow’s milk
contains fats; hence these may have got absorbed during the Shashtikashalipindasweda.
Bala contains an alkaloid ephedrine and this may also have contributed to the effect.
Nirgundi and Chincha, which are used for Bashpa sweda, may have contributed to the
effect of Bashpa sweda. Nirgundi is Kaphavata shamana, Ushna and has Shothahara
property. Chincha is Vata shamana and has Ushna guna.
Discussion 161
Oil in the form of Sahacharadi taila had been used in this study. This may
also have contributed to the effect. All the drugs of Sahacharadi taila are Vata shamana,
Snigdha and Ushna.Also, the medicinal effect of the Gandharvahastadi Kwatha, which
pacifies the Vata kopa, relieves the mala sanga and strengthens the agni has to be
considered.
Bhrajakapitta, one among the panchavidhapittas, is located in the twak. It
is this Bhrajakapitta that takes up and metabolizes the drugs applied in the form of
Abhyanga, Parisheka, Avagaha, Alepa etc. As a matter of fact, no one single mechanism
appears to be solely responsible for the therapeutic effects of Swedana.
Discussion on Shashtikashalipindasweda
Sandhigatavata is a Vatavyadhi affecting people in the vardhakya avastha.
The disease is characterized by dhatu kshaya and lakshanas reflective of vitiated Vata.
Therefore, the agents/therapies of brimhana-shoolahara-stambhahara-balya properties
should be used in this disease.
Shashtikashali is snigdha, Sthira, bala vardhana, tarunya sthapaka and
deha dardhyakrit. Bala that is used to cook the Shashtikashali and to heat the bolus is
snigdha, rasayana and vatahara. Go-ksheera that is also used to cook the Shashtikashali
and to heat the bolus is snigdha, rasayana and vatahara. These drugs are made use in the
Shashtikashalipindaswedakarma. The karma imparts Swedana and this opens up the
srotas the shareera facilitating more nourishment and free movement of Vata dosha. This
results in the relief of stambha and facilitates free movement of the sandhis. All the drugs
are having shoolahara properties and the Swedana by itself is shoolahara due to the
pacification of Vata. Thereby, it is an ideal treatment of choice in Sandhigatavata.
Discussion 162
Shashtikashalipindasweda is a modification of Sankara sweda and it
contributes the principles of Snehana and Swedana. All the ingredients of the pinda
sweda are of Snehana nature and Abhyanga also is performed as a part of this procedure.
The massage performed during the procedure is advantageous in relieving shoola and
stambha. Heat is maintained for more time period inside the pinda. Also the pindas are
heated often and hence there is no reduction in the amount of heat applied over the body.
Hence the advantages of the karma can be listed as, 1) temperature gradient produced is
higher which facilitates the absorption of the sneha amsha, 2) simultaneous massage
performed creates the pressure gradient necessary for the absorption of the sneha amsha
and 3) dravyas used are of snehana-brimhana qualities.
Discussion 163
Certain conclusions can be drawn on the basis of the present study.
Shashtikashalipindaswedakarma is a modification of the Sankara sweda (or sagni
upanaha) that comes under the Ushma type of Swedana.
Bashpa sweda is also belonging to the Ushma type of Swedana.
Sandhigatavata is a disease commonly associated with the vardhakya avastha and
dhatu kshaya is a prominent feature in its manifestation.
Shashtikashalipindaswedakarma was selected as the therapy in this study as the
treatment line of Sandhigatavata emphasizes Snehana and Swedana and this
particular karma is capable of exerting both these effects.
No complications (Sweda atiyoga, ayoga & mithya yoga) were observed in this
study.
Observance of Shamana swedagunas were performed in both the treatment groups
and all the benefits were found highly significant in both the groups.
Treatment response of all parameters was highly significant in both the groups,
but in intergroup comparison Ruk and AIMS score was found significant in
Shashtikashalipindasweda group than Bashpa sweda group.
At the same time overall treatment response was better in the
Shashtikashalipindasweda group as no patient in the Bashpa sweda group got
good response. This suggests that there was considerable improvement in both the
groups but Shashtikashalipindasweda group got more beneficial effects.
During the follow-up period (after the 28th day) the results attained seemed to
wear out in the Bashpa sweda group, but results lasted throughout thr follow-up
period in the Shashtikashalipindasweda group.
Conclusion 164
Both the Swedakarmas were found to impart the Shamana sweda gunas explained
by Sushruta.
SUGGESTIONS FOR FUTURE STUDIES
⇒ The study should be conducted in a large sample.
⇒ The study should be conducted for a longer duration so as to know the lasting of
the clinical effects.
⇒ The effects of Shashtikashalipindasweda and Bashpa sweda can be studied by
performing for 21days.
Conclusion 165
SUMMARY
The dissertation work entitled “evaluation of the efficacy of
Shashtikashalipindaswedakarma in the management of Sandhigatavata (Osteoarthritis)”
consists of seven parts. They are
1. Introduction
2. Objectives
3. Review of literature
4. Methodology
5. Results
6. Discussion
7. Conclusion.
The introduction highlights on Panchakarmas, Swedana, Pindasweda and
Sandhigatavata. The objectives part describes the need for the study, previous studies on
Shashtikashalipindasweda, title of the present study and the objectives of the present
study. Review of literature part covers the historical view on Swedana and
Sandhigatavata, Nirukti and Paribhasha of Shashtikashalipindasweda and Sandhigatavata,
Shareera of Twak and Sandhi, description of Swedakarma, Pindaswedas in particular and
description of Sandhigatavata. Methodology part contains review of the properties and
chemical composition of the drugs used, methodology of the clinical study, procedures of
Shashtikashalipindasweda and Bashpa sweda and the parameters for clinical & functional
assessment and the Swedakarmukatha parameters. The results part contain demographic
data, data related to the disease, data related to the overall response to the treatment,
statistical analysis of the clinical and functional parameters & Intergroup comparison and
statistical analysis of Swedakaarmukata. Discussion part consists of the headings
Sandhigatavata vis-à-vis Osteoarthritis, role of Snehana and Swedana in the management
of Sandhigatavata, clinical study, probable mechanism of action of Swedana and
discussion on Shashtikashalipindasweda. Conclusion part contains the conclusions of the
present study and suggestions for future study.
Summary 166
BIBLIOGRAPHY 1. Agnivesa, Charakasamhitha Suthrasthana chapter 14. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 87-92. (Kasi Sanskrit series 228). 2. Bhelacharya, Bhelasamhitha Suthrasthana chapter 23. Girijadayal Shukla editor. Varanasi: Chaukhambha Vidyabhavan; 1959. p. 38-40. 3. Vrudhajeevaka, Kashyapasamhita Suthrasthana chapter 23 sloka 20-21. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1988. p. 24-29. (Kasi Sanskrit series 154). 4. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 32. Varanasi: Krishnadas Academy; 1980. p. 513-515. (Krishnadas Ayurveda series 51). 5. Vaghbhata, Ashtangasangraha with Sashilekha teeka Suthrasthana chapter 26 Rudraparasava editor. Trichur: Mangalodayam publication; 1913.p. 192-199. 6. Vagbhata, Ashtangahridaya Suthrasthana chapter 17. Varanasi: Krishnadas Academy; 1982. p.253-259. (Krishnadas Academic series 4). 7. a. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 25-27. 4th ed.
Varanasi:Chaukhambha Sanskrit Sansthan; 1994. p. 89. (Kasi Sanskrit series 228).
b. Bhelacharya, Bhelasamhitha Chikitsasthana chapter 23. Girijadayal Shukla editor.
Varanasi: Chaukhambha Vidyabhavan; 1959. p. 38-40.
c. Vrudhajeevaka, Kashyapasamhita Suthrasthana chapter 23 sloka 20-21. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1988. p. 24-29. (Kasi Sanskrit series 154).
d. Dalhana, Nibandhasamgraha teeka on Sushruthasamhitha Chikitsasthana chapter
32 sloka 12. Varanasi: Krishnadas Academy; 1980. p. 513. (Krishnadas Ayurveda series 51).
e. Vaghbhata, Ashtangasangraha with Sashilekha teeka Suthrasthana chapter 26 sloka
5, Rudraparasava editor. Trichur: Mangalodayam publication; 1913.p. 193.
f. Vagbhata, Ashtangahridaya Suthrasthana chapter 17 sloka 6-7. Varanasi: Krishnadas Academy; 1982. p.254. (Krishnadas Academic series 4).
8. Sharma P V, Classical age of Indian literature. Varanasi: Chaukhambha Sanskrit Studies; 1972.p. 67. (Chaukhambha Sanskrit Series Volume LXXXV).
Bibliographic references
9. Sharangadhara, Sharngadharasamhitha Utharakhanda chapter 2. 3rd ed. Varanasi: Chaukhambha Orientalia; 1983. p. 294. (Jaikrishnadas Ayurveda Granthamala 53). 10. Chakrapanidatta, Chakradatta . P.V.Sharma, editor. Varanasi: Chaukhambha Publishers; 1998. p. 183-214. (Kasi Ayurveda series 17). 11. Bhavamishra, Bhavaprakasha Madhyamakhanda chapter 24. 5th ed.Varanasi: Chaukhambha Sanskrit series 130; 1988. p. 227. 12. Govindadasa, Bhaishajyaratnavali chapter 27. 7th ed. Kaviraj Ambikadatta Shastri editor. Varanasi: Chaukhambha Orientalia; 1983. p. 373-417. (Kasi Sanskrit series 152). 13. Yogaratnakara with Vidyotini Hindi commentary Vatavyadhichikitsa sloka 117, Brahmashankar sastry editor. Varanasi: Chaukhambha Sanskrit sansthan; 1988. p. 517.(Kasi Sanskrit series 160). 14. a. Agnivesa, Charakasamhitha Suthrasthana chapter 27 sloka 13. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 154. (Kasi Sanskrit series 228).
b. Sushrutha, Sushruthasamhitha Suthrasthana chapter 46 sloka 8-11. Varanasi: Krishnadas Academy; 1980. p. 215. (Krishnadas Ayurveda series 51).
c. Vagbhata, Ashtangahridaya Suthrasthana chapter 6 sloka 7-8. Varanasi: Krishnadas Academy; 1982. p.85. (Krishnadas Academic series 4).
15. Arunadatta, Arurvedarasayana teeka on Ashtangahridaya Suthrasthana chapter 6 sloka 7-8. Varanasi: Krishnadas Academy; 1982. p.85. (Krishnadas Academic series 4). 16. Chikitsamanjari(Malayalam) D..Sreeman Nambudiri editor. 3rd ed. Kollam,Kerala: Vidyarambham publishers; 1996. p.377. 17. Warrier Rama, Arogyakalpadruma chapter 17 sloka 35. Thrissur: Sulabha books; 2002. p. 279. 18. Mooss.N.S. Vayaskara, Ayurvedic Treatments of Kerala chapter 1. Kottayam: Vaidyasarathy Publications. 1946. p. 3-12. 19. Encyclopedia Brittanica (concised edition). Kottayam: DC Books; 2002. p. 89. 20. Leenakumari. S, Genetic Diversity, Characterization and Evaluation of Medicinal Rice in Kerala. Chennai: MS.Swaminathan Research Foundation. 2004. p. 7.
Bibliographic references
21. Shastri Ramgopal, Vedom mein Ayurved. Delhi: Madan Mohanlal Ayurveda Anusandhan Trust; 1956. p. 36. 22. Sharma PV, Ayurved ka Vaijnanik Ithihas. 2nd ed. Varanasi: Chaukhambha Orientalia; 1981. p. 13. 23. Shastri Ramgopal, Vedom mein Ayurved. Delhi: Madan Mohanlal Ayurveda Anusandhan Trust; 1956. p. 18. 24. Sharma P V, Classical age of Indian literature. Varanasi: Chaukhambha Sanskrit Studies; 1972.p. 47. (Chaukhambha Sanskrit Series Volume LXXXV). 25. Shastri Ramgopal, Vedom mein Ayurved. Delhi: Madan Mohanlal Ayurveda Anusandhan Trust; 1956. p. 69. 26. Shastri Ramgopal, Vedom mein Ayurved. Delhi: Madan Mohanlal Ayurveda Anusandhan Trust; 1956. p. 69. 27. a. Agnivesa, Charakasamhitha Chikitsasthana chapter 28 sloka 37. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 618 . (Kasi Sanskrit series 228).
b. Sushrutha, Sushruthasamhitha Nidanasthana chapter 1 sloka 28- Chikitsasthana chapter 4 sloka 8. Varanasi: Krishnadas Academy; 1980. p. 261,420. (Krishnadas Ayurveda series 51).
c. Vagbhata, Ashtangahridaya Nidanasthana chapter 15 sloka 14- Chikitsasthan chapter 21 sloka 22. Varanasi: Krishnadas Academy; 1982. p.531, 724. (Krishnadas Academic series 4).
d. Vaghbhata, Ashtangasangraha with Sashilekha teeka Nidanasthana chapter 15 sloka 15 – Chikitsa chapter 23 sloka 13. Rudraparasava editor. Trichur: Mangalodayam publication; 1913.p. 76, 292.
e. Madhavakara, Madhavanidana chapter 22 sloka 212. Varanasi: Chaukhambha Surbharathi Prakashan; 1998. p. 520. (Chaukhambha Ayurvijnana Granthamala 46).
f. Bhavamishra, Bhavaprakasha Madhyamakhanda chapter 24 sloka 258-259. 5th ed. Varanasi: Chaukhambha Orientalia; 1988. p. 264-265. (Chaukhambha Sanskrit series 130).
g. Govindadasa, Bhaishajyaratnavali chapter 26. 7th ed. Kaviraj Ambikadatta Shastri editor. Varanasi: Chaukhambha Orientalia; 1983. p. 373-417. (Kasi Sanskrit series 152).
Bibliographic references
h. Yogaratnakara Vatavyadhinidana – Vatavyadhichikitsa. Vaidya Lakshmipatisastry editor. Varanasi: Chaukhambha Sanskrit Sansthan; 1988. p. 520. (Kasi Sanskrit series 160).
28. Bhelacharya, Bhelasamhitha Chikitsasthana chapter 26. Girijadayal Shukla editor. Varanasi: Chaukhambha Vidyabhavan; 1959. p. 215-220. 29. Kelly William, Textbook of Rheumatology chapter 89. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1471. 30. Kelly William, Textbook of Rheumatology chapter 89. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1471. 31. Kelly William, Textbook of Rheumatology chapter 89. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1471. 32. Kelly William, Textbook of Rheumatology chapter 89. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1471. 33. Kelly William, Textbook of Rheumatology chapter 89. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1472. 34. Kelly William, Textbook of Rheumatology chapter 89. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1472. 35. Raja Radhakantha Deva Bahadur, Shabdakalpadruma vol 5, 3rd ed. Varanasi:Chaukambha Sanskrit Series; p. 191.(Chaukambha Samskrita Granthamala-93). 36. Raja Radhakantha Deva Bahadur, Shabdakalpadruma vol 5, 3rd ed. Varanasi:Chaukambha Sanskrit Series; p. 65.(Chaukambha Samskrita Granthamala-93). 37. Raja Radhakantha Deva Bahadur, Shabdakalpadruma vol 3, 3rd ed. Varanasi:Chaukambha Sanskrit Series; p. 139.(Chaukambha Samskrita Granthamala-93). 38. Raja Radhakantha Deva Bahadur, Shabdakalpadruma vol 5, 3rd ed. Varanasi:Chaukambha Sanskrit Series; p. 495.(Chaukambha Samskrita Granthamala-93). 39. Raja Radhakantha Deva Bahadur, Shabdakalpadruma vol 1, 3rd ed. Varanasi:Chaukambha Sanskrit Series; p. 45.(Chaukambha Samskrita Granthamala-93). 40. Raja Radhakantha Deva Bahadur, Shabdakalpadruma vol 5, 3rd ed. Varanasi:Chaukambha Sanskrit Series; p. 240.(Chaukambha Samskrita Granthamala-93). 41. Raja Radhakantha Deva Bahadur, Shabdakalpadruma vol 1, 3rd ed. Varanasi:Chaukambha Sanskrit Series; p. 298.(Chaukambha Samskrita Granthamala-93).
Bibliographic references
42. Raja Radhakantha Deva Bahadur, Shabdakalpadruma vol 5, 3rd ed. Varanasi:Chaukambha Sanskrit Series; p. 325.(Chaukambha Samskrita Granthamala-93). 43. Mish C Fredrick, Webster’s Ninth New Collegiate Dictionary. Philippines: Merriam- Webster; 1987. p. 835. 44. Agnivesa, Charakasamhitha Chikitsasthana chapter 15 sloka 17. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 514 . (Kasi Sanskrit series 228). 45. Rao Ramasundara M, Sarira rachana vijnana chapter 4. Vijayawada: Susruta opticals;2003.p. 565. 46. Sushrutha, Sushruthasamhitha Shareerasthana chapter 4 sloka 4. Varanasi: Krishnadas Academy; 1980. p. 355. (Krishnadas Ayurveda series 51). 47. Agnivesa, Charakasamhitha Shareerasthana chapter 7 sloka 4. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 337 . (Kasi Sanskrit series 228). 48. Sushrutha, Sushruthasamhitha Suthrasthana chapter 21 sloka 10. Varanasi: Krishnadas Academy; 1980. p. 101. (Krishnadas Ayurveda series 51). 49. Martini.F.H, Fundamentals of Anatomy and Physiology chapter 5. 4th ed. New Jersey: Prentice Hall Inc. Simon & Schuster; 1998. p. 148. 50. Martini.F.H, Fundamentals of Anatomy and Physiology chapter 5. 4th ed. New Jersey: Prentice Hall Inc. Simon & Schuster; 1998. p. 148-155. 51. Martini.F.H, Fundamentals of Anatomy and Physiology chapter 5. 4th ed. New Jersey: Prentice Hall Inc. Simon & Schuster; 1998. p. 160-161. 52. Swash Michael, Hutchinsons clinical methods appendix I. 21st ed. India: W B Saunders; 2002. p. 471. 53. Agnivesa, Charakasamhitha Chikitsasthana chapter 15 sloka 18. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 515 . (Kasi Sanskrit series 228). 54. Agnivesa, Charakasamhitha Shareerasthana chapter 7 sloka 15. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 339 . (Kasi Sanskrit series 228). 55. Agnivesa, Charakasamhitha Shareerasthana chapter 7 sloka 16. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 339 . (Kasi Sanskrit series 228).
Bibliographic references
56. Vaghbhata, Ashtangasangraha with Sashilekha teeka Suthrasthana chapter 20 sloka 3. Rudraparasava editor. Trichur: Mangalodayam publication; 1913. p. 147. 57. Sushrutha, Sushruthasamhitha Suthrasthana chapter 15 sloka 2. Varanasi: Krishnadas Academy; 1980. p. 68. (Krishnadas Ayurveda series 51). 58. Vagbhata, Ashtangahridaya Suthrasthana chapter 11 sloka 5. Varanasi: Krishnadas Academy; 1982. p.173. (Krishnadas Academic series 4). 59. Agnivesa, Charakasamhitha Vimanasthana chapter 5 sloka 8. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 251 . (Kasi Sanskrit series 228). 60. Agnivesa, Charakasamhitha Vimanasthana chapter 5 sloka 22. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 252 . (Kasi Sanskrit series 228). 61. Agnivesa, Charakasamhitha Vimanasthana chapter 5 sloka 8. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 251 . (Kasi Sanskrit series 228). 62. Sushrutha, Sushruthasamhitha Suthrasthana chapter 21 sloka 74. Varanasi: Krishnadas Academy; 1980. p. 102. (Krishnadas Ayurveda series 51). 63. Sushrutha, Sushruthasamhitha Nidanasthana chapter 1 sloka 17-18. Varanasi: Krishnadas Academy; 1980. p. 260. (Krishnadas Ayurveda series 51). 64. Sushrutha, Sushruthasamhitha Shareerasthana chapter 4 sloka 14-15. Varanasi: Krishnadas Academy; 1980. p. 356. (Krishnadas Ayurveda series 51). 65. Sushrutha, Sushruthasamhitha Shareerasthana chapter 5 sloka 24-25. Varanasi: Krishnadas Academy; 1980. p. 366. (Krishnadas Ayurveda series 51). 66. Sushrutha, Sushruthasamhitha Shareerasthana chapter 5 sloka 27. Varanasi: Krishnadas Academy; 1980. p. 367. (Krishnadas Ayurveda series 51). 67. Sushrutha, Sushruthasamhitha Shareerasthana chapter 5 sloka 6. Varanasi: Krishnadas Academy; 1980. p. 364. (Krishnadas Ayurveda series 51). 68. Rao Ramasundara M, Sarira rachana vijnana chapter 4. Vijayawada: Susruta opticals;2003.p. 273-275. 69. Martini.F.H, Fundamentals of Anatomy and Physiology chapter 9. 4th ed. New Jersey: Prentice Hall Inc. Simon & Schuster; 1998. p. 269,271.
Bibliographic references
70. Martini.F.H, Fundamentals of Anatomy and Physiology chapter 9. 4th ed. New Jersey: Prentice Hall Inc. Simon & Schuster; 1998. p. 218-222. 71. Sushrutha, Sushruthasamhitha Shareerasthana chapter 5 sloka 29-36. Varanasi: Krishnadas Academy; 1980. p. 367. (Krishnadas Ayurveda series 51). 72. Sushrutha, Sushruthasamhitha Shareerasthana chapter 5 sloka 37-38. Varanasi: Krishnadas Academy; 1980. p. 367-368. (Krishnadas Ayurveda series 51). 73. Sushrutha, Sushruthasamhitha Shareerasthana chapter 6 sloka 24, 26. Varanasi: Krishnadas Academy; 1980. p. 373, 374. (Krishnadas Ayurveda series 51). 74. Agnivesa, Charakasamhitha Suthrasthana chapter 22 sloka 11. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 120. (Kasi Sanskrit series 228). 75. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 8. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 88. (Kasi Sanskrit series 228). 76. Agnivesa, Charakasamhitha Suthrasthana chapter 22 sloka 11. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 120. (Kasi Sanskrit series 228). 77. Kasture VG, Ayurvediyapanchakarmavigyan chapter 3. 6th ed. Nagpur: Shree Baidyanath Ayurved Bhavan Ltd.; 1998. p. 159. 78. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 20-24. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 89. (Kasi Sanskrit series 228). 79. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 32 sloka 17-19. Varanasi: Krishnadas Academy; 1980. p. 514. (Krishnadas Ayurveda series 51). 80. Vagbhata, Ashtangahridaya Suthrasthana chapter 17 sloka 25-27. Varanasi: Krishnadas Academy; 1982. p.259. (Krishnadas Academic series 4). 81. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 32 sloka 17-19. Varanasi: Krishnadas Academy; 1980. p. 514. (Krishnadas Ayurveda series 51). 82. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 16-19. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 88. (Kasi Sanskrit series 228). 83. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 32 sloka 25. Varanasi: Krishnadas Academy; 1980. p. 515. (Krishnadas Ayurveda series 51). 84. Vagbhata, Ashtangahridaya Suthrasthana chapter 17 sloka 21-24. Varanasi: Krishnadas Academy; 1982. p.258. (Krishnadas Academic series 4).
Bibliographic references
85. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 32 sloka 25. Varanasi: Krishnadas Academy; 1980. p. 515. (Krishnadas Ayurveda series 51). 86. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 16-19. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 88. (Kasi Sanskrit series 228). 87. Vagbhata, Ashtangahridaya Suthrasthana chapter 17 sloka 21-24. Varanasi: Krishnadas Academy; 1982. p.258. (Krishnadas Academic series 4). 88. Vagbhata, Ashtangahridaya Suthrasthana chapter 17 sloka 21-24. Varanasi: Krishnadas Academy; 1982. p.258. (Krishnadas Academic series 4). 89. Arunadatta, Sarvangasundari teeka on Ashtangahridaya Suthrasthana chapter 17 sloka 15. Varanasi: Krishnadas Academy; 1982. p. 257. (Krishnadas Academic series 4). 90. Hemadri, Ayurvedarasayana teeka on Ashtangahridaya Suthrasthana chapter 17 sloka 15.Varanasi: Krishnadas Academy; 1982. p. 257. (Krishnadas Academic series 4). 91. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 13. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 88. (Kasi Sanskrit series 228). 92. Dalhana, Nibandhasangraha teeka on Sushruthasamhitha Chikitsasthana chapter 32 sloka 22-24. Varanasi: Krishnadas Academy; 1980. p. 514. (Krishnadas Ayurveda series 51). 93. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 14-15. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 88. (Kasi Sanskrit series 228). 94. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 32 sloka 24. Varanasi: Krishnadas Academy; 1980. p. 514. (Krishnadas Ayurveda series 51). 95. Vagbhata, Ashtangahridaya Suthrasthana chapter 17 sloka 16-17. Varanasi: Krishnadas Academy; 1982. p.258. (Krishnadas Academic series 4). 96. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 15. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 88. (Kasi Sanskrit series 228). 97. Agnivesa, Charakasamhitha Suthrasthana chapter 6 sloka 27-32. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 47. (Kasi Sanskrit series 228). 98. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 32 sloka 24. Varanasi: Krishnadas Academy; 1980. p. 514. (Krishnadas Ayurveda series 51). 99. Vagbhata, Ashtangahridaya Suthrasthana chapter 17 sloka 18. Varanasi: Krishnadas Academy; 1982. p.258. (Krishnadas Academic series 4).
Bibliographic references
100. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 65. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 92. (Kasi Sanskrit series 228). 101. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 66. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 92. (Kasi Sanskrit series 228). 102. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 66. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 92. (Kasi Sanskrit series 228). 103. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 7-8. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 88. (Kasi Sanskrit series 228). 104. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 32 sloka 1. Varanasi: Krishnadas Academy; 1980. p. 513. (Krishnadas Ayurveda series 51). 105. Vagbhata, Ashtangahridaya Suthrasthana chapter 17 sloka 1. Varanasi: Krishnadas Academy; 1982. p.255. (Krishnadas Academic series 4). 106. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 39-40. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 90. (Kasi Sanskrit series 228). 107. Dalhana, Nibandhasangraha teeka on Sushruthasamhitha Chikitsasthana chapter 32 sloka 22. Varanasi: Krishnadas Academy; 1980. p. 514. (Krishnadas Ayurveda series 51). 108. Kasture VG, Ayurvediyapanchakarmavigyan chapter 3. 6th ed. Nagpur: Shree Baidyanath Ayurved Bhavan Ltd.; 1998. p. 164. 109. Vrudhajeevaka, Kashyapasamhita Suthrasthana chapter 23 sloka 26. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1988. p. 277. (Kasi Sanskrit series 154). 110. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 64. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 92. (Kasi Sanskrit series 228). 111. Dalhana, Nibandhasangraha teeka on Sushruthasamhitha Chikitsasthana chapter 32 sloka 3. Varanasi: Krishnadas Academy; 1980. p. 513. (Krishnadas Ayurveda series 51). 112. Dalhana, Nibandhasangraha teeka on Sushruthasamhitha Chikitsasthana chapter 32 sloka 3. Varanasi: Krishnadas Academy; 1980. p. 513. (Krishnadas Ayurveda series 51). 113. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 32 sloka 14. Varanasi: Krishnadas Academy; 1980. p. 514. (Krishnadas Ayurveda series 51).
Bibliographic references
114. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 32 sloka 5-7. Varanasi: Krishnadas Academy; 1980. p. 513. (Krishnadas Ayurveda series 51). 115. Agnivesa, Charakasamhitha Suthrasthana chapter 14 sloka 25-27. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 89. (Kasi Sanskrit series 228). 116. Chakrapani, Ayurvedadeepika teeka on Charakasamhitha Suthrasthana chapter 14 sloka 64. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 92. (Kasi Sanskrit series 228). 117. Dalhana, Nibandhasangraha teeka on Sushruthasamhitha Chikitsasthana chapter 32 sloka 3. Varanasi: Krishnadas Academy; 1980. p. 513. (Krishnadas Ayurveda series 51). 118. Mooss.N.S. Vayaskara, Ayurvedic Treatments of Kerala chapter 1. Kottayam: Vaidyasarathy Publications. 1946. p. 3-12. 119. Keraleeya Chikitsakrama (Malayalam) Chapter 2. Trivandrum: Vasudevavalasam Publications; 1982. p. 5. 120. Keraleeya Chikitsakrama (Malayalam) Chapter 2. Trivandrum: Vasudevavalasam Publications; 1982. p. 6. 121. Keraleeya Chikitsakrama (Malayalam) Chapter 2. Trivandrum: Vasudevavalasam Publications; 1982. p. 6. 122. Keraleeya Chikitsakrama (Malayalam) Chapter 2. Trivandrum: Vasudevavalasam Publications; 1982. p. 6. 123. Keraleeya Chikitsakrama (Malayalam) Chapter 2. Trivandrum: Vasudevavalasam Publications; 1982. p. 7. 124. Keraleeya Chikitsakrama (Malayalam) Chapter 2. Trivandrum: Vasudevavalasam Publications; 1982. p. 8. 125. Keraleeya Chikitsakrama (Malayalam) Chapter 2. Trivandrum: Vasudevavalasam Publications; 1982. p. 9. 126. Keraleeya Chikitsakrama (Malayalam) Chapter 2. Trivandrum: Vasudevavalasam Publications; 1982. p. 9. 127. Keraleeya Chikitsakrama (Malayalam) Chapter 2. Trivandrum: Vasudevavalasam Publications; 1982. p. 10.
Bibliographic references
128. Namboodiri VMC, Notes on Panchakarma. Mezhathur: Vaidyamadham Vaidyasala; 1960. p. 41. 129. Keraleeya Chikitsakrama (Malayalam) Chapter 2. Trivandrum: Vasudevavalasam Publications; 1982. p. 7. 130. Agnivesa, Charakasamhitha Chikitsasthana chapter 28 sloka 37. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 618. (Kasi Sanskrit series 228). 131.Agnivesa, Charakasamhitha Chikitsasthana chapter 28 sloka 37. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 618. (Kasi Sanskrit series 228). 132. Kelly William, Textbook of Rheumatology chapter 89. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1471 133. Agnivesa, Charakasamhitha Chikitsasthana chapter 28 sloka 15-18. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 617. (Kasi Sanskrit series 228). 134. Sushrutha, Sushruthasamhitha Suthrasthana chapter 21 sloka 19. Varanasi: Krishnadas Academy; 1980. p. 103. (Krishnadas Ayurveda series 51). 135. Vagbhata, Ashtangahridaya Nidanasthana chapter 1 sloka 14-15. Varanasi: Krishnadas Academy; 1982. p.444. (Krishnadas Academic series 4). 136. Bhavamishra, Bhavaprakasha Madhyamakhanda chapter 24. 5th ed. Varanasi: Chaukhambha Orientalia; 1988. p. 241-243. (Chaukhambha Sanskrit series 130). 137. Sushrutha, Sushruthasamhitha Suthrasthana chapter 15 sloka 32. Varanasi: Krishnadas Academy; 1980. p. 73. (Krishnadas Ayurveda series 51). 138. Vagbhata, Ashtangahridaya Suthrasthana chapter 1 sloka 8. Varanasi: Krishnadas Academy; 1982. p.7. (Krishnadas Academic series 4). 139. Vagbhata, Ashtangahridaya Suthrasthana chapter 1 sloka 23. Varanasi: Krishnadas Academy; 1982. p.15. (Krishnadas Academic series 4). 140. Vagbhata, Ashtangahridaya Suthrasthana chapter 1 sloka 8. Varanasi: Krishnadas Academy; 1982. p.7. (Krishnadas Academic series 4). 141. Vagbhata, Ashtangahridaya Suthrasthana chapter 1 sloka 15. Varanasi: Krishnadas Academy; 1982. p.11. (Krishnadas Academic series 4).
Bibliographic references
142. Agnivesa, Charakasamhitha Vimanasthana chapter 5 sloka 17. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 251. (Kasi Sanskrit series 228). 143. Harrisons principles of internal medicine vol 2 Petersdorf R G editor. 10th ed. India: Mcgrawhill; 1987. 144. Kelly William, Textbook of Rheumatology chapter 89. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1472. 145. Vagbhata, Ashtangahridaya Nidanasthana chapter 1 sloka 3. Varanasi: Krishnadas Academy; 1982. p.441. (Krishnadas Academic series 4). 146. Vijayarakshitha, Madhukosha commentary on Madhavanidana chapter 1 sloka 6. Varanasi: Chaukhambha Surbharathi Prakashan; 1998. p. 33. (Chaukhambha Ayurvijnana Granthamala 46). 147. Agnivesa, Charakasamhitha Chikitsasthana chapter 28 sloka 19. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 617. (Kasi Sanskrit series 228). 148. Agnivesa, Charakasamhitha Chikitsasthana chapter 18 sloka 19. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 617. (Kasi Sanskrit series 228). 149. Vagbhata, Ashtangahridaya Nidanasthana chapter 15 sloka 6. Varanasi: Krishnadas Academy; 1982. p. 531. (Krishnadas Academic series 4). 150. Agnivesa, Charakasamhitha Chikitsasthana chapter 28 sloka 24-37. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 617-618. (Kasi Sanskrit series 228). 151. Singh Gurdip Prof, Avrithavata and its importance in clinical practice- Souvenir on National Seminar on Vatavyadhis: 2001. p. 15. 152. Sushrutha, Sushruthasamhitha Suthrasthana chapter 15 sloka 32. Varanasi: Krishnadas Academy; 1980. p. 73. (Krishnadas Ayurveda series 51). 153. Dalhana, Nibandhasangraha teeka on Sushruthasamhitha Suthrasthana chapter 15 sloka 32. Varanasi: Krishnadas Academy; 1980. p. 74. (Krishnadas Ayurveda series 51). 154. Cotran SR, Pathologic Basis of Disease chapter 28. 6th ed. Philadelphia: Saunders; 2003. p. 1246. 155. Agnivesa, Charakasamhitha Chikitsasthana chapter 28 sloka 37. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 618. (Kasi Sanskrit series 228).
Bibliographic references
156. Agnivesa, Charakasamhitha Chikitsasthana chapter 28 sloka 37. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 618. (Kasi Sanskrit series 228). 157. Sushrutha, Sushruthasamhitha Nidanasthana chapter 1 sloka 28. Varanasi: Krishnadas Academy; 1980. p. 261. (Krishnadas Ayurveda series 51). 158. Sushrutha, Sushruthasamhitha Nidanasthana chapter 1 sloka 28. Varanasi: Krishnadas Academy; 1980. p. 261. (Krishnadas Ayurveda series 51). 159. Madhavakara, Madhavanidana chapter 22 sloka 21. Varanasi: Chaukhambha Surbharathi Prakashan; 1998. p. 521. (Chaukhambha Ayurvijnana Granthamala 46). 160. Kelly William, Textbook of Rheumatology chapter 89. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1479. 161. Kelly William, Textbook of Rheumatology chapter 89. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1479. 162. Kelly William, Textbook of Rheumatology chapter 89. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1479-1480. 163. Agnivesa, Charakasamhitha Chikitsasthana chapter 21 sloka 40. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 461. (Kasi Sanskrit series 228). 164. Madhavakara, Madhavanidana chapter 1 sloka 8. Varanasi: Chaukhambha Surbharathi Prakashan; 1998. p. 45. (Chaukhambha Ayurvijnana Granthamala 46). 165. Agnivesa, Charakasamhitha Indriyasthana chapter 9 sloka 8. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 368. (Kasi Sanskrit series 228). 166. Chakrapani, Ayurvedadipika teeka on Charakasamhitha Chikitsasthana chapter 28 sloka 12-14. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 620. (Kasi Sanskrit series 228). 167. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 4 sloka 8. Varanasi: Krishnadas Academy; 1980. p. 420. (Krishnadas Ayurveda series 51). 168. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 4 sloka 8. Varanasi: Krishnadas Academy; 1980. p. 420. (Krishnadas Ayurveda series 51). 169. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 4 sloka 8. Varanasi: Krishnadas Academy; 1980. p. 420. (Krishnadas Ayurveda series 51). 170. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 4 sloka 8. Varanasi: Krishnadas Academy; 1980. p. 420. (Krishnadas Ayurveda series 51).
Bibliographic references
171. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 4 sloka 8. Varanasi: Krishnadas Academy; 1980. p. 420. (Krishnadas Ayurveda series 51). 172. Vagbhata, Ashtangahridaya Suthrasthana chapter 1 sloka 25. Varanasi: Krishnadas Academy; 1982. p. 16. (Krishnadas Academic series 4). 173. Govindadasa, Bhaishajyaratnavali Vatavyadhi prakarana sloka 442-446. 7th ed. Kaviraj Ambikadatta Shastri editor. Varanasi: Chaukhambha Orientalia; 1983. p. 130. (Kasi Sanskrit series 152). 174. Govindadasa, Bhaishajyaratnavali Vatavyadhi prakarana sloka 447-449. 7th ed. Kaviraj Ambikadatta Shastri editor. Varanasi: Chaukhambha Orientalia; 1983. p. 130. (Kasi Sanskrit series 152). 175. Manek J Nisha, Lane E Nancy, Osteoarthritis:- Current concepts in diagnosis and management. American academy of family physicians 2000. Available from: www.aafp.org. Accessed on 15th March 2003. 176. Kelly William, Textbook of Rheumatology chapter 90. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1497. 177. Nadkarni KM Dr, Indian Materia Medica vol 1. 3rd ed. Bombay: Popular prakashan; 1976. p. 878. 178. Vagbhata, Ashtangahridaya Suthrasthana chapter 6 sloka 7. Varanasi: Krishnadas Academy; 1982. p. 85. (Krishnadas Academic series 4). 179. Sushrutha, Sushruthasamhitha Suthrasthana chapter 46 sloka 8-11. Varanasi: Krishnadas Academy; 1980. p. 215. (Krishnadas Ayurveda series 51). 180. Dalhana, Nibandhasangraha teeka on Sushruthasamhitha Suthrasthana chapter 46 sloka 8-11. Varanasi: Krishnadas Academy; 1980. p. 215. (Krishnadas Ayurveda series 51). 181. Anilkumar. N, Role of Njavara rice in Traditional Healing and Health care system in Kerala. Chennai: MS Swaminathan Foundation; 2004. p. 3. 182. Anilkumar. N, Role of Njavara rice in Traditional Healing and Health care system in Kerala. Chennai: MS Swaminathan Foundation; 2004. p. 8. 183. Nadkarni KM Dr, Indian Materia Medica vol 1. 3rd ed. Bombay: Popular prakashan; 1976. p. 878. 184. Gogte.V.M, Ayurvedic Pharmacology and Therapeutic uses of Medicinal plants. Mumbai: Bharatheeya Vidyabhavan; 2000. p. 434. 185. Jensen.R.G, Handbook of milk composition. New York: Academic press; 1995. Available from: www.dairyhealth.com. Accessed on 4th November 2004.
Bibliographic references
186. Nadkarni KM Dr, Indian Materia Medica vol 1. 3rd ed. Bombay: Popular prakashan; 1976. p. 1278-1280. 187. Nair.P.R, Management of Khanja and Pangu with Panchakarma. New Delhi: CCRAS; 1999. p. 113. 188. Nadkarni KM Dr, Indian Materia Medica vol 1. 3rd ed. Bombay: Popular prakashan; 1976. p. 1191, 1192. 189. Sahasrayoga Kwatha Prakarana Vatarogahara, Dr. Ramnivas Sharma and Dr. Surendra Sharma, editors. 2nd ed. Hyderabad: Dakshin prakasan; 1990. 190. Gogte.V.M, Ayurvedic Pharmacology and Therapeutic uses of Medicinal plants. Mumbai: Bharatheeya Vidyabhavan; 2000. p. 321-322. 191. Sharma. PV, Dravyagunavigyan vol 2. 5th ed.Varanasi: Chaukhambha Bharathi Academy;1981. p. 717. (Varanasi Ayurveda series). 192. Gogte.V.M, Ayurvedic Pharmacology and Therapeutic uses of Medicinal plants. Mumbai: Bharatheeya Vidyabhavan; 2000. p. 370, 371. 193. Gogte.V.M, Ayurvedic Pharmacology and Therapeutic uses of Medicinal plants. Mumbai: Bharatheeya Vidyabhavan; 2000. p. 313, 314. 194. Sharma. PV, Dravyagunavigyan vol 2. 5th ed.Varanasi: Chaukhambha Bharathi Academy;1981. p. 754. (Varanasi Ayurveda series). 195. Sharma. PV, Dravyagunavigyan vol 2. 5th ed.Varanasi: Chaukhambha Bharathi Academy;1981. p. 630. (Varanasi Ayurveda series). 196. Sharma. PV, Dravyagunavigyan vol 2. 5th ed.Varanasi: Chaukhambha Bharathi Academy;1981. p. 316. (Varanasi Ayurveda series). 197. Sharma. PV, Dravyagunavigyan vol 2. 5th ed.Varanasi: Chaukhambha Bharathi Academy;1981. p. 555. (Varanasi Ayurveda series). 198. Sahasrayoga Kwatha Prakarana Vatarogahara, Dr. Ramnivas Sharma and Dr. Surendra Sharma, editors. 2nd ed. Hyderabad: Dakshin prakasan; 1990. 199. Vagbhata, Ashtangahridaya Chikitsasthana chapter 21 sloka 67-69. Varanasi: Krishnadas Academy; 1982. p. 727. (Krishnadas Academic series 4). 200. Gogte.V.M, Ayurvedic Pharmacology and Therapeutic uses of Medicinal plants. Mumbai: Bharatheeya Vidyabhavan; 2000. p. 748. 201. Gogte.V.M, Ayurvedic Pharmacology and Therapeutic uses of Medicinal plants. Mumbai: Bharatheeya Vidyabhavan; 2000. p. 397-398.
Bibliographic references
202. Gogte.V.M, Ayurvedic Pharmacology and Therapeutic uses of Medicinal plants. Mumbai: Bharatheeya Vidyabhavan; 2000. p. 313-314. 203. Das Somen, A manual on Clinical Surgery chapter 15. 4th ed. Calcutta: Dr.S.Das; 1996. p. 188-192. 204. Das Somen, A manual on Clinical Surgery chapter 18. 4th ed. Calcutta: Dr.S.Das; 1996. p. 219-226. 205a. Mooss.N.S. Vayaskara, Ayurvedic Treatments of Kerala chapter 1. Kottayam: Vaidyasarathy Publications. 1946. p. 3-12. 205b. Mooss.N.S. Vayaskara, Ayurvedic Treatments of Kerala chapter 1. Kottayam: Vaidyasarathy Publications. 1946. p. 3-12. 205c. Mooss.N.S. Vayaskara, Ayurvedic Treatments of Kerala chapter 1. Kottayam: Vaidyasarathy Publications. 1946. p. 3-12. 206. AIMS Score- Arthritis section.2002. Available from: www.arthritis-research.org/aims. Accessed on December 2002. 207. Nair.P.R, Management of Khanja and Pangu with Panchakarma. New Delhi: CCRAS; 1999. p. 40.
Bibliographic references
SPECIAL CASE SHEET FOR SANDHIGATAVATA Post Graduate Research And Studies Center (Panchakarma)
Shree DGM Ayurvedic Medical College, Gadag.
Guide : Dr. G.Purushothamacharyulu, PG Scholar : Subin.V.R. MD (Ayu).
Co-Guide: Dr. Shashidhar.H. Doddamani, MD (Ayu). 1. Name of the patient : Sl. No : 2. Father’s / Husband’s Name : OPD No : 3. Age : IPD No : 4. Sex : Bed No : 5. Religion : 6. Occupation : 7. Economical Status : 8. Address :_____________________________ Phone No : ____________________________ Email ID : _____________________________ 9. Type of treatment : Group A Group B
10.Date of Schedule Initiation :
M F
Poor Middle Aristocrat
Hindu Muslim Christian Others
Sedentary Active Labor Others
Date of Schedule Completion : 11. Result:
Good Response
Moderate Response
Poor Response
No Response
12. Consent: I here by agree that, I have been fully educated with the disease and
treatment, here by satisfied whole heartedly, and accept the medical trial over
me.
Investigator’s Signature Patient’s Signature
1
I. COMPLAINTS WITH DURATION :
Sl.
No
Chief complaints Before
Treatment
Duration After
Treatment
After
Follow-
up
1 Sandhisothaha (Swelling)
2 Prasaarana Aakunchanayoho
Savedana Pravruthihi (Pain
on extension & flexion)
3 Sandhigraha (Joint Stiffness)
- Morning stiffness
(15-30 ms)
- Stiffness after disuse
4 Sandhigathi asaamarthya
(Limitation of joint
movement)
5
6
Sparsha akshamatva
(Tenderness)
Atopa (Crepitation)
II. HISTORY OF PRESENT ILLNESS :
Mode of onset
Chronic Insidious Acute Traumatic
Nature of pain
Pricking Aching Generalized Tearing Burning
Variation of pain
Increased on use Increased on disuse Nocturnal
Routine activities affected
Yes No
2
III. HISTORY OF PAST ILLNESS :
Episodes of same illness Yes/No
Obesity Yes/No
Trauma/Fracture of involved or related joint Yes/No
Diabetes Mellitus Yes/No
Hypertension Yes/No
Other Vatavyadhees Yes/No
Vataraktha Yes/No
Acromegaly Yes/No
Septic arthritis Yes/No
Psoriatic arthritis Yes/No
Rheumatoid arthritis Yes/No
Fever Yes/No
Others Yes/No
IV. TREATMENT HISTORY :
Modern Medicine
Ayurveda Medicine/Therapy
Other Systems
Relief with previous treatment Partial / No relief
V. FAMILY HISTORY RELEVANT :
If Yes, specify the relation No
3
VI. PERSONAL HISTORY :
> Ahaara
Veg Mixed
> Agni
Manda Teekshna Vishama Sama
> Koshta
Madhya Mrudu Kroora
> Nidra
Sukha Alpa Ati Vishama
> Vyasana
Smoking Tobacco Alcohol Others None
> Aarthavapravruthi
Alpa Ati Vishama Rajonivruthi
> Malapravruthi (Frequency)
> Muthrapravruthi(Frequency)
Day Night
VII A. VITAL EXAMINATION
Weight in kgs Height in cms Temperature in
degree Celsius
Pulse rate per
Minute
Heart rate per
Minute
Blood pressure in
mm Hg
Respiration per
Minute
4
B. ASHTASTHAANAPAREEKSHA
1. Nadee :
Dosha
Gati
Poornata
Spandana
Kathinya
2. Muthra :
3. Mala :
4. Jihwa :
5. Sabda :
6. Sparsha :
7. Druk :
8. Aakruthi :
VIII. DASAVIDHAPAREEKSHA
A. PRAKRUTHI
V P K VP VK PK SANNIPATHA
B. VIKRUTHI
Hethu AL M A Prakruthi Aasukaari Chirakaari
Dosha AL M A Desa AL M A
Dushya Al M A Kaala AL M A
Bala AL M A Linga AL M A
( AL- Alpa, M- Madhyama, A- Adhika)
5
C. SAARA
Pravara Madhyama Avara
D. SAMHANANA
Susamhatha Madhyasamhatha Asamhatha
E. PRAMAANA
Sama Heena Adhika
F. SAATMYA
Ekarasa Sarvarasa Vyamishra
Rookshasaatmya Snigdhasaatmya
G. SATVA
Pravara Madhya Avara
H. AAHAARASAKTHI
Abhyavahaara Pravara Madhyama Avara
Jaranasakthi Pravara Madhyama Avara
I. VYAAYAAMASAKTHI
Pravara Madhyama Avara
J. VAYAHA
Baala Madhya Vrudha
IX. SROTOPAREEKSHA
Srotas Observed Lakshana
Pranavaha
Annavaha
Udakavaha
Rasavaha
Rakthavaha
Mamsavaha
Medovaha
6
Asthivaha
Majjavaha
Sukravaha
Pureeshavaha
Muthravaha
Swedovaha
Aarthavavaha
X. SPECIAL EXAMINATION OF JOINTS
A. Darshana (Inspection)
1. Joint Swelling
Grading 0 1 2 3
Varna a v h Raag Shyaa a Prakrut a
Herbeden’s N odes Present Absent
2.a. Deformity
Present Absent
b. Joint Instability
Present Absent
3. Gait
Nature
Walking Time (Grade)
4. Joint Movement
Active Completely Restricted Partially Restricted Free
Passive Completely Restricted Partially Restricted Free
5. Muscular spasm
Present Absent
7
6. Muscular Wasting
Above the affected joint Yes No
Below the affected joint Yes No
B. Sparshana (Palpitation)
1. Vaatapoornadruthisparsha
Yes No
2. Local Temperature
Raised Not raised
3. Tenderness
Grading 0 1 2 3
4. Limitation of Joint Movement (In Terms Of Grading)
Axial Joints Cervical Lumbar Spine
Distal Joints
Knee Right Left
Hip Right Left
Ankle Right Left
First Carpometametacarpal Right Left
Distal Interphalangeal Right Left
Proximal Interphalangel Right Left
C. Shravana (Auscultation)
Crepitus Heard Felt None
8
X1. NIDAANAPAREEKSHA
1. Nidaanapareeksha
a. Aahaara
Tiktharasa Athyupayoga Kashayarasa Athyupayoga Katurasa Athyupayoga
Alpa Bhojana Pramitha Bhojana Rooksha Bhojana
b. Vihaara
Vega Dhaarana Vegoodeerana Ativyavaya
Nisaajaagarana Atyucha Bhaashana Ativyaayama
c. Maanasika
Atibhaya Atishoka Atichintha
d. Occupational
e. Chikitsa Aparaadhaja
Shodhanakarma Atiyogaja Yes No
2. Poorvarupa :
3. Upashaya/Anupashaya :
Ushna Seetha
Rooksha Snigdha
4. Rupa :
5. Samprapthi :
XII. SAADHYAASAADHYATA:
9
XIII. LAB INVESTIGATIONS :
Sl.No Name of the Test Values
1. ESR /1st Hr.
2. Hb% Gm%
3. Total Count
WBC Per cm
RBC Per cm
4. Differential Count
N E B M L
5.
Blood Glucose Mg/dl
6.
RA Factor +ve -ve
7. Serum Alkaline Phosphatase : unit/L.
XIV. RADIOLOGICAL EXAMINATION OF JOINTS
( Antero posterior and Lateral View)
1 Joint space Reduced Increased Unaltered
2 Subchondral bony sclerosis Present Absent
3 Formation of osteophytes Present Absent
4 Periarticular ossicles Present Absent
5 Altered shape of bone end Present Absent
10
XV. SWEDAKARMA DAINAMDINA NIREEKSHANA
(SHASHTIKASHALIPINDASWEDA / ABHYANGA & BASHPASWEDA)
DAY TIME DURATION LAKSHANAS
OBSERVED
ANY
UPADRAVAS
UPACHARAS
ADVISED
11
XVI. ASSESSMENT OF RESULTS
A. CLINICAL PARAMETERS
Subjective
Parameters Day 0 Day 14 Day 28
Ruk (Pain)
Graha (Stiffness)
Objective
Parameters Day 0 Day14 Day 28
Sparsha Akshamatva (Tenderness)
Sandhigati Atisaamarthya (Range of Joint Movement)
Sotha (Swelling)
B. SWEDAKAARMUKATA PARAMETERS
Subjective
Parameters Day 0 Day 14 Day 28
Agnideepthi
Bhakthasradha
Tandraahaani
Sandhicheshta
Srotonirmalatva
Objective
Parameters Day 0 Day 14 Day 28
Maardava
Tvak Prasada
12
C. FUNCTIONAL PARAMETERS
Subjective
(Based on Arthritis Impact Measurement Scale)
Parameters Before treatment After Treatment After Follow-up
Mobility Level
Walking & Bending
Hand & Finger Function
Arm Function
Self care tasks (Exercise & Wt.
Bearing)
Household tasks
Social activity
Support from family & friends
Arthritis Pain
Work
Level of tension
Mood
Objective
Parameters Before Treatment After Treatment After Follow-up
Walking Time
XV11. INVESTIGATORS NOTE :
Signature of Co-Guide Signature of Guide
13